{"id": "mX8RcWMAAAAJ", "citedby": 164477, "citedby5y": 74780, "hindex": 132, "hindex5y": 88, "i10index": 631, "i10index5y": 412, "coauthors": [], "name": "George Bakris", "affiliation": "Professor The University of Chicago Medicine", "interests": ["Hypertension", "Diabetic Nephropathy", "renal and cardiovascular outcomes"], "cites_per_year": {"1997": 422, "1998": 536, "1999": 613, "2000": 767, "2001": 989, "2002": 1294, "2003": 1830, "2004": 2890, "2005": 3670, "2006": 4174, "2007": 5229, "2008": 5924, "2009": 6961, "2010": 7403, "2011": 8200, "2012": 8824, "2013": 10957, "2014": 13223, "2015": 14009, "2016": 13262, "2017": 12556, "2018": 13876, "2019": 14897, "2020": 5787}, "publications": [{"bib": {"title": "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:u-x6o8ySG0sC", "citedby": "42720"}, {"bib": {"title": "Executive summary: heart disease and stroke statistics\u20142013 update: a report from the American Heart Association", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H3xT48m3F74C", "citedby": "20242"}, {"bib": {"title": "Heart disease and stroke statistics-2017 update: a report from the American Heart Association.", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vxVQT5kDUaMC", "citedby": "7890"}, {"bib": {"title": "Heart disease and stroke statistics: 2006 update", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UBnQDr5gPskC", "citedby": "3127"}, {"bib": {"title": "Task force on hypertension in pregnancy", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:URGbnSt0D2cC", "citedby": "3116"}, {"bib": {"title": "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8k81kl-MbHgC", "citedby": "2629"}, {"bib": {"title": "Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9yKSN-GCB0IC", "citedby": "2579"}, {"bib": {"title": "Alogliptin after acute coronary syndrome in patients with type 2 diabetes", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yNlG6JgpFqoC", "citedby": "2276"}, {"bib": {"title": "American heart association statistics committee and stroke statistics subcommittee", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q-jS9JxWzv0C", "citedby": "2165"}, {"bib": {"title": "Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6nNZn6i0kyMC", "citedby": "1981"}, {"bib": {"title": "Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2osOgNQ5qMEC", "citedby": "1946"}, {"bib": {"title": "A controlled trial of renal denervation for resistant hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mnAcAzq93VMC", "citedby": "1821"}, {"bib": {"title": "Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AOwgc6nnr1EC", "citedby": "1748"}, {"bib": {"title": "A calcium antagonist vs a non\u2013calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril Study \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qjMakFHDy7sC", "citedby": "1708"}, {"bib": {"title": "Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IjCSPb-OGe4C", "citedby": "1673"}, {"bib": {"title": "Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QYmifXMdJWgC", "citedby": "1628"}, {"bib": {"title": "Preserving renal function in adults with hypertension and diabetes: a consensus approach", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:d1gkVwhDpl0C", "citedby": "1605"}, {"bib": {"title": "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zYLM7Y9cAGgC", "citedby": "1481"}, {"bib": {"title": "Aliskiren combined with losartan in type 2 diabetes and nephropathy", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_WP0DvM6eX8C", "citedby": "1424"}, {"bib": {"title": "ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aFwNBOTKqaYC", "citedby": "1159"}, {"bib": {"title": "Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Tyk-4Ss8FVUC", "citedby": "1049"}, {"bib": {"title": "Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:W7OEmFMy1HYC", "citedby": "983"}, {"bib": {"title": "Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M05iB0D1s5AC", "citedby": "917"}, {"bib": {"title": "K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LiF7i2gyBHwC", "citedby": "902"}, {"bib": {"title": "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jvrRlaHg2sAC", "citedby": "884"}, {"bib": {"title": "Angiotensin-converting enzyme inhibitor\u2013associated elevations in serum creatinine: is this a cause for concern?", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Y0pCki6q_DkC", "citedby": "871"}, {"bib": {"title": "Diabetic kidney disease: a report from an ADA Consensus Conference", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KYgttONoxcsC", "citedby": "829"}, {"bib": {"title": "Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UebtZRa9Y70C", "citedby": "723"}, {"bib": {"title": "Canagliflozin and renal outcomes in type 2 diabetes and nephropathy", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1tvASLRm6poC", "citedby": "689"}, {"bib": {"title": "Intensive blood-pressure control in hypertensive chronic kidney disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3fE2CSJIrl8C", "citedby": "688"}, {"bib": {"title": "The pathogenesis of diabetic nephropathy", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9ZlFYXVOiuMC", "citedby": "658"}, {"bib": {"title": "Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eLRq4zTgah0C", "citedby": "615"}, {"bib": {"title": "Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YFjsv_pBGBYC", "citedby": "590"}, {"bib": {"title": "Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ddB7do2jUx8C", "citedby": "587"}, {"bib": {"title": "Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7PzlFSSx8tAC", "citedby": "543"}, {"bib": {"title": "Thiazide diuretics, potassium, and the development of diabetes: a quantitative review", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5nxA0vEk-isC", "citedby": "513"}, {"bib": {"title": "Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ufrVoPGSRksC", "citedby": "508"}, {"bib": {"title": "Combination therapy in hypertension", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hFOr9nPyWt4C", "citedby": "507"}, {"bib": {"title": "Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eQOLeE2rZwMC", "citedby": "505"}, {"bib": {"title": "Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_FxGoFyzp5QC", "citedby": "490"}, {"bib": {"title": "Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zGdJYJv2LkUC", "citedby": "488"}, {"bib": {"title": "Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YsMSGLbcyi4C", "citedby": "484"}, {"bib": {"title": "Resistant hypertension: an overview of evaluation and treatment", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Zph67rFs4hoC", "citedby": "477"}, {"bib": {"title": "Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Se3iqnhoufwC", "citedby": "455"}, {"bib": {"title": "The National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xyvS_IvSCKsC", "citedby": "439"}, {"bib": {"title": "\u03b2-Lactam monotherapy vs \u03b2-lactam\u2013macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JVJ6OkSwpHsC", "citedby": "422"}, {"bib": {"title": "Predictors of blood pressure response in the SYMPLICITY HTN-3 trial", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:S0RksyIsHSIC", "citedby": "421"}, {"bib": {"title": "Writing Group Members; American Heart Association Statistics Committee; Stroke Statistics Subcommittee", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rblf-tZpB2YC", "citedby": "415"}, {"bib": {"title": "Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SeFeTyx0c_EC", "citedby": "405"}, {"bib": {"title": "Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rAN7mHg6NlYC", "citedby": "397"}, {"bib": {"title": "Catheter\u2010based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN\u20103 Trial", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VL0QpB8kHFEC", "citedby": "393"}, {"bib": {"title": "Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hqOjcs7Dif8C", "citedby": "393"}, {"bib": {"title": "Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:roLk4NBRz8UC", "citedby": "374"}, {"bib": {"title": "Rosiglitazone reduces urinary albumin excretion in type II diabetes", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LkGwnXOMwfcC", "citedby": "340"}, {"bib": {"title": "Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:O3NaXMp0MMsC", "citedby": "329"}, {"bib": {"title": "Renal sodium\u2013glucose transport: role in diabetes mellitus and potential clinical implications", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:g5m5HwL7SMYC", "citedby": "328"}, {"bib": {"title": "Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_kc_bZDykSQC", "citedby": "314"}, {"bib": {"title": "The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qxL8FJ1GzNcC", "citedby": "314"}, {"bib": {"title": "A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:L8Ckcad2t8MC", "citedby": "304"}, {"bib": {"title": "The effect of ruboxistaurin on nephropathy in type 2 diabetes", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4TOpqqG69KYC", "citedby": "299"}, {"bib": {"title": "Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sNmaIFBj_lkC", "citedby": "287"}, {"bib": {"title": "Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MXK_kJrjxJIC", "citedby": "287"}, {"bib": {"title": "Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP)", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aqlVkmm33-oC", "citedby": "286"}, {"bib": {"title": "ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ULOm3_A8WrAC", "citedby": "273"}, {"bib": {"title": "Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HDshCWvjkbEC", "citedby": "269"}, {"bib": {"title": "Hypertension awareness, treatment, and control in chronic kidney disease", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bEWYMUwI8FkC", "citedby": "267"}, {"bib": {"title": "Renal handling of albumin: a critical review of basic concepts and perspective", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kNdYIx-mwKoC", "citedby": "266"}, {"bib": {"title": "Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:C2yK8tfAHAgC", "citedby": "251"}, {"bib": {"title": "Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:m03se8k-GH0C", "citedby": "243"}, {"bib": {"title": "Differential effects of calcium antagonist subclasses on markers of nephropathy progression", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IWHjjKOFINEC", "citedby": "241"}, {"bib": {"title": "Protection of the kidney by thiazolidinediones: an assessment from bench to bedside", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mVmsd5A6BfQC", "citedby": "236"}, {"bib": {"title": "National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Preserving renal function in adults with hypertension and diabetes: a consensus approach", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KlAtU1dfN6UC", "citedby": "235"}, {"bib": {"title": "Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP)", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:B3FOqHPlNUQC", "citedby": "234"}, {"bib": {"title": "Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:maZDTaKrznsC", "citedby": "234"}, {"bib": {"title": "Differentiation of diabetes by pathophysiology, natural history, and prognosis", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TPlbvKeUp3cC", "citedby": "233"}, {"bib": {"title": "Diabetes and hypertension: a position statement by the American Diabetes Association", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gUOu-QWEMMQC", "citedby": "232"}, {"bib": {"title": "Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RYcK_YlVTxYC", "citedby": "229"}, {"bib": {"title": "Cardiovascular events during differing hypertension therapies in patients with diabetes", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yD5IFk8b50cC", "citedby": "227"}, {"bib": {"title": "Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lonyfjS0l_UC", "citedby": "220"}, {"bib": {"title": "Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1sJd4Hv_s6UC", "citedby": "219"}, {"bib": {"title": "Antihypertensive therapy in the presence of proteinuria", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:R3hNpaxXUhUC", "citedby": "216"}, {"bib": {"title": "A role for calcium in radiocontrast-induced reductions in renal hemodynamics", "year": "1985"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4DMP91E08xMC", "citedby": "214"}, {"bib": {"title": "Advanced glycation end-product cross-link breakers: a novel approach to cardiovascular pathologies related to the aging process", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-f6ydRqryjwC", "citedby": "213"}, {"bib": {"title": "Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M3ejUd6NZC8C", "citedby": "211"}, {"bib": {"title": "The message for World Kidney Day 2009: hypertension and kidney disease\u2014a marriage that should be prevented", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:70eg2SAEIzsC", "citedby": "208"}, {"bib": {"title": "Newer approaches to antihypertensive therapy: use of fixed-dose combination therapy", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dhFuZR0502QC", "citedby": "204"}, {"bib": {"title": "Noninvasive evaluation of left ventricular performance based on peak aortic blood acceleration measured with a continuous-wave Doppler velocity meter.", "year": "1986"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AbS6eEh_b9AC", "citedby": "199"}, {"bib": {"title": "Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized \u2026", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZeXyd9-uunAC", "citedby": "196"}, {"bib": {"title": "Role for intrarenal adenosine in the renal hemodynamic response to contrast media", "year": "1987"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QIV2ME_5wuYC", "citedby": "194"}, {"bib": {"title": "Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DOLguN9Lh8sC", "citedby": "187"}, {"bib": {"title": "Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RHpTSmoSYBkC", "citedby": "187"}, {"bib": {"title": "Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vV6vV6tmYwMC", "citedby": "186"}, {"bib": {"title": "International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cTy_cm4PQvYC", "citedby": "183"}, {"bib": {"title": "American Heart Association Statistics C, Stroke Statistics S: Heart disease and stroke statistics--2015 update: a report from the American Heart Association", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PBZ9sWDp-nEC", "citedby": "182"}, {"bib": {"title": "Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ldfaerwXgEUC", "citedby": "182"}, {"bib": {"title": "Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mB3voiENLucC", "citedby": "182"}, {"bib": {"title": "Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tzM49s52ZIMC", "citedby": "180"}, {"bib": {"title": "Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KxtntwgDAa4C", "citedby": "177"}, {"bib": {"title": "Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dfsIfKJdRG4C", "citedby": "173"}, {"bib": {"title": "Comparative effects of different antihypertensive treatments on progression of diabetic renal disease", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qUcmZB5y_30C", "citedby": "173"}, {"bib": {"title": "Beta blockers in the management of chronic kidney disease", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RGFaLdJalmkC", "citedby": "171"}, {"bib": {"title": "Effect of calcium channel or \u03b2-blockade on the progression of diabetic nephropathy in African Americans", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hC7cP41nSMkC", "citedby": "169"}, {"bib": {"title": "Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dT4-KZ621vcC", "citedby": "168"}, {"bib": {"title": "Blood pressure effects of sodium\u2013glucose co-transport 2 (SGLT2) inhibitors", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kiex5tMzGo8C", "citedby": "165"}, {"bib": {"title": "Resistant hypertension\u2014its identification and epidemiology", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rTD5ala9j4wC", "citedby": "165"}, {"bib": {"title": "Antihypertensive therapy and the risk of type 2 diabetes mellitus", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TQgYirikUcIC", "citedby": "163"}, {"bib": {"title": "Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OcBU2YAGkTUC", "citedby": "162"}, {"bib": {"title": "Heart failure as a cause for hospitalization in chronic dialysis patients", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GnPB-g6toBAC", "citedby": "162"}, {"bib": {"title": "Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4JMBOYKVnBMC", "citedby": "161"}, {"bib": {"title": "Predictors of hyperkalemia risk following hypertension control with aldosterone blockade", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q3oQSFYPqjQC", "citedby": "158"}, {"bib": {"title": "Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cnT3a81PI4sC", "citedby": "157"}, {"bib": {"title": "Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eflP2zaiRacC", "citedby": "156"}, {"bib": {"title": "Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hcF2OqvMasEC", "citedby": "155"}, {"bib": {"title": "Alcohol and hypertension", "year": "1977"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:W91e3rS6dHEC", "citedby": "155"}, {"bib": {"title": "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:u_mOZUIutIEC", "citedby": "154"}, {"bib": {"title": "Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:raTqNPD5sRQC", "citedby": "154"}, {"bib": {"title": "The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kRWSkSYxWN8C", "citedby": "154"}, {"bib": {"title": "Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor \u2026", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JhbybO29vGQC", "citedby": "153"}, {"bib": {"title": "EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i2xiXl-TujoC", "citedby": "153"}, {"bib": {"title": "Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M3NEmzRMIkIC", "citedby": "153"}, {"bib": {"title": "Exceptional early blood pressure control rates: the ACCOMPLISH trial", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Wp0gIr-vW9MC", "citedby": "152"}, {"bib": {"title": "Implications of a health lifestyle and medication analysis for improving hypertension control", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j3f4tGmQtD8C", "citedby": "149"}, {"bib": {"title": "Effects of different calcium antagonists on proteinuria associated with diabetes mellitus", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:e5wmG9Sq2KIC", "citedby": "148"}, {"bib": {"title": "Standards of medical care in diabetes", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Zo6E4E6iJKMC", "citedby": "145"}, {"bib": {"title": "African American Study of Kidney Disease, Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney \u2026", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WF5omc3nYNoC", "citedby": "145"}, {"bib": {"title": "Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:l7t_Zn2s7bgC", "citedby": "143"}, {"bib": {"title": "Microalbuminuria as a risk predictor in diabetes: the continuing saga", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pYRxIbzCxX0C", "citedby": "142"}, {"bib": {"title": "Differential effects of \u03b2-blockers on albuminuria in patients with type 2 diabetes", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BqipwSGYUEgC", "citedby": "140"}, {"bib": {"title": "Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_Qo2XoVZTnwC", "citedby": "140"}, {"bib": {"title": "Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZfRJV9d4-WMC", "citedby": "138"}, {"bib": {"title": "Long-term effects of renin-angiotensin system\u2013blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in african americans", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4OULZ7Gr8RgC", "citedby": "138"}, {"bib": {"title": "National Heart", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eKGuBlYFiu8C", "citedby": "138"}, {"bib": {"title": "Combination therapy in hypertension", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:evX43VCCuoAC", "citedby": "129"}, {"bib": {"title": "Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rmuvC79q63oC", "citedby": "128"}, {"bib": {"title": "Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ubry08Y2EpUC", "citedby": "127"}, {"bib": {"title": "Class differences in the effects of calcium channel blockers in the rat remnant kidney model", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TFP_iSt0sucC", "citedby": "127"}, {"bib": {"title": "Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ye4kPcJQO24C", "citedby": "126"}, {"bib": {"title": "Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:iH-uZ7U-co4C", "citedby": "125"}, {"bib": {"title": "\u03b2-blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zA6iFVUQeVQC", "citedby": "124"}, {"bib": {"title": "Microalbuminuria: what is it? Why is it important? What should be done about it?", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JV2RwH3_ST0C", "citedby": "124"}, {"bib": {"title": "Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:isC4tDSrTZIC", "citedby": "124"}, {"bib": {"title": "The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristics", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PXxrOWvQdDgC", "citedby": "123"}, {"bib": {"title": "ASH position paper: treatment of hypertension in patients with diabetes\u2014an update", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LPZeul_q3PIC", "citedby": "123"}, {"bib": {"title": "Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lSLTfruPkqcC", "citedby": "122"}, {"bib": {"title": "The importance of blood pressure control in the patient with diabetes", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hMod-77fHWUC", "citedby": "121"}, {"bib": {"title": "Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NaGl4SEjCO4C", "citedby": "121"}, {"bib": {"title": "Insulin and endothelin: an interplay contributing to hypertension development?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cFHS6HbyZ2cC", "citedby": "119"}, {"bib": {"title": "Guidelines for the diagnosis and management of patients with thoracic aortic disease: A report of the american college of cardiology foundation/american heart association task \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NWFKKQzSIN4C", "citedby": "118"}, {"bib": {"title": "State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_xSYboBqXhAC", "citedby": "118"}, {"bib": {"title": "Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NMxIlDl6LWMC", "citedby": "118"}, {"bib": {"title": "Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fPk4N6BV_jEC", "citedby": "118"}, {"bib": {"title": "Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP)", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5qfkUJPXOUwC", "citedby": "117"}, {"bib": {"title": "Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo\u2010controlled studies", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3s1wT3WcHBgC", "citedby": "116"}, {"bib": {"title": "Jones DW, Materson BJ, Oparil S, Wright JT Jr. Roccella EJ", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:n84Jz4DGfQYC", "citedby": "115"}, {"bib": {"title": "INVEST investigatorsA calcium antagonist vs a noncalcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hL6j_VNiN9gC", "citedby": "114"}, {"bib": {"title": "A practical approach to achieving recommended blood pressure goals in diabetic patients", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ns9cj8rnVeAC", "citedby": "114"}, {"bib": {"title": "Comparison of the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study equations: risk factors for and complications of CKD and \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bnK-pcrLprsC", "citedby": "112"}, {"bib": {"title": "Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP)", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9vf0nzSNQJEC", "citedby": "112"}, {"bib": {"title": "Low birth weight is associated with chronic kidney disease only in men", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:08ZZubdj9fEC", "citedby": "112"}, {"bib": {"title": "The efficacy and safety of low\u2010and high\u2010dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the \u2026", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pqnbT2bcN3wC", "citedby": "112"}, {"bib": {"title": "Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FKYJxdYMdFIC", "citedby": "110"}, {"bib": {"title": "and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP)", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QXXbHxWZe5oC", "citedby": "110"}, {"bib": {"title": "Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6ScxedgR18sC", "citedby": "109"}, {"bib": {"title": "Maximizing cardiorenal benefit in the management of hypertension: achieve blood pressure goals.", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:35N4QoGY0k4C", "citedby": "109"}, {"bib": {"title": "Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:N5tVd3kTz84C", "citedby": "108"}, {"bib": {"title": "Pheochromocytoma in pregnancy: a case series and review", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NJ774b8OgUMC", "citedby": "108"}, {"bib": {"title": "Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY \u2026", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QlnOKEPDpKwC", "citedby": "107"}, {"bib": {"title": "Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:P5F9QuxV20EC", "citedby": "107"}, {"bib": {"title": "Slowing nephropathy progression: focus on proteinuria reduction", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wbdj-CoPYUoC", "citedby": "107"}, {"bib": {"title": "An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eJXPG6dFmWUC", "citedby": "107"}, {"bib": {"title": "Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:blknAaTinKkC", "citedby": "107"}, {"bib": {"title": "12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kxd3qP2_5uAC", "citedby": "105"}, {"bib": {"title": "Body weight changes with \u03b2-blocker use: results from GEMINI", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Tiz5es2fbqcC", "citedby": "105"}, {"bib": {"title": "Archaeology and the Media", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H30kdXGRGPkC", "citedby": "105"}, {"bib": {"title": "Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vbGhcppDl1QC", "citedby": "104"}, {"bib": {"title": "Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive \u2026", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:u_35RYKgDlwC", "citedby": "104"}, {"bib": {"title": "Effects of drospirenone/17-\u03b2 estradiol on blood pressure and potassium balance in hypertensive postmenopausal women", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:D03iK_w7-QYC", "citedby": "104"}, {"bib": {"title": "Pathogenesis and clinical physiology of hypertension", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZuybSZzF8UAC", "citedby": "103"}, {"bib": {"title": "Diabetes mellitus and CKD awareness: the kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES)", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vRqMK49ujn8C", "citedby": "103"}, {"bib": {"title": "Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0kLwNjf3oFwC", "citedby": "102"}, {"bib": {"title": "Epidemiology of hypertensive kidney disease", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q3CdL3IzO_QC", "citedby": "102"}, {"bib": {"title": "Role of vasopressin in essential hypertension: racial differences", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:f2IySw72cVMC", "citedby": "102"}, {"bib": {"title": "Arginine vasopressin stimulates human mesangial cell production of endothelin.", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Rj7SuZOA3CsC", "citedby": "102"}, {"bib": {"title": "Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5o6HiIVP414C", "citedby": "100"}, {"bib": {"title": "Prevalence and associations of anemia of CKD: Kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999-2004", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hkOj_22Ku90C", "citedby": "100"}, {"bib": {"title": "Cardiometabolic syndrome and chronic kidney disease: what is the link?", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Mojj43d5GZwC", "citedby": "99"}, {"bib": {"title": "Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pyW8ca7W8N0C", "citedby": "99"}, {"bib": {"title": "Microalbuminuria: prognostic implications.", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZHo1McVdvXMC", "citedby": "99"}, {"bib": {"title": "Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: outcomes from TECOS", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9AucIJLffosC", "citedby": "98"}, {"bib": {"title": "Angiotensin receptor blockers: therapeutic targets and cardiovascular protection", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J_g5lzvAfSwC", "citedby": "98"}, {"bib": {"title": "Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed\u2010dose combination approaches", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SP6oXDckpogC", "citedby": "98"}, {"bib": {"title": "Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:a0OBvERweLwC", "citedby": "97"}, {"bib": {"title": "Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xtRiw3GOFMkC", "citedby": "97"}, {"bib": {"title": "Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jL-93Qbq4QoC", "citedby": "96"}, {"bib": {"title": "Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double\u2010blind, placebo\u2010controlled dose\u2010ranging study", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CHSYGLWDkRkC", "citedby": "96"}, {"bib": {"title": "The double challenge of resistant hypertension and chronic kidney disease", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Fx13dKtzC7kC", "citedby": "94"}, {"bib": {"title": "Renal function and target organ damage in hypertension", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VaXvl8Fpj5cC", "citedby": "93"}, {"bib": {"title": "Calcium antagonists: effects on cardio-renal risk in hypertensive patients", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:abG-DnoFyZgC", "citedby": "93"}, {"bib": {"title": "Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HoB7MX3m0LUC", "citedby": "93"}, {"bib": {"title": "The past, present and future of renin\u2013angiotensin aldosterone system inhibition", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RtRctb2lSbAC", "citedby": "92"}, {"bib": {"title": "Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PYBJJbyH-FwC", "citedby": "92"}, {"bib": {"title": "The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:adFjLtLvNj0C", "citedby": "92"}, {"bib": {"title": "Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mvPsJ3kp5DgC", "citedby": "91"}, {"bib": {"title": "Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UPMPWMAU16oC", "citedby": "90"}, {"bib": {"title": "Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:a3BOlSfXSfwC", "citedby": "90"}, {"bib": {"title": "The rationale and design of the AASK cohort study", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4fKUyHm3Qg0C", "citedby": "90"}, {"bib": {"title": "Chronic kidney disease as a coronary artery disease risk equivalent", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xa5BkEQK8BgC", "citedby": "89"}, {"bib": {"title": "Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function: data from the CANVAS Program", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0t1ZDozeHsAC", "citedby": "88"}, {"bib": {"title": "Preservation of renal function: the spectrum of effects by calcium-channel blockers.", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rO6llkc54NcC", "citedby": "88"}, {"bib": {"title": "Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LoiWQfKZB3kC", "citedby": "87"}, {"bib": {"title": "Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WbkHhVStYXYC", "citedby": "87"}, {"bib": {"title": "Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nb7KW1ujOQ8C", "citedby": "86"}, {"bib": {"title": "Association of NEDD4L ubiquitin ligase with essential hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dshw04ExmUIC", "citedby": "85"}, {"bib": {"title": "Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yY8dUDjMDt8C", "citedby": "84"}, {"bib": {"title": "GEMINI Investigators. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9jvjDF91bz4C", "citedby": "84"}, {"bib": {"title": "Vitamin D Life", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H6myOybQgeYC", "citedby": "83"}, {"bib": {"title": "The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression \u2026", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cNepPnSnVCgC", "citedby": "82"}, {"bib": {"title": "Prediction and management of hyperkalemia across the spectrum of chronic kidney disease", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wH03y5nBhxsC", "citedby": "81"}, {"bib": {"title": "Guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fLJJVVwU7EQC", "citedby": "81"}, {"bib": {"title": "Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TIZ-Mc8IlK0C", "citedby": "81"}, {"bib": {"title": "Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:olpn-zPbct0C", "citedby": "81"}, {"bib": {"title": "Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:b0M2c_1WBrUC", "citedby": "81"}, {"bib": {"title": "Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EUQCXRtRnyEC", "citedby": "80"}, {"bib": {"title": "Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti\u2010inflammatory agents: a review of its clinical spectrum and effects of steroid therapy", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5qu0sgD3nvwC", "citedby": "80"}, {"bib": {"title": "Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yaBp1wUtcLsC", "citedby": "79"}, {"bib": {"title": "Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:prdVHNxh-e8C", "citedby": "79"}, {"bib": {"title": "The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OU6Ihb5iCvQC", "citedby": "78"}, {"bib": {"title": "Microalbuminuria", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1qzjygNMrQYC", "citedby": "78"}, {"bib": {"title": "Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR \u2026", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XiSMed-E-HIC", "citedby": "77"}, {"bib": {"title": "Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1lhNe0rCu4AC", "citedby": "75"}, {"bib": {"title": "Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fQNAKQ3IYiAC", "citedby": "74"}, {"bib": {"title": "The implications of blood pressure measurement methods on treatment targets for blood pressure", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FGHlONkF9GcC", "citedby": "73"}, {"bib": {"title": "ACCOMPLISH Trial investigators: Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2P1L_qKh6hAC", "citedby": "73"}, {"bib": {"title": "Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LjlpjdlvIbIC", "citedby": "73"}, {"bib": {"title": "Blood pressure reduction: an added benefit of sodium\u2013glucose cotransporter 2 inhibitors in patients with type 2 diabetes", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ec1XJgWlWRUC", "citedby": "71"}, {"bib": {"title": "Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7T2F9Uy0os0C", "citedby": "71"}, {"bib": {"title": "National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:COU-sansr_wC", "citedby": "71"}, {"bib": {"title": "American Diabetes Association: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and \u2026", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:k_IJM867U9cC", "citedby": "70"}, {"bib": {"title": "Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ?", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bFI3QPDXJZMC", "citedby": "69"}, {"bib": {"title": "Prehypertension: is it relevant for nephrologists?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:v1_lew4L6wgC", "citedby": "67"}, {"bib": {"title": "Hypertension in patients with diabetes: overcoming barriers to effective control", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J-pR_7NvFogC", "citedby": "66"}, {"bib": {"title": "Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HAmI6pRF5skC", "citedby": "65"}, {"bib": {"title": "Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:p2g8aNsByqUC", "citedby": "65"}, {"bib": {"title": "Renin-angiotensin blockade and kidney disease", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BrmTIyaxlBUC", "citedby": "64"}, {"bib": {"title": "Antihypertensive therapy and the risk of new-onset diabetes", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:geHnlv5EZngC", "citedby": "64"}, {"bib": {"title": "Cardiovascular Toxicities Panel, Convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Drug Steering Committee. Initial assessment \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uimFh4UyggMC", "citedby": "63"}, {"bib": {"title": "National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:z_wVstp3MssC", "citedby": "62"}, {"bib": {"title": "Are chlorthalidone and hydrochlorothiazide equivalent blood\u2010pressure\u2010lowering medications?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9Nmd_mFXekcC", "citedby": "62"}, {"bib": {"title": "Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BzfGm06jWhQC", "citedby": "61"}, {"bib": {"title": "National Academy of Clinical Biochemistry; Evidence-Based Laboratory Medicine Committee of the American Association for Clinical Chemistry. Guidelines and recommendations for \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VofzgsFG4o0C", "citedby": "61"}, {"bib": {"title": "Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UxriW0iASnsC", "citedby": "61"}, {"bib": {"title": "Joint National Committee on Prevention DE, Treatment of High Blood Pressure. National Heart L, Blood I, National High Blood Pressure Education Program Coordinating C", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oXpGQvThPk8C", "citedby": "61"}, {"bib": {"title": "Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LWqeokA2EBkC", "citedby": "60"}, {"bib": {"title": "Limitations of metformin use in patients with kidney disease: are they warranted?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:foquWX3nUaYC", "citedby": "60"}, {"bib": {"title": "Effect of ruboxistaurin on urinary transforming growth factor-\u03b2 in patients with diabetic nephropathy and type 2 diabetes", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WqliGbK-hY8C", "citedby": "60"}, {"bib": {"title": "Angiotensin-converting enzyme inhibitors", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9LrdxYebArsC", "citedby": "60"}, {"bib": {"title": "ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8AbLer7MMksC", "citedby": "60"}, {"bib": {"title": "Introduction: standards of medical care in diabetes\u20142018", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_E0j-SBEHDwC", "citedby": "59"}, {"bib": {"title": "Systolic blood pressure and cardiovascular outcomes during treatment of hypertension", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3BvdIg-l-ZAC", "citedby": "59"}, {"bib": {"title": "Lessons learned from recent hypertension trials about kidney disease", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tOudhMTPpwUC", "citedby": "59"}, {"bib": {"title": "Hypertension-related disease in African Americans: factors underlying disparities in illness and its outcome", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5Ul4iDaHHb8C", "citedby": "59"}, {"bib": {"title": "Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sSrBHYA8nusC", "citedby": "59"}, {"bib": {"title": "Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events (BEACON)", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:X9ykpCP0fEIC", "citedby": "58"}, {"bib": {"title": "The kidney, hypertension, and remaining challenges", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EkHepimYqZsC", "citedby": "58"}, {"bib": {"title": "G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:umqufdRvDiIC", "citedby": "58"}, {"bib": {"title": "Effects of thiazolidinediones beyond glycaemic control", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dTyEYWd-f8wC", "citedby": "58"}, {"bib": {"title": "Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathy", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uWQEDVKXjbEC", "citedby": "58"}, {"bib": {"title": "Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: post-hoc analyses from bardoxolone methyl evaluation in \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:auQHJw8QJBgC", "citedby": "57"}, {"bib": {"title": "Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PWMd_Z0sy-4C", "citedby": "57"}, {"bib": {"title": "Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE trial", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:43LB_KcVqeAC", "citedby": "57"}, {"bib": {"title": "The role of calcium antagonists in chronic kidney disease", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:738O_yMBCRsC", "citedby": "57"}, {"bib": {"title": "Comparative effects of selective T-and L-type calcium channel blockers in the remnant kidney model", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tS2w5q8j5-wC", "citedby": "57"}, {"bib": {"title": "Hypertension in Diabetic Patients An Overview of Interventional Studies to Preserve Renal Function", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:K3LRdlH-MEoC", "citedby": "57"}, {"bib": {"title": "Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oMtqKo3K3HAC", "citedby": "56"}, {"bib": {"title": "Review of blood pressure control rates and outcomes", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0paDrhnEFY0C", "citedby": "56"}, {"bib": {"title": "Association of BP variability with mortality among African Americans with CKD", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NXYAu82O0W8C", "citedby": "56"}, {"bib": {"title": "Efficacy and duration of benazepril plus amlodipine or hydrochlorthiazide on 24-hour ambulatory systolic blood pressure control", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:38eRAUXPO10C", "citedby": "56"}, {"bib": {"title": "Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SdhP9T11ey4C", "citedby": "56"}, {"bib": {"title": "Type 2 diabetes: RENAAL and IDNT\u2014the emergence of new treatment options", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:D_sINldO8mEC", "citedby": "56"}, {"bib": {"title": "Management of patients with diabetes and CKD: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d(KDIGO) Controversies Conference", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oR5SthnA400C", "citedby": "55"}, {"bib": {"title": "Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q7LczdTNAjsC", "citedby": "55"}, {"bib": {"title": "Is it time for a cardiovascular primary prevention trial in the elderly?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eMMeJKvmdy0C", "citedby": "55"}, {"bib": {"title": "From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-cHHJ4ChvFsC", "citedby": "54"}, {"bib": {"title": "Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, USA \u2026", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0qX8s2k1IRwC", "citedby": "54"}, {"bib": {"title": "Awareness of kidney disease and relationship to end-stage renal disease and mortality", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1taIhTC69MYC", "citedby": "54"}, {"bib": {"title": "Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mNrWkgRL2YcC", "citedby": "54"}, {"bib": {"title": "World Kidney Day: hypertension and chronic kidney disease", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ILKRHgRFtOwC", "citedby": "54"}, {"bib": {"title": "Novel therapies of diabetic nephropathy", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AXPGKjj_ei8C", "citedby": "54"}, {"bib": {"title": "Blood-pressure measurement", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:StPPYsf1FV0C", "citedby": "54"}, {"bib": {"title": "Development of explicit criteria to measure adherence to hypertension guidelines", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uLbwQdceFCQC", "citedby": "54"}, {"bib": {"title": "Hypertension: a companion to Brenner & Rector's The kidney", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1xqo9R7SDZkC", "citedby": "54"}, {"bib": {"title": "Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium.", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vofGIMt6cyEC", "citedby": "54"}, {"bib": {"title": "Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension\u2013Insights From the SYMPLICITY HTN-3 Trial\u2013", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3s2jc9hNhkQC", "citedby": "53"}, {"bib": {"title": "A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OBSaB-F7qqsC", "citedby": "53"}, {"bib": {"title": "Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FAceZFleit8C", "citedby": "53"}, {"bib": {"title": "A comparative evaluation of various methods for microalbuminuria screening", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UHK10RUVsp4C", "citedby": "53"}, {"bib": {"title": "Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6fs0NoO7GbkC", "citedby": "52"}, {"bib": {"title": "Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LhH-TYMQEocC", "citedby": "52"}, {"bib": {"title": "Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP)", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_Ybze24A_UAC", "citedby": "52"}, {"bib": {"title": "Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:t6usbXjVLHcC", "citedby": "52"}, {"bib": {"title": "Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:u9iWguZQMMsC", "citedby": "52"}, {"bib": {"title": "ACE inhibitor-mediated attenuation of mesangial cell growth: a role for endothelin", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VOx2b1Wkg3QC", "citedby": "52"}, {"bib": {"title": "Characterizing absolute lymphocyte count profiles in dimethyl fumarate\u2013treated patients with MS: Patient management considerations", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WIVIxizkzXoC", "citedby": "51"}, {"bib": {"title": "Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nj26e0utjpAC", "citedby": "51"}, {"bib": {"title": "Blood pressure\u2013lowering efficacy of the fixed\u2010dose combination of azilsartan medoxomil and chlorthalidone: a factorial study", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Br1UauaknNIC", "citedby": "51"}, {"bib": {"title": "Are there effects of renin\u2013angiotensin system antagonists beyond blood pressure control?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tKAzc9rXhukC", "citedby": "51"}, {"bib": {"title": "on behalf of the ACCOMPLISH investigators", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HFi42EZPDb4C", "citedby": "51"}, {"bib": {"title": "Barriers to blood pressure control in African Americans: overcoming obstacles is challenging, but target goals can be attained", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_B80troHkn4C", "citedby": "51"}, {"bib": {"title": "A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5ugPr518TE4C", "citedby": "51"}, {"bib": {"title": "National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2010: Executive Summary", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5awf1xo2G04C", "citedby": "50"}, {"bib": {"title": "Reversal of Diuretic\u2010Associated Impaired Glucose Tolerance and New\u2010Onset Diabetes: Results of the STAR\u2010LET Study", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:35r97b3x0nAC", "citedby": "50"}, {"bib": {"title": "Rosiglitazone improves blood pressure in patients with type 2 diabetes mellitus", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8O4vDxvErlEC", "citedby": "50"}, {"bib": {"title": "BP control and long-term risk of ESRD and mortality", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oQ8ZOKt5vhAC", "citedby": "49"}, {"bib": {"title": "A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:a9-T7VOCCH8C", "citedby": "49"}, {"bib": {"title": "Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-_dYPAW6P2MC", "citedby": "49"}, {"bib": {"title": "Therapeutic challenges in the obese diabetic patient with hypertension", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:V3AGJWp-ZtQC", "citedby": "49"}, {"bib": {"title": "Sustained reduction of blood pressure with baroreceptor activation therapy: results of the 6-year open follow-up", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:z2g7kDSNNyoC", "citedby": "48"}, {"bib": {"title": "Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YJSMXgW81ikC", "citedby": "48"}, {"bib": {"title": "Isolated diastolic hypotension and incident heart failure in older adults", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HIFyuExEbWQC", "citedby": "47"}, {"bib": {"title": "CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_OXeSy2IsFwC", "citedby": "47"}, {"bib": {"title": "Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP)", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tuHXwOkdijsC", "citedby": "47"}, {"bib": {"title": "Comparison of commonly used assays for the detection of microalbuminuria", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4MWp96NkSFoC", "citedby": "47"}, {"bib": {"title": "S\u00e9ptimo Informe del Comit\u00e9 Nacional Conjunto en Prevenci\u00f3n, Detecci\u00f3n Evaluaci\u00f3n y Tratamiento de la Hipertensi\u00f3n Arterial", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MSzX15-gZgkC", "citedby": "47"}, {"bib": {"title": "The effects of calcium antagonists on renal hemodynamics, urinary protein excretion, and glomerular morphology in diabetic states.", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WA5NYHcadZ8C", "citedby": "47"}, {"bib": {"title": "CLINICAL PERSPECTIVE", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XoXfffV-tXoC", "citedby": "46"}, {"bib": {"title": "Antihypertensive agents, insulin sensitivity, and new-onset diabetes", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AvfA0Oy_GE0C", "citedby": "46"}, {"bib": {"title": "Salt intake and reductions in arterial pressure and proteinuria is there a direct link?", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tkaPQYYpVKoC", "citedby": "46"}, {"bib": {"title": "Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gYnLYBw1zZMC", "citedby": "45"}, {"bib": {"title": "Microalbuminuria: what is it? Why is it important? What should be done about it? An update", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EYYDruWGBe4C", "citedby": "45"}, {"bib": {"title": "Pathogenesis of hypertension in diabetes", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MLfJN-KU85MC", "citedby": "45"}, {"bib": {"title": "Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1yQoGdGgb4wC", "citedby": "44"}, {"bib": {"title": "Renal denervation for resistant hypertension.", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0vYOBEH00j0C", "citedby": "43"}, {"bib": {"title": "Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PR6Y55bgFSsC", "citedby": "43"}, {"bib": {"title": "Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gFcjaLVeiroC", "citedby": "43"}, {"bib": {"title": "Risk factor assessment for new onset diabetes: literature review", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:g3aElNc5_aQC", "citedby": "42"}, {"bib": {"title": "Clinical importance of microalbuminuria in diabetes and hypertension", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JoZmwDi-zQgC", "citedby": "42"}, {"bib": {"title": "Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Y5dfb0dijaUC", "citedby": "42"}, {"bib": {"title": "Renal denervation for the treatment of resistant hypertension: review and clinical perspective", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qzPvQt7yPGwC", "citedby": "41"}, {"bib": {"title": "Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:It0W0vAlS5QC", "citedby": "41"}, {"bib": {"title": "Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vDijr-p_gm4C", "citedby": "41"}, {"bib": {"title": "Efficacy of a once\u2010daily formulation of carvedilol for the treatment of hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VLnqNzywnoUC", "citedby": "41"}, {"bib": {"title": "Hypertension in patients with diabetes: Why is aggressive treatment essential?", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JQOojiI6XY0C", "citedby": "41"}, {"bib": {"title": "Progression of diabetic nephropathy: a focus on arterial pressure level and methods of reduction", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XiVPGOgt02cC", "citedby": "41"}, {"bib": {"title": "Renal effects of calcium antagonists in diabetes mellitus: an overview of studies in animal models and in humans", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PELIpwtuRlgC", "citedby": "41"}, {"bib": {"title": "Pulmonary scar carcinoma a clinicopathologic analysis", "year": "1983"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kzcrU_BdoSEC", "citedby": "41"}, {"bib": {"title": "Management of hypertension in the elderly population", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:v_tt_AnqfNMC", "citedby": "40"}, {"bib": {"title": "CKD awareness in the United States: the kidney early evaluation program (KEEP)", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:86PQX7AUzd4C", "citedby": "40"}, {"bib": {"title": "Hypertension: Principles and Practice", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QyXJ3EUuO1IC", "citedby": "40"}, {"bib": {"title": "Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eq2jaN3J8jMC", "citedby": "40"}, {"bib": {"title": "Effect of catheter-based renal denervation on morning and nocturnal blood pressure: insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:00hq1xGbIBsC", "citedby": "39"}, {"bib": {"title": "Effects of angiotensin II receptor blockers on diabetic nephropathy", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xtoqd-5pKcoC", "citedby": "39"}, {"bib": {"title": "The renin-angiotensin system in diabetic nephropathy: the endothelial connection", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HE397vMXCloC", "citedby": "39"}, {"bib": {"title": "The evolution of antihypertensive therapy: an overview of four decades of experience", "year": "1989"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WZBGuue-350C", "citedby": "39"}, {"bib": {"title": "Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results \u2026", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TAWzVH7WYHIC", "citedby": "38"}, {"bib": {"title": "Hypertensive nephropathy: prevention and treatment recommendations", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sJsF-0ZLhtgC", "citedby": "38"}, {"bib": {"title": "Controlled-release carvedilol in the treatment of essential hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yB1At4FlUx8C", "citedby": "38"}, {"bib": {"title": "Protecting renal function in the hypertensive patient: clinical guidelines", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j8SEvjWlNXcC", "citedby": "38"}, {"bib": {"title": "Blood pressure control and nephroprotection in diabetes", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:W5xh706n7nkC", "citedby": "38"}, {"bib": {"title": "Evaluation and treatment of patients with systemic hypertension", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_Re3VWB3Y0AC", "citedby": "38"}, {"bib": {"title": "Individualizing blood pressure targets for people with diabetes and hypertension: Comparing the ADA and the ACC/AHA recommendations", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KVD38NuK74kC", "citedby": "37"}, {"bib": {"title": "New potassium binders for the treatment of hyperkalemia: current data and opportunities for the future", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kk7MRXTjMocC", "citedby": "37"}, {"bib": {"title": "Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP)", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7H_jS4BsgvYC", "citedby": "37"}, {"bib": {"title": "Differential effect of \u03b2\u2010blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-FonjvnnhkoC", "citedby": "37"}, {"bib": {"title": "\u03b2\u2010Blocker use and diabetes symptom score: results from the GEMINI study", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SpbeaW3--B0C", "citedby": "37"}, {"bib": {"title": "Treatment and control of high blood pressure in adults", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gKiMpY-AVTkC", "citedby": "36"}, {"bib": {"title": "Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Dip1O2bNi0gC", "citedby": "36"}, {"bib": {"title": "Hypertension and nephropathy", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:t7zJ5fGR-2UC", "citedby": "36"}, {"bib": {"title": "Pathogenesis and clinical physiology of hypertension", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_axFR9aDTf0C", "citedby": "36"}, {"bib": {"title": "Hypertension in patients with diabetes: strategies for drug therapy to reduce complications", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fEOibwPWpKIC", "citedby": "36"}, {"bib": {"title": "Recognition and management of masked hypertension: a review and novel approach", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:m92CDrhVnKEC", "citedby": "35"}, {"bib": {"title": "What have we learned from the current trials?", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dQ2og3OwTAUC", "citedby": "35"}, {"bib": {"title": "Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZM__uENUXnMC", "citedby": "34"}, {"bib": {"title": "Should \u03b2-blockers be used to control hypertension in people with chronic kidney disease?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:S16KYo8Pm5AC", "citedby": "34"}, {"bib": {"title": "Slowing the progression of diabetic nephropathy and its cardiovascular consequences", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Z5m8FVwuT1cC", "citedby": "34"}, {"bib": {"title": "Rosiglitazone produces long-term reductions in urinary albumin excretion in type 2 diabetes.", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r56sNq9gaawC", "citedby": "34"}, {"bib": {"title": "Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-R_Z4shfoosC", "citedby": "33"}, {"bib": {"title": "Serial measurement of high-sensitivity troponin I and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE trial (Examination of Cardiovascular \u2026", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rMiSbtrAJs8C", "citedby": "33"}, {"bib": {"title": "Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Xtec1x7NZGAC", "citedby": "33"}, {"bib": {"title": "Obesity and insulin resistance as risk factors for chronic kidney disease", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FPJr55Dyh1AC", "citedby": "33"}, {"bib": {"title": "The rationale and design of the Glycemic Effects in Diabetes Mellitus: Carvedilol\u2013Metoprolol Comparison in Hypertensives (GEMINI) trial", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uc_IGeMz5qoC", "citedby": "33"}, {"bib": {"title": "Renal outcomes in hypertensive Black patients at high cardiovascular risk", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5icHVeHT4IsC", "citedby": "32"}, {"bib": {"title": "Current perspectives on hypertension and metabolic syndrome", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7xtfDMUJqJkC", "citedby": "32"}, {"bib": {"title": "The kidney and cardiovascular risk\u2013implications for management: a consensus statement from the European Society of Hypertension", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BUYA1_V_uYcC", "citedby": "32"}, {"bib": {"title": "Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ipzZ9siozwsC", "citedby": "32"}, {"bib": {"title": "Effect of fixed\u2010dose ACE\u2010inhibitor/calcium channel blocker combination therapy vs. ACE\u2010inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KUbvn5osdkgC", "citedby": "32"}, {"bib": {"title": "Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2KloaMYe4IUC", "citedby": "32"}, {"bib": {"title": "Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hCrLmN-GePgC", "citedby": "32"}, {"bib": {"title": "Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Fu2w8maKXqMC", "citedby": "32"}, {"bib": {"title": "Microalbuminuria in Non\u2014Insulin-Dependent Diabetes Mellitus: Implications for Renal Survival", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ML0RJ9NH7IQC", "citedby": "32"}, {"bib": {"title": "American Heart Association Statistics C, Stroke Statistics S, 2014. Executive summary: heart disease and stroke statistics\u20132014 update: a report from the American Heart Association"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TA1nTKmGtTgC", "citedby": "32"}, {"bib": {"title": "Interaction between adiponectin and aldosterone", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:buQ7SEKw-1sC", "citedby": "31"}, {"bib": {"title": "Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ak0FvsSvgGUC", "citedby": "31"}, {"bib": {"title": "Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans: consensus \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NhqRSupF_l8C", "citedby": "31"}, {"bib": {"title": "An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XAEgxC7iu0MC", "citedby": "30"}, {"bib": {"title": "Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a \u2026", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9fRKRCJz75UC", "citedby": "30"}, {"bib": {"title": "Noninsulin glucose-lowering agents for the treatment of patients on dialysis", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:orDZ08hpP44C", "citedby": "30"}, {"bib": {"title": "ACCF", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5CmvP2Up3ZUC", "citedby": "30"}, {"bib": {"title": "Importance of blood pressure control in left ventricular mass regression", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:U4n9YNQMCAIC", "citedby": "30"}, {"bib": {"title": "An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DJbcl8HfkQkC", "citedby": "30"}, {"bib": {"title": "Renal hemodynamic changes in heart failure", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZzlSgRqYykMC", "citedby": "30"}, {"bib": {"title": "Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WJVC3Jt7v1AC", "citedby": "30"}, {"bib": {"title": "A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BwyfMAYsbu0C", "citedby": "30"}, {"bib": {"title": "Blood pressure targets for patients with diabetes or kidney disease", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mlAyqtXpCwEC", "citedby": "29"}, {"bib": {"title": "The role of vasodilating \u03b2-blockers in patients with hypertension and the cardiometabolic syndrome", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DUooU5lO8OsC", "citedby": "29"}, {"bib": {"title": "Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic \u2026", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kVjdVfd2voEC", "citedby": "29"}, {"bib": {"title": "Combination therapy with renin\u2010angiotensin\u2010aldosterone receptor blockers for hypertension: how far have we come?", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:anf4URPfarAC", "citedby": "29"}, {"bib": {"title": "Microalbuminuria and progressive renal disease.", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tYavs44e6CUC", "citedby": "29"}, {"bib": {"title": "Diabetic nephropathy: What you need to know to preserve kidney function", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:edDO8Oi4QzsC", "citedby": "29"}, {"bib": {"title": "On-treatment blood pressure and cardiovascular outcomes in older adults with isolated systolic hypertension", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H2XcuePHLsAC", "citedby": "28"}, {"bib": {"title": "\u201cPrediabetes\u201d: are there problems with this label? No, we need heightened awareness of this condition!", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vPKCt-r_nWsC", "citedby": "28"}, {"bib": {"title": "Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CB6W3GmKGOEC", "citedby": "28"}, {"bib": {"title": "Renal denervation and left ventricular mass regression: a benefit beyond blood pressure reduction?", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SEKBqlyTJecC", "citedby": "28"}, {"bib": {"title": "Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA)", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-BKJ5vZJwzMC", "citedby": "28"}, {"bib": {"title": "Using an established telehealth model to train urban primary care providers on hypertension management", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7VEv-pLvLSsC", "citedby": "28"}, {"bib": {"title": "Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fFSKOagxvKUC", "citedby": "28"}, {"bib": {"title": "Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_FM0Bhl9EiAC", "citedby": "28"}, {"bib": {"title": "CLINICAL PERSPECTIVE", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qyhmnyLat1gC", "citedby": "28"}, {"bib": {"title": "Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bkKuixW_xMkC", "citedby": "28"}, {"bib": {"title": "Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hMsQuOkrut0C", "citedby": "28"}, {"bib": {"title": "Antihypertensive treatment with and without Benazepril in patients with chronic renal insufficiency", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kh2fBNsKQNwC", "citedby": "28"}, {"bib": {"title": "The role of combination antihypertensive therapy and the progression of renal disease hypertension: looking toward the next millennium", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HtEfBTGE9r8C", "citedby": "28"}, {"bib": {"title": "Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uJ-U7cs_P_0C", "citedby": "28"}, {"bib": {"title": "Long\u2010term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin\u2010converting enzymes/angiotensin receptor \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rPbfW60zdgkC", "citedby": "27"}, {"bib": {"title": "Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_5pobawY6TYC", "citedby": "27"}, {"bib": {"title": "Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he \u2026", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SQZOXlr1FBsC", "citedby": "27"}, {"bib": {"title": "Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4n0clTBhZ78C", "citedby": "27"}, {"bib": {"title": "Lipid disorders in uremia and dialysis", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6bLC7aUMtPcC", "citedby": "27"}, {"bib": {"title": "When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0KyAp5RtaNEC", "citedby": "27"}, {"bib": {"title": "Role for \u03b2-blockers in the management of diabetic kidney disease", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0N-VGjzr574C", "citedby": "27"}, {"bib": {"title": "Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zLWjf1WUPmwC", "citedby": "27"}, {"bib": {"title": "Diabetic hypertensive patients: improving their prognosis", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ClCfbGk0d_YC", "citedby": "27"}, {"bib": {"title": "SGLT2 inhibitors and mechanisms of hypertension", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZnWe2zbntUIC", "citedby": "26"}, {"bib": {"title": "Acute declines in renal function during intensive BP lowering: implications for future ESRD risk", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1n-LKbgTOzoC", "citedby": "26"}, {"bib": {"title": "Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ibZ2AwG9z6wC", "citedby": "26"}, {"bib": {"title": "Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jgBuDB5drN8C", "citedby": "26"}, {"bib": {"title": "24-hour ambulatory blood pressure in the ACCOMPLISH trial", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ruyezt5ZtCIC", "citedby": "26"}, {"bib": {"title": "Does dietary salt increase the risk for progression of kidney disease?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HbR8gkJAVGIC", "citedby": "26"}, {"bib": {"title": "Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResi\u00f3n Arterial en DIab\u00e9ticos tipo DOS) study", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kuK5TVdYjLIC", "citedby": "26"}, {"bib": {"title": "How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:epqYDVWIO7EC", "citedby": "26"}, {"bib": {"title": "Angiotensin-converting enzyme inhibition to enhance vascular health\u2014clinical and research models", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NXb4pA-qfm4C", "citedby": "26"}, {"bib": {"title": "Predictors of renal and cardiovascular mortality in patients with non-insulin-dependent diabetes: a brief overview of microalbuminuria and insulin resistance", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:L7CI7m0gUJcC", "citedby": "26"}, {"bib": {"title": "Intensive hemodialysis, blood pressure, and antihypertensive medication use", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2ZctHUgIzyAC", "citedby": "25"}, {"bib": {"title": "The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised placebo-controlled trial", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KI9T_ytC6pkC", "citedby": "25"}, {"bib": {"title": "Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6yz0xqPARnAC", "citedby": "25"}, {"bib": {"title": "Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP)", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:F1b5ZUV5XREC", "citedby": "25"}, {"bib": {"title": "Should nephrologists use beta-blockers? A perspective", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:F9fV5C73w3QC", "citedby": "25"}, {"bib": {"title": "Mechanistic insights into diuretic-induced insulin resistance", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LO7wyVUgiFcC", "citedby": "25"}, {"bib": {"title": "Do the metabolic effects of \u03b2 blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ug5p-4gJ2f0C", "citedby": "25"}, {"bib": {"title": "Quality of life measured in a practice\u2010based hypertension trial of an angiotensin receptor blocker", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:k8Z6L05lTy4C", "citedby": "25"}, {"bib": {"title": "ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence?", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:b1wdh0AR-JQC", "citedby": "25"}, {"bib": {"title": "Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-Rb0Dl3RFGgC", "citedby": "24"}, {"bib": {"title": "Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:o0tJHVzi6PsC", "citedby": "24"}, {"bib": {"title": "Comparison of the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study equations: prevalence of and risk factors for diabetes \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DrR-2ekChdkC", "citedby": "24"}, {"bib": {"title": "Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GtLg2Ama23sC", "citedby": "24"}, {"bib": {"title": "Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6ZxmRoH8BuwC", "citedby": "24"}, {"bib": {"title": "Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yMeIxYmEMEAC", "citedby": "24"}, {"bib": {"title": "Blood pressure measurement", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aK62MiYD7mUC", "citedby": "24"}, {"bib": {"title": "Choreoathetosis associated with lithium: case report and literature review", "year": "1983"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bFuYayV9R1gC", "citedby": "24"}, {"bib": {"title": "The use of clonidine for management of opiate abstinence in a chronic pain patient.", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:k6nH7jlkaTkC", "citedby": "24"}, {"bib": {"title": "ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JZsVLox4iN8C", "citedby": "23"}, {"bib": {"title": "Regression to the mean in SYMPLICITY HTN-3: implications for design and reporting of future trials", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lf0D1wPZyaoC", "citedby": "23"}, {"bib": {"title": "Cardiovascular outcomes according to systolic blood pressure in patients with and without diabetes: an ACCOMPLISH substudy", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yBxuCEhX224C", "citedby": "23"}, {"bib": {"title": "Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LHtfzE5_5AIC", "citedby": "23"}, {"bib": {"title": "Randomized study of antihypertensive efficacy and safety of combination aliskiren/valsartan vs valsartan monotherapy in hypertensive participants with type 2 diabetes mellitus", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CNPyR2KL9-0C", "citedby": "23"}, {"bib": {"title": "The promise of renal denervation", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7BrZ7Jt4UNcC", "citedby": "23"}, {"bib": {"title": "Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KbBQZpvPDL4C", "citedby": "23"}, {"bib": {"title": "A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kz9GbA2Ns4gC", "citedby": "23"}, {"bib": {"title": "Level of kidney function determines cardiovascular fate after coronary bypass graft surgery", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OP4eGU-M3BUC", "citedby": "23"}, {"bib": {"title": "Should restrictions be relaxed for metformin use in chronic kidney disease? Yes, they should be relaxed! What\u2019s the fuss?", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kyHTWmgVackC", "citedby": "22"}, {"bib": {"title": "Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2TuIPqOg0e0C", "citedby": "22"}, {"bib": {"title": "Alogliptin in patients with type 2 diabetes after acute coronary syndromes: heart failure outcomes and cardiovascular safety in heart failure patients", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xckinRaLORAC", "citedby": "22"}, {"bib": {"title": "Comparative antihypertensive efficacy of angiotensin receptor blocker\u2010based treatment in African\u2010American and white patients", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M7yex6snE4oC", "citedby": "22"}, {"bib": {"title": "And the National High Blood Pressure Education Program Coordinating Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OmZH4w0uHW8C", "citedby": "22"}, {"bib": {"title": "Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ODE9OILHJdcC", "citedby": "22"}, {"bib": {"title": "Treatment of the diabetic patient: focus on cardiovascular and renal risk reduction", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PVjk1bu6vJQC", "citedby": "22"}, {"bib": {"title": "Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects: a double-blind, placebo-controlled, multicenter trial.", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LI9QrySNdTsC", "citedby": "22"}, {"bib": {"title": "Renal dysfunction resulting from NSAIDs.", "year": "1989"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3htObqc8RwsC", "citedby": "22"}, {"bib": {"title": "The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol.", "year": "1986"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:p__nRnzSRKYC", "citedby": "22"}, {"bib": {"title": "Differences in dynamic diurnal blood pressure variability between Japanese and American treatment-resistant hypertensive populations", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KtrhGiDecpEC", "citedby": "21"}, {"bib": {"title": "Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hx4mni8B3JkC", "citedby": "21"}, {"bib": {"title": "Evaluating the role of key learning theories in ECHO: a telehealth educational program for primary care providers", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Amrzk_ktLr0C", "citedby": "21"}, {"bib": {"title": "Effect of combining extended\u2010release carvedilol and lisinopril in hypertension: results of the COSMOS study", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AHdEip9mkN0C", "citedby": "21"}, {"bib": {"title": "Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP)", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9c2xU6iGI7YC", "citedby": "21"}, {"bib": {"title": "Hypertension goals in advanced-stage kidney disease", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nVrZBo8bIpAC", "citedby": "21"}, {"bib": {"title": "Does Evidence Support Renin\u2013Angiotensin System Blockade for Slowing Nephropathy Progression in Elderly Persons?", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PaBasH6fAo0C", "citedby": "21"}, {"bib": {"title": "Comparative Efficacy of Two Different \u03b2\u2010Blockers on 24\u2010Hour Blood Pressure Control", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yqoGN6RLRZoC", "citedby": "21"}, {"bib": {"title": "Lowering Blood Pressure With \u03b2\u2010Blockers in Combination With Other Renin\u2010Angiotensin System Blockers in Patients With Hypertension and Type 2 Diabetes: Results From the GEMINI Trial", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IRz6iEL74y4C", "citedby": "21"}, {"bib": {"title": "Metabolic effects of \u03b2-blockers: importance of dissociating newer from conventional agents", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r_AWSJRzSzQC", "citedby": "21"}, {"bib": {"title": "Proteinuria: a link to understanding changes in vascular compliance?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0izLItjtcgwC", "citedby": "21"}, {"bib": {"title": "Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uWiczbcajpAC", "citedby": "21"}, {"bib": {"title": "Analogy between endothelial/mesangial cell and endothelial/vascular smooth muscle cell interactions", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lmc2jWPfTJgC", "citedby": "21"}, {"bib": {"title": "Heart Disease and Stroke Statistics\u20142016 Update: A Report From the American Heart Association. 2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lxZgYf9FOvoC", "citedby": "21"}, {"bib": {"title": "Effect of patiromer on hyperkalemia recurrence in older chronic kidney disease patients taking RAAS inhibitors", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Q3_nmhWTCy0C", "citedby": "20"}, {"bib": {"title": "The kidney in hypertension", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:w2Gke83ceDMC", "citedby": "20"}, {"bib": {"title": "Intensive hemodialysis and potential risks with increasing treatment", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1AS7WB7zg6gC", "citedby": "20"}, {"bib": {"title": "Advances in treatment of hyperkalemia in chronic kidney disease", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xyzrkeHX5M4C", "citedby": "20"}, {"bib": {"title": "Mohler 3rd", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uDl620nrkPcC", "citedby": "20"}, {"bib": {"title": "Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RoXSNcbkSzsC", "citedby": "20"}, {"bib": {"title": "Diabetic cardiovascular disease predicts chronic kidney disease awareness in the Kidney Early Evaluation Program", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sszUF3NjhM4C", "citedby": "20"}, {"bib": {"title": "The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NyGDZy8z5eUC", "citedby": "20"}, {"bib": {"title": "Comparison of antihypertensive efficacy of the new angiotensin receptor blocker azilsartan medoxomil with ramipril: Pp. 16.112", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4xDN1ZYqzskC", "citedby": "20"}, {"bib": {"title": "Influence of microalbuminuria in achieving blood pressure goals", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oNZyr7d5Mn4C", "citedby": "20"}, {"bib": {"title": "Clinical efficacy and safety profiles of AT1 receptor antagonists", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dBIO0h50nwkC", "citedby": "20"}, {"bib": {"title": "The appropriate blood pressure control in diabetes (ABCD) trial", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4hFrxpcac9AC", "citedby": "20"}, {"bib": {"title": "Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease.", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:URolC5Kub84C", "citedby": "20"}, {"bib": {"title": "Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PoWvk5oyLR8C", "citedby": "20"}, {"bib": {"title": "Antihypertensive therapy and progression of diabetic renal disease.", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gsN89kCJA0AC", "citedby": "20"}, {"bib": {"title": "The use of antisense oligonucleotides to establish autocrine angiotensin growth effects in human neuroblastoma and mesangial cells", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:e_rmSamDkqQC", "citedby": "20"}, {"bib": {"title": "Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RtDPZMhf-s8C", "citedby": "19"}, {"bib": {"title": "New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:R1TrASrH5esC", "citedby": "19"}, {"bib": {"title": "Complete renin\u2013angiotensin\u2013aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studies", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0Kh4an1R61UC", "citedby": "19"}, {"bib": {"title": "Telmisartan in incipient and overt diabetic renal disease.", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CdxZDUztZiMC", "citedby": "19"}, {"bib": {"title": "Endothelin antagonism in patients with resistant hypertension and hypertension nephropathy", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ALROH1vI_8AC", "citedby": "19"}, {"bib": {"title": "Antihypertensive efficacy of the novel angiotensin receptor blocker azilsartan medoxomil in combination with amlodipine: PP. 16.99", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cWzG1nlazyYC", "citedby": "19"}, {"bib": {"title": "Calcium antagonists: Do they equally protect against kidney injury?", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vDZJ-YLwNdEC", "citedby": "19"}, {"bib": {"title": "Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YohjEiUPhakC", "citedby": "19"}, {"bib": {"title": "Pharmacological augmentation of endothelium-derived nitric oxide synthesis", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bKqednn6t2AC", "citedby": "19"}, {"bib": {"title": "Is proteinuria a plausible target of therapy?", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2VqYfGB8ITEC", "citedby": "19"}, {"bib": {"title": "Hypertension in the Elderly: Pocketbook", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:F0CZgh39Fi0C", "citedby": "19"}, {"bib": {"title": "Hypertension: epidemiology, pathophysiology, diagnosis, and treatment", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XvxMoLDsR5gC", "citedby": "19"}, {"bib": {"title": "Renal hemodynamic and antiproteinuric response to an ACE inhibitor, trandolopril (T) or calcium antagonist, verapamil (V) alone or in fixed dose combination in patients with \u2026", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rJyh6hJnyfgC", "citedby": "19"}, {"bib": {"title": "An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:l2sC-qQILUoC", "citedby": "18"}, {"bib": {"title": "Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HoDPlbN_d1QC", "citedby": "18"}, {"bib": {"title": "Dual RAAS blockade is desirable in kidney disease: con", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gVv57TyPmFsC", "citedby": "18"}, {"bib": {"title": "Management of hypertension in patients with diabetes: the place of angiotensin\u2010II receptor blockers", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0CzhzZyukY4C", "citedby": "18"}, {"bib": {"title": "Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8d8msizDQcsC", "citedby": "18"}, {"bib": {"title": "Kidney disease and hypertension", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GzlcqhCAosUC", "citedby": "18"}, {"bib": {"title": "Kidney failure and cardiovascular disease", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:u-coK7KVo8oC", "citedby": "18"}, {"bib": {"title": "Target Organ Damage in Hypertension.", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bz8QjSJIRt4C", "citedby": "18"}, {"bib": {"title": "Hypertension and diabetes", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RMVrO4bo-SsC", "citedby": "18"}, {"bib": {"title": "The future of renal denervation in resistant hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PcT55Ow6fAIC", "citedby": "17"}, {"bib": {"title": "Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yL7DKRohVA8C", "citedby": "17"}, {"bib": {"title": "Chronic kidney disease: a coronary heart disease equivalent?", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wKETBy42zhYC", "citedby": "17"}, {"bib": {"title": "Predictors of hypertension control in a diverse general cardiology practice", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:owLR8QvbtFgC", "citedby": "17"}, {"bib": {"title": "The current state of RAAS blockade in the treatment of hypertension and proteinuria", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KaMxkj08jr0C", "citedby": "17"}, {"bib": {"title": "Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular \u2026", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4fGpz3EwCPoC", "citedby": "17"}, {"bib": {"title": "Diabetes and chronic kidney disease: tragedy and challenge", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OTTXONDVkokC", "citedby": "17"}, {"bib": {"title": "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 7", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:N75c7piKpcAC", "citedby": "17"}, {"bib": {"title": "Proceedings from Duke resistant hypertension think tank", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZZwcLRaXOV4C", "citedby": "16"}, {"bib": {"title": "Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AkvegQHRDQ8C", "citedby": "16"}, {"bib": {"title": "Effects of naproxcinod on blood pressure in patients with osteoarthritis", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q-HalDI95KYC", "citedby": "16"}, {"bib": {"title": "The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jU7OWUQzBzMC", "citedby": "16"}, {"bib": {"title": "Summary of revisions for the 2005 clinical practice recommendations", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Id9pRtCSqO0C", "citedby": "16"}, {"bib": {"title": "Inclusion of albuminuria in hypertension and heart guidelines", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IUKN3-7HHlwC", "citedby": "16"}, {"bib": {"title": "The JNC 7 Approach Compared to Conventional Treatment in Diabetic Patients With Hypertension: A Double\u2010Blind Trial of Initial Monotherapy vs. Combination Therapy", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_5tno0g5mFcC", "citedby": "16"}, {"bib": {"title": "The future of clinical trials in chronic renal disease: Outcome of an NIH/FDA/physician specialist conference", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9pM33mqn1YgC", "citedby": "16"}, {"bib": {"title": "Combination therapy for hypertension and renal disease in diabetics as compared to non-diabetics", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-ZoC36zw86wC", "citedby": "16"}, {"bib": {"title": "INSULIN, ANGIOTENSIN-II ANTAGONISM AND CONVERTING ENZYME-INHIBITION-EFFECT ON HUMAN MESANGIAL CELL MITOGENICITY AND ENDOTHELIN", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9o6PfxSMcEIC", "citedby": "16"}, {"bib": {"title": "Psychogenic vertigo: A review", "year": "1981"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JQPmwQThujIC", "citedby": "16"}, {"bib": {"title": "MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4JjQL45tqTYC", "citedby": "15"}, {"bib": {"title": "Baseline characteristics and enrichment results from the SONAR trial", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q2Dn1KgioksC", "citedby": "15"}, {"bib": {"title": "Novel therapies for diabetic kidney disease", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SGnGYi2HwEIC", "citedby": "15"}, {"bib": {"title": "Hypertension: A Companion to Braunwald's Heart Disease E-Book", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:K6kyChav4UkC", "citedby": "15"}, {"bib": {"title": "Management of hypertension in diabetic nephropathy: how low should we go?", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IwGqIHSOC8kC", "citedby": "15"}, {"bib": {"title": "Renal denervation after SYMPLICITY HTN-3: Where do we go?", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xEMdJR0kL_sC", "citedby": "15"}, {"bib": {"title": "Efficacy and safety of perindopril arginine+ amlodipine in hypertension", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cxS_fjKIGZMC", "citedby": "15"}, {"bib": {"title": "Endothelin antagonism and hypertension: an evolving target", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cAWJABFkdiUC", "citedby": "15"}, {"bib": {"title": "Anxiety in the \u201cage of hypertension\u201d", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tfDI-GPdlUQC", "citedby": "15"}, {"bib": {"title": "Executive summary: Kidney Early Evaluation Program (KEEP) 2008 annual data report", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tH6gc1N1XXoC", "citedby": "15"}, {"bib": {"title": "\u03b2\u2010Blockers in the Treatment of Hypertension: New Data, New Directions", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fbc8zXXH2BUC", "citedby": "15"}, {"bib": {"title": "Renal adaptation to the failing heart: Avoiding a \u2018therapeutic misadventure\u2019", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QD3KBmkZPeQC", "citedby": "15"}, {"bib": {"title": "Has RAAS blockade reached its limits in the treatment of diabetic nephropathy?", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vkDViGfkvYEC", "citedby": "14"}, {"bib": {"title": "Hypertension management in diabetic kidney disease", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SyxJh60XUSQC", "citedby": "14"}, {"bib": {"title": "Sympathetic activation in resistant hypertension: theory and therapy", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mu2_AnMl8iYC", "citedby": "14"}, {"bib": {"title": "Association of cognitive dysfunction with cardiovascular disease events in elderly hypertensive patients", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PazO6pb-sMwC", "citedby": "14"}, {"bib": {"title": "The association between parathyroid hormone levels and the cardiorenal metabolic syndrome in non-diabetic chronic kidney disease", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RJOyoaXV5v8C", "citedby": "14"}, {"bib": {"title": "Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible?", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OR75R8vi5nAC", "citedby": "14"}, {"bib": {"title": "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of high blood pressure. JNC VII", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vuU-T12QLgwC", "citedby": "14"}, {"bib": {"title": "Microalbuminuria in diabetes: focus on cardiovascular and renal risk reduction", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ehil0879vHcC", "citedby": "14"}, {"bib": {"title": "Adding to the freshwater red algal diversity in North America: Lympha mucosa gen. et sp. nov. (Batrachospermales, Rhodophyta)", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SxCCDk4iOpsC", "citedby": "13"}, {"bib": {"title": "Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6LV2YwJzdtgC", "citedby": "13"}, {"bib": {"title": "Timing and efficacy of alternative methods of sympathetic blockade", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MIg0yeAD4ggC", "citedby": "13"}, {"bib": {"title": "Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lvd772isFD0C", "citedby": "13"}, {"bib": {"title": "Glycemic control and cardiovascular disease in chronic kidney disease", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wMgC3FpKEyYC", "citedby": "13"}, {"bib": {"title": "The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Aul-kAQHnToC", "citedby": "13"}, {"bib": {"title": "Hypertension treatment guidelines: practical implications", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:artPoR2Yc-kC", "citedby": "13"}, {"bib": {"title": "Treatment of hypertension in patients with renal disease", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QYdC8u9Cj1oC", "citedby": "13"}, {"bib": {"title": "Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus.", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IyxfXMz2bNAC", "citedby": "13"}, {"bib": {"title": "Hypertension in diabetic patients: an update of interventional studies to preserve renal function", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Bg7qf7VwUHIC", "citedby": "13"}, {"bib": {"title": "Major advancements in slowing diabetic kidney disease progression: focus on SGLT2 inhibitors", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:R3JqVFXIqpYC", "citedby": "12"}, {"bib": {"title": "Blood pressure lowering and sodium-glucose co-transporter 2 Inhibitors (SGLT2is): more than osmotic diuresis", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gXFvZ3BI3UoC", "citedby": "12"}, {"bib": {"title": "Are all patients with type 1 diabetes destined for dialysis if they live long enough? Probably not", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JtjtGO9FvpUC", "citedby": "12"}, {"bib": {"title": "Blood pressure control and cardiovascular/renal outcomes", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:afsF9h1fxg0C", "citedby": "12"}, {"bib": {"title": "Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zCpYd49hD24C", "citedby": "12"}, {"bib": {"title": "Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lBZ7XAAYe3oC", "citedby": "12"}, {"bib": {"title": "Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TewouNez5YAC", "citedby": "12"}, {"bib": {"title": "Heart Disease and Stroke Statistics\u20142014 Update: A Report from the American Heart Association. 2014", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3yMDF_cvnR8C", "citedby": "12"}, {"bib": {"title": "Investigators SH", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KmkpU35IWjAC", "citedby": "12"}, {"bib": {"title": "Management of hypertension in pregnant and postpartum women", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Kmip3zU-C7YC", "citedby": "12"}, {"bib": {"title": "Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-LHtoeeytlUC", "citedby": "12"}, {"bib": {"title": "Canagliflozin (CANA), a sodium glucose co-transporter 2 (SGLT2) inhibitor, improves glycemia and is well tolerated in type 2 diabetes mellitus (T2DM) subjects with moderate \u2026", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1Ye0OR6EYb4C", "citedby": "12"}, {"bib": {"title": "Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DyXnQzXoVgIC", "citedby": "12"}, {"bib": {"title": "Assessing blood pressure control in dialysis patients: finally a step forward", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MpfHP-DdYjUC", "citedby": "12"}, {"bib": {"title": "Benazepril plus amlodipine or hydrochlorothiazide for hypertension.", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yFnVuubrUp4C", "citedby": "12"}, {"bib": {"title": "Clinical practice recommendations", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xO3Y8ErbwlsC", "citedby": "12"}, {"bib": {"title": "Implications of albuminuria on kidney disease progression", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uDGL6kOW6j0C", "citedby": "12"}, {"bib": {"title": "Choices and goals in the treatment of the diabetic hypertensive patient", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:w1MjKQ0l0TYC", "citedby": "12"}, {"bib": {"title": "Rosiglitazone-mediated reductions in urinary albumin excretion are associated with changes in ambulatory blood pressure in type 2 diabetes patients", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3WNXLiBY60kC", "citedby": "12"}, {"bib": {"title": "Differential effects of valsartan (V) and lisinopril (L) on potassium [K+] homeostasis in hypertensive patients with nephropathy", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qhW0HyKmSusC", "citedby": "12"}, {"bib": {"title": "Socioeconomic impact of diabetic nephropathy: can we improve the outcome?", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4vMrXwiscB8C", "citedby": "12"}, {"bib": {"title": "Pathogenesis and therapeutic aspects of radiocontrast-induced renal dysfunction", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HeT0ZceujKMC", "citedby": "12"}, {"bib": {"title": "Renal effects of antihypertensive medications: an overview", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GFxP56DSvIMC", "citedby": "12"}, {"bib": {"title": "Kidney biomarkers and decline in eGFR in patients with type 2 diabetes", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HiznBx5RP3QC", "citedby": "11"}, {"bib": {"title": "High\u2010sensitivity C\u2010reactive protein, low\u2010density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8QO3eJiZnkEC", "citedby": "11"}, {"bib": {"title": "Mineralocorticoid antagonists in chronic kidney disease", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5bFWG3eDk9wC", "citedby": "11"}, {"bib": {"title": "Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3UHJKpZgG5wC", "citedby": "11"}, {"bib": {"title": "Hypertension and new treatment approaches targeting the sympathetic nervous system", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YanO1q2l3soC", "citedby": "11"}, {"bib": {"title": "Effect of cardiovascular comorbidities on the mortality risk associated with serum potassium", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1pC5hbHeJ6IC", "citedby": "11"}, {"bib": {"title": "Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:654Jc7Ppz2kC", "citedby": "11"}, {"bib": {"title": "Hypertension in 2011: New insights--from risk factors to treatment implications", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Dem6FJhTUoYC", "citedby": "11"}, {"bib": {"title": "The United Nations high level meeting addresses noncommunicable diseases, but where is hypertension?", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aIdbFUkbNIkC", "citedby": "11"}, {"bib": {"title": "Initial combination antihypertensives: let's ACCELERATE", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XUvXOeBm_78C", "citedby": "11"}, {"bib": {"title": "NEW ANGIOTENSIN II RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL COADMINISTERED WITH CHLORTHALIDONE PROVIDES POTENT BLOOD PRESSURE REDUCTION IN STAGE 2 HYPERTENSION: PO-238", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fGgrif5g-LMC", "citedby": "11"}, {"bib": {"title": "Hypertension control rates: time for translation of guidelines into clinical practice", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7Hz3ACDFbsoC", "citedby": "11"}, {"bib": {"title": "Disopyramide-associated liver dysfunction.", "year": "1983"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MvIMIWP2nqIC", "citedby": "11"}, {"bib": {"title": "Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ncwx4PHgTB8C", "citedby": "10"}, {"bib": {"title": "The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oJBA3oede64C", "citedby": "10"}, {"bib": {"title": "Relationship between obesity, hypertension, and aldosterone production in postmenopausal African American women: a pilot study", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UwpDZDXJMDUC", "citedby": "10"}, {"bib": {"title": "Spironolactone for resistant hypertension\u2014hard to resist?", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GUJN1xMjMHAC", "citedby": "10"}, {"bib": {"title": "Chronic kidney disease (CKD) and hypertension essentials", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:inmFHauC9wsC", "citedby": "10"}, {"bib": {"title": "Cardiovascular protection for all individuals at high risk: evidence-based best practice", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nZcligLrVowC", "citedby": "10"}, {"bib": {"title": "Chlorthalidone combinations", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lms347EBdh4C", "citedby": "10"}, {"bib": {"title": "Overview of diabetic nephropathy", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QoJ_w57xiyAC", "citedby": "10"}, {"bib": {"title": "Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jFemdcug13IC", "citedby": "10"}, {"bib": {"title": "Are beta blockers pass\u00e9 for the treatment of hypertension?", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PVgj2kMGcgYC", "citedby": "10"}, {"bib": {"title": "Insulin therapy in type 1 diabetes mellitus", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0SnApaDgcCoC", "citedby": "10"}, {"bib": {"title": "Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BJbdYPG6LGMC", "citedby": "10"}, {"bib": {"title": "The evolution of treatment guidelines for diabetic nephropathy: Strategies integrate JNC VI, more recent protocols", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:P7Ujq4OLJYoC", "citedby": "10"}, {"bib": {"title": "EFFECT OF NONDIHYDROPYRIDINE CALCIUM-ANTAGONISTS (NDCAS) ON PROGRESSION OF NEPHROPATHY FROM NONINSULIN-DEPENDENT DIABETES (NIDDM)-A 5-YEAR FOLLOW-UP-STUDY", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Zbx7W2Xs4QsC", "citedby": "10"}, {"bib": {"title": "Drug dosing in patients with renal insufficiency: a simplified approach", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:48xauSegjOkC", "citedby": "10"}, {"bib": {"title": "Dermatologic manifestations of lithium: A review", "year": "1981"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lYbyOjaXH8MC", "citedby": "10"}, {"bib": {"title": "Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines?\u2015An Asian Perspective\u2015", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8v7czoltWYsC", "citedby": "9"}, {"bib": {"title": "American Diabetes Association standards of medical care in diabetes 2016: Approaches to glycemic treatment", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lQh10hhnIEIC", "citedby": "9"}, {"bib": {"title": "Renal denervation for resistant hypertension and beyond", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PD-wXv1Sh1EC", "citedby": "9"}, {"bib": {"title": "Prevalence of coronary heart disease by age and sex", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VHymtrwLyIYC", "citedby": "9"}, {"bib": {"title": "Baroreflex activation therapy safely reduces blood pressure for at least five years in a large resistant hypertension cohort", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3jqAvCjcdfEC", "citedby": "9"}, {"bib": {"title": "The future of interventional management of hypertension: threats and opportunities", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WgvcDLhf7hwC", "citedby": "9"}, {"bib": {"title": "Treatment of hypertension in patients with diabetes mellitus", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Xz60mAmATU4C", "citedby": "9"}, {"bib": {"title": "Use of a single target blood pressure level in type 2 diabetes mellitus for all cardiovascular risk reduction: Comment on \u201cintensive and standard blood pressure targets in \u2026", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-nhnvRiOwuoC", "citedby": "9"}, {"bib": {"title": "EFFECTS OF A NOVEL ANEMIA TREATMENT, FG-4592\u2013AN ORAL HYPOXIA-INDUCIBLE PROLYL HYDROXYLASE INHIBITOR (HIF-PHI) ON BLOOD PRESSURE AND CHOLESTEROL IN PATIENTS WITH CHRONIC KIDNEY \u2026", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MDBbo4b0KHEC", "citedby": "9"}, {"bib": {"title": "Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nRpfm8aw39MC", "citedby": "9"}, {"bib": {"title": "GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators. Effects of different ACE inhibitor combinations on albuminuria \u2026", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gQbQcM3rmFsC", "citedby": "9"}, {"bib": {"title": "Improving blood pressure control rates: is there more we can do?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rHJHxKgnXwkC", "citedby": "9"}, {"bib": {"title": "Microalbuminuria: Marker of Kidney and Cardiovascular Disease", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FiytvqdAVhgC", "citedby": "9"}, {"bib": {"title": "Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5MTHONV0fEkC", "citedby": "9"}, {"bib": {"title": "ImmunoDip\u00ae: An improved Screening method for microalbuminuria", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:otzGkya1bYkC", "citedby": "9"}, {"bib": {"title": "Optimal management of hypertension and obesity in the metabolic syndrome", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HGTzPopzzJcC", "citedby": "9"}, {"bib": {"title": "New therapies in diabetes\u2013thiazolidinediones", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LdasjJ6CEcoC", "citedby": "9"}, {"bib": {"title": "Angiotensin receptor blocker use for hypertension treatment in the elderly", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CaZNVDsoPx4C", "citedby": "9"}, {"bib": {"title": "Is the level of arterial pressure reduction important for preservation of renal function", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lgwcVrK6X84C", "citedby": "9"}, {"bib": {"title": "The effects of enalapril on urinary protein excretion in patients with idiopathic membranous nephropathy", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4X0JR2_MtJMC", "citedby": "9"}, {"bib": {"title": "Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1zNUifcpCKoC", "citedby": "8"}, {"bib": {"title": "Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qE25ZKhNtbAC", "citedby": "8"}, {"bib": {"title": "Average Clinician\u2010Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:h-fwNd0rmTkC", "citedby": "8"}, {"bib": {"title": "Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vlECJaBXBlQC", "citedby": "8"}, {"bib": {"title": "Arterial Hypertension-Update 2017", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:d4paSpBSrDQC", "citedby": "8"}, {"bib": {"title": "Update on blood pressure goals in diabetes mellitus", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6YFk0eKgftsC", "citedby": "8"}, {"bib": {"title": "1-year safety and efficacy of patiromer for hyperkalemia in heart failure patients with chronic kidney disease on renin-angiotensin-aldosterone system inhibitors", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WsFh9Szeq2wC", "citedby": "8"}, {"bib": {"title": "Status of Diabetes Care: \u201cIt Just Doesn\u2019t Get Any Better . . . or Does It?\u201d", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:n1qY4L4uFdgC", "citedby": "8"}, {"bib": {"title": "Early patterns of blood pressure change and future coronary atherosclerosis", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Wqn_fehR_TUC", "citedby": "8"}, {"bib": {"title": "doi: doi: 10.1097/01", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fhMX52Pd6iQC", "citedby": "8"}, {"bib": {"title": "Chronic kidney disease: Do fibrates truly preserve kidney function?", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:D_tqNUsBuKoC", "citedby": "8"}, {"bib": {"title": "Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VN7nJs4JPk0C", "citedby": "8"}, {"bib": {"title": "THE NEW ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL HAS SUPERIOR 24-HOUR BLOOD PRESSURE LOWERING EFFICACY TO BOTH OLMESARTAN AND VALSARTAN: PO-242", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yymuTJNBJz4C", "citedby": "8"}, {"bib": {"title": "American College of Cardiology Foundation", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6tHXJaRVc1QC", "citedby": "8"}, {"bib": {"title": "Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DBa1UEJaJKAC", "citedby": "8"}, {"bib": {"title": "Pulse pressure and arterial stiffness: an emerging renal risk predictor?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BrOSOlqYqPUC", "citedby": "8"}, {"bib": {"title": "Lower extremity arterial disease", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j5aT6aphRxQC", "citedby": "8"}, {"bib": {"title": "Calcium Antagonism Abolishes the Antipressor Action of Vasopressin (V1) Receptor Antagonism", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cK4Rrx0J3m0C", "citedby": "8"}, {"bib": {"title": "Angiotension converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ?", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OfCb3DkOstsC", "citedby": "8"}, {"bib": {"title": "Renal adaptation to the failing heart: Understanding the cascade of responses", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3bvyWxjaHKcC", "citedby": "8"}, {"bib": {"title": "Endothelin production is attenuated in cultured human mesangial cells by insulin", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CLhUwle04lcC", "citedby": "8"}, {"bib": {"title": "Theophylline attenuates radiocontrast-induced intrarenal vasoconstriction", "year": "1985"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rp474-M6Y4oC", "citedby": "8"}, {"bib": {"title": "Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including \u2026", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1fM7sLBYaPUC", "citedby": "7"}, {"bib": {"title": "Redefining diuretics use in hypertension: why select a thiazide-like diuretic?", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:h0mLeC6b6wcC", "citedby": "7"}, {"bib": {"title": "Design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KrOX6H5u0oYC", "citedby": "7"}, {"bib": {"title": "Sodium/glucose cotransporter 2 inhibitors in patients with diabetes mellitus and chronic kidney disease: turning the page", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rKOGDx9nJ1EC", "citedby": "7"}, {"bib": {"title": "Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathy", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CzVmvSWNoUEC", "citedby": "7"}, {"bib": {"title": "Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the \u2026", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BSZS1fLCB98C", "citedby": "7"}, {"bib": {"title": "Cardiovascular risks of hypertension", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5LOebrzo1TYC", "citedby": "7"}, {"bib": {"title": "New agents for hyperkalemia.", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:E10ZYwHxBI8C", "citedby": "7"}, {"bib": {"title": "A clinician's perspective of the role of renal sympathetic nerves in hypertension", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TuM7UPshZo8C", "citedby": "7"}, {"bib": {"title": "Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vefPE_iVbj4C", "citedby": "7"}, {"bib": {"title": "Smoking and hypertension", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hNSvKAmkeYkC", "citedby": "7"}, {"bib": {"title": "Drug treatment of hypertensive emergencies", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:m44aUaJR3ikC", "citedby": "7"}, {"bib": {"title": "Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-XtG2q47PdUC", "citedby": "7"}, {"bib": {"title": "Metformin nephrotoxicity insights: will they change clinical management?", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NKlx0PmyA3cC", "citedby": "7"}, {"bib": {"title": "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves glycaemic control and is well tolerated in type 2 diabetes subjects with moderate renal impairment", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:P2d6BWbXU0IC", "citedby": "7"}, {"bib": {"title": "Approaches for targeting blood pressure control in sleep disorders", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-DxkuPiZhfEC", "citedby": "7"}, {"bib": {"title": "Kidney dysfunction, cardiorespiratory fitness, and the risk of death in women", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5bg8sr1QxYwC", "citedby": "7"}, {"bib": {"title": "Management of severe asymptomatic hypertension (hypertensive urgencies)", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-mN3Mh-tlDkC", "citedby": "7"}, {"bib": {"title": "Baroreflex hypertension therapy improves cardiac structure and function in resistant hypertension: results from the Pivotal trial of the Rheos system", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TlpoogIpr_IC", "citedby": "7"}, {"bib": {"title": "ACHIEVEMENT OF BLOOD PRESSURE GOAL IN PATIENTS WITH RESISTANT HYPERTENSION TREATED WITH BAROREFLEX ACTIVATION THERAPY\u00ae: PP. 16.107", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hsZV8lGYWTMC", "citedby": "7"}, {"bib": {"title": "Thiazide diuretics.", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dIILA_La5fwC", "citedby": "7"}, {"bib": {"title": "Screening and study enrolment in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) Replacement Therapy Trial", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q2HS4OCVtYIC", "citedby": "7"}, {"bib": {"title": "for the Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) Investigators", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dj1AAMDQi3QC", "citedby": "7"}, {"bib": {"title": "ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WC9gN4BGCRcC", "citedby": "7"}, {"bib": {"title": "Regulation of fluid and electrolyte balance in hypertension: role of hormones and peptides", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eiwtZcG9oBcC", "citedby": "7"}, {"bib": {"title": "Major clinical trials of hypertension: what should be done next?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:U5uP8zs9lfgC", "citedby": "7"}, {"bib": {"title": "Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LgRImbQfgY4C", "citedby": "7"}, {"bib": {"title": "Promise of prevention and reversal of target organ involvement in hypertension", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SNyOjmPOlygC", "citedby": "7"}, {"bib": {"title": "Antihypertensive therapy in type 2 diabetes with nephropathy", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hZ5_QnqxF7AC", "citedby": "7"}, {"bib": {"title": "Hypertension: A clinician's guide to diagnosis and treatment", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zCSUwVk65WsC", "citedby": "7"}, {"bib": {"title": "African lineage, hypertension linked", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:A7-hzOuI2KQC", "citedby": "7"}, {"bib": {"title": "Synthesis and Characterization of Block Copolymers: Poly (ethylene oxide-b-methacrylonitrile) and Poly (ethylene oxide-b-acrylonitrile)", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QhqSGEHatosC", "citedby": "7"}, {"bib": {"title": "Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL trial", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:foJkpVhfThEC", "citedby": "6"}, {"bib": {"title": "Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:22N0J9dj6kwC", "citedby": "6"}, {"bib": {"title": "The management of hypertension in 2018: what should the targets be?", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lM7bPffmjyEC", "citedby": "6"}, {"bib": {"title": "Similarities and differences between the ACC/AHA and ESH/ESC guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults: a perspective", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vq7B84E5p90C", "citedby": "6"}, {"bib": {"title": "Long\u2010term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:K5ggCqHMkpcC", "citedby": "6"}, {"bib": {"title": "Prior Medications and the Cardiovascular Benefits From Combination Angiotensin\u2010Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High\u2010Risk Hypertensive Patients", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Xc-mKOjpdrwC", "citedby": "6"}, {"bib": {"title": "Primary and secondary hypertension", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:o4Qvs5Y5TLQC", "citedby": "6"}, {"bib": {"title": "Patiromer controls hyperkalemia in resistant hypertensive patients on RAASi, with diabetic kidney disease", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cocyvO7vrcwC", "citedby": "6"}, {"bib": {"title": "Status of diabetes care: new challenges, new concepts, new measures\u2014focusing on the future!", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dgXhHFWAKKUC", "citedby": "6"}, {"bib": {"title": "Evaluation and treatment of hypertensive urgencies and emergencies", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cDbf6tmpeSoC", "citedby": "6"}, {"bib": {"title": "Rationale for establishing a mechanism to increase reimbursement to hypertension specialists", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eH23hyXCXa4C", "citedby": "6"}, {"bib": {"title": "Efficacy of baroreflex activation therapy for the treatment of resistant hypertension.", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UKB2i6g6GNMC", "citedby": "6"}, {"bib": {"title": "Diabetes and hypertension: evaluation and management", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Oi-j_DTgP3cC", "citedby": "6"}, {"bib": {"title": "EFFICACY AND SAFETY OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE VS OLMESARTAN/HCTZ COMBINATIONS IN STAGE 2 SYSTOLIC HTN: PO-162", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zEYdoEEwLqEC", "citedby": "6"}, {"bib": {"title": "Optimal blood pressure for a patient with type 2 diabetes mellitus: insight from the ACCORD study", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WHdLCjDvYFkC", "citedby": "6"}, {"bib": {"title": "Potential of implantable carotid sinus stimulator for drug-resistant hypertension", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pAkWuXOU-OoC", "citedby": "6"}, {"bib": {"title": "Pediatrics: masked hypertension: a risk factor in children with CKD", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DkZNVXde3BIC", "citedby": "6"}, {"bib": {"title": "Hypertension and its management in the elderly", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-6RzNnnwWf8C", "citedby": "6"}, {"bib": {"title": "Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ade32sEp0pkC", "citedby": "6"}, {"bib": {"title": "Avoiding Cardiovascular Events Through COMbination Therapy in Patients LIving With Systolic Hypertension (ACCOMPLISH-Trial)", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qS3OQCqhxh0C", "citedby": "6"}, {"bib": {"title": "Choice of therapy in essential hypertension: Recommendations", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WC23djZS0W4C", "citedby": "6"}, {"bib": {"title": "Dual therapy in hypertensive patients with coronary artery disease: The role of calcium channel blockers and \u03b2-blockers", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OzeSX8-yOCQC", "citedby": "6"}, {"bib": {"title": "The editor\u2019s roundtable: revisiting the role of beta blockers in hypertension", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MhiOAD_qIWkC", "citedby": "6"}, {"bib": {"title": "Protein kinase C-\u03b2 inhibition: a promise not yet fulfilled", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j7_hQOaDUrUC", "citedby": "6"}, {"bib": {"title": "Comparative long term effects of two AT1 receptor blockers on proteinuria in patients with type-2 diabetes and overt nephropathy and hypertension: Results of the AMADEO trial", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kvJssbFybhEC", "citedby": "6"}, {"bib": {"title": "Effect of ruboxistaurin on albuminuria and GFR in persons with type 2 diabetes and nephropathy", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3_f9JqYsqVQC", "citedby": "6"}, {"bib": {"title": "Rosiglitazone added to metformin reduces urinary albumin/creatinine ratio and ambulatory blood pressure in subjects with microalbuminuria and type 2 diabetes", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:R6EwkKsDylYC", "citedby": "6"}, {"bib": {"title": "Who should be treated with combination therapy as initial treatment for hypertension?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:L1USKYWJimsC", "citedby": "6"}, {"bib": {"title": "P-431: Design of the accomplish (avoiding cardiovascular events through combination therapy in patients living with systolic hypertension) trial", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7H_MAutzIkAC", "citedby": "6"}, {"bib": {"title": "Hipertansiyon: Epidemiyoloji, patofizyoloji, tan\u0131 ve tedavi", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NGoJ35N4lvkC", "citedby": "6"}, {"bib": {"title": "The influence of dietary salt on the antiproteinuric effect of calcium channel blockers", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JTqpx9DYBaYC", "citedby": "6"}, {"bib": {"title": "Inhibition of the vasopressin receptor attenuates mitogenesis and increases endothelin in rat mesangial cells", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:09LM3QYkMKUC", "citedby": "6"}, {"bib": {"title": "Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zQyJfvL_HJsC", "citedby": "5"}, {"bib": {"title": "Creatinine Bump Following Antihypertensive Therapy: Think Before You Act", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sArNgO4T4MoC", "citedby": "5"}, {"bib": {"title": "Has the Sun Set on Nighttime Dosing in Uncomplicated Hypertension?", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uSQurnFbQXsC", "citedby": "5"}, {"bib": {"title": "Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African\u2010American patients with hypertension", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:s_JjmAzd-pQC", "citedby": "5"}, {"bib": {"title": "Evaluation and treatment of hypertensive emergencies in adults", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6DzZfY3qH5gC", "citedby": "5"}, {"bib": {"title": "Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: insights from AQUARIUS", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pxLfhFzThFYC", "citedby": "5"}, {"bib": {"title": "The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IqrShC7OVU0C", "citedby": "5"}, {"bib": {"title": "Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:iHNVki4A1WcC", "citedby": "5"}, {"bib": {"title": "Hypertension after renal transplantation", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GZelqfngyKEC", "citedby": "5"}, {"bib": {"title": "Role of ambulatory blood pressure monitoring in hypertension and diabetes", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QKtdBID3u5MC", "citedby": "5"}, {"bib": {"title": "Perioperative management of hypertension", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8Xgff_V0N9gC", "citedby": "5"}, {"bib": {"title": "Newer renin\u2013angiotensin\u2013aldosterone system blocker combinations: is there an advantage?", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kF1pexMAQbMC", "citedby": "5"}, {"bib": {"title": "SINGLE-PILL COMBINATION OF TELMISARTAN 80 MG/AMLODIPINE 10 MG PROVIDES SUPERIOR BLOOD PRESSURE REDUCTIONS TO AMLODIPINE IN ADDED-RISK HYPERTENSIVE PATIENTS: SUB-ANALYSIS OF THE \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YbLjypsZzowC", "citedby": "5"}, {"bib": {"title": "Optimizing blood pressure and reducing proteinuria", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PbVfkCSoiPoC", "citedby": "5"}, {"bib": {"title": "Lower blood pressure goals in high-risk cardiovascular patients: are they defensible?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pS0ncopqnHgC", "citedby": "5"}, {"bib": {"title": "A PHASE III TRIAL OF BAROREFLEX ACTIVATION THERAPY FOR RESISTANT HYPERTENSION: TRIAL DESIGN AND BASELINE CHARACTERISTICS IN THE RHEOS PIVOTAL TRIAL: PO-239", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dhZ1Wuf5EGsC", "citedby": "5"}, {"bib": {"title": "Blood pressure reduction with potassium supplementation", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7CU1mCQUTf4C", "citedby": "5"}, {"bib": {"title": "World Kidney Day 2009: Hypertension and kidney disease is a marriage that should be prevented", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vkuYBMKU6wEC", "citedby": "5"}, {"bib": {"title": "Genetic factors in the pathogenesis of essential hypertension", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2l5NCbZemmgC", "citedby": "5"}, {"bib": {"title": "The cardiometabolic syndrome and calcium channel blocker combination drugs", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kWvqk_afx_IC", "citedby": "5"}, {"bib": {"title": "Case study: the link between hypertension and diabetes.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6_hjMsCP8ZoC", "citedby": "5"}, {"bib": {"title": "Darusentan anti hypertensive effect in patients with resistant hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aNch6Af-aFkC", "citedby": "5"}, {"bib": {"title": "Clinical implications of blockade of the renin-angiotensin system in management of hypertension", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7wO8s98CvbsC", "citedby": "5"}, {"bib": {"title": "Less heart is more", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MappHbsApxQC", "citedby": "5"}, {"bib": {"title": "Optimal treatment of hypertension in African Americans: Reaching and maintaining target blood pressure goals", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KNjnJ3z-R6IC", "citedby": "5"}, {"bib": {"title": "Evolution of drugs that preserve renal function", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yxmsSjX2EkcC", "citedby": "5"}, {"bib": {"title": "Renal components of the hypertensive syndrome", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LPtt_HFRSbwC", "citedby": "5"}, {"bib": {"title": "New therapeutic approaches to achieve the desired blood pressure goal", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IaI1MmNe2tcC", "citedby": "5"}, {"bib": {"title": "BLOOD-PRESSURE REDUCTION AND PROGRESSION OF DIABETIC NEPHROPATHY IN AFRICAN-AMERICANS (AA)-A 5-YEAR FOLLOW-UP", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ON9TkA72AHEC", "citedby": "5"}, {"bib": {"title": "It may seem obvious to you...: giving medication instructions to patients", "year": "1988"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FSHXWovK7t4C", "citedby": "5"}, {"bib": {"title": "Heart failure and changes in kidney function: focus on understanding, not reacting", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DQQjGlBKAuwC", "citedby": "4"}, {"bib": {"title": "Barriers to guideline mandated renin\u2013angiotensin inhibitor use: focus on hyperkalaemia", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OcT3jDimY5MC", "citedby": "4"}, {"bib": {"title": "Relation of serum and urine renal biomarkers to cardiovascular risk in patients with type 2 diabetes mellitus and recent acute coronary syndromes (from the EXAMINE Trial)", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:N3SpgoQaeaUC", "citedby": "4"}, {"bib": {"title": "Early and chronic dipeptidyl\u2010peptidase\u2010IV inhibition and cardiovascular events in patients with type 2 diabetes mellitus after an acute coronary syndrome: a landmark analysis \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XWcFhoZvYIAC", "citedby": "4"}, {"bib": {"title": "A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qmyJBmpVKbYC", "citedby": "4"}, {"bib": {"title": "Consequences of overinterpreting serum creatinine increases when achieving BP reduction: balancing risks and benefits of BP reduction in hypertension", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8IsQavbT1M8C", "citedby": "4"}, {"bib": {"title": "Diabetes Care:\u201cTaking It to the Limit One More Time\u201d", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WYleWgRJor0C", "citedby": "4"}, {"bib": {"title": "Management of severe asymptomatic hypertension (hypertensive urgencies) in adults", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DGpvO1n63MYC", "citedby": "4"}, {"bib": {"title": "Masked and nocturnal hypertension in the ARTS-DN ABPM sub-study with finerenone", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4_yl7nwqy4oC", "citedby": "4"}, {"bib": {"title": "Renal denervation: a field in flux", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ult01sCh7k0C", "citedby": "4"}, {"bib": {"title": "Blood pressure measurement in the diagnosis and management of hypertension in adults", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eHo_KFcuhuIC", "citedby": "4"}, {"bib": {"title": "8B. 06: Baroreflex activation therapy consistently maintains blood pressure reduction in a large resistant hypertension cohort for at least 6 years", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GO2DTSf4MZMC", "citedby": "4"}, {"bib": {"title": "Reduced blood pressure lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from pooled Symplicity HTN trials", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5Y1KH4bkPm0C", "citedby": "4"}, {"bib": {"title": "Treatment of hypertension in the elderly patient, particularly isolated systolic hypertension", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9hNLEifDsrsC", "citedby": "4"}, {"bib": {"title": "Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UY3hNwcQ290C", "citedby": "4"}, {"bib": {"title": "Interventional cardiology: Indications for renal denervation: a balanced approach?", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gkldIfsazJcC", "citedby": "4"}, {"bib": {"title": "Predictors of systolic BP< 140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LXmCCkuhhTsC", "citedby": "4"}, {"bib": {"title": "INDIVIDUALIZED PROGRAMMING DEMONSTRATES FEASIBILITY OF UNILATERAL APPROACH TO DELIVERY OF BAROREFLEX ACTIVATION THERAPY\u00ae: OR-22", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:c2LjitseEfMC", "citedby": "4"}, {"bib": {"title": "CON: blood pressure treatment goal for patients with diabetes should be< 130/80 mm Hg", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kw52XkFRtyQC", "citedby": "4"}, {"bib": {"title": "EFFECTS OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL IN PATIENTS WITH PRIMARY HYPERTENSION: PO-221", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0aNKY9CYzMkC", "citedby": "4"}, {"bib": {"title": "Prehypertension and borderline hypertension", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1DsIQWDZLl8C", "citedby": "4"}, {"bib": {"title": "Diet in the treatment and prevention of hypertension", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VGxY11nYJJYC", "citedby": "4"}, {"bib": {"title": "Hipertansiyon: temelleri ve uygulama", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1yhUMift6wIC", "citedby": "4"}, {"bib": {"title": "\u201cStiff central arteries\u201d syndrome: does a weak heart really stiff the kidney?", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_AkkBXT-jcoC", "citedby": "4"}, {"bib": {"title": "Newer combination therapies in the management of hypertension: an update", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WAzi4Gm8nLoC", "citedby": "4"}, {"bib": {"title": "the early termination of the ACCOMPLISH Trial for efficacy", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ri6SYOTghG4C", "citedby": "4"}, {"bib": {"title": "Beta-blocker therapy in hypertension: a need to pause and reflect", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NDuN12AVoxsC", "citedby": "4"}, {"bib": {"title": "An Effectiveness Study Comparing Algorithm\u2010Based Antihypertensive Therapy With Previous Treatments Using Conventional and Ambulatory Blood Pressure Measurements", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CB2v5VPnA5kC", "citedby": "4"}, {"bib": {"title": "Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YsrPvlHIBpEC", "citedby": "4"}, {"bib": {"title": "Hypertension. The American Society of Nephrology: Nephrology Self-Assessment Program", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:O0MA3yP7Y3UC", "citedby": "4"}, {"bib": {"title": "459 Risk/benefit analysis of hyperkalemia in the eplerenone post\u2010acute myocardial infarction heart failure efficacy and survival study (EPHESUS)", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1yWc8FF-_SYC", "citedby": "4"}, {"bib": {"title": "P-401: Safety and efficacy of combination ace inhibitor/calcium channel blocker therapy versus ace inhibitor monotherapy in african american patients with hypertension and type \u2026", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eO3_k5sD8BwC", "citedby": "4"}, {"bib": {"title": "Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:svGagg1hbZMC", "citedby": "4"}, {"bib": {"title": "\u7f8e\u56fd\u9884\u9632, \u68c0\u6d4b, \u8bc4\u4f30\u4e0e\u6cbb\u7597\u9ad8\u8840\u538b\u8054\u5408\u59d4\u5458\u4f1a\u7b2c\u4e03\u6b21\u62a5\u544a", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RXiHnyRawswC", "citedby": "4"}, {"bib": {"title": "Treatment of stage I hypertension and development of renal dysfunction", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ce2CqMG-AY4C", "citedby": "4"}, {"bib": {"title": "Paroxysmal hypertension (pseudopheochromocytoma)", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SnGPuo6Feq8C", "citedby": "4"}, {"bib": {"title": "Hypertension and the progression of renal disease", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:w0F2JDEymm0C", "citedby": "4"}, {"bib": {"title": "Improving prognosis of nondiabetic chronic renal insufficiency: the role of ACE inhibitors", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AXkvAH5U_nMC", "citedby": "4"}, {"bib": {"title": "Differences in glomerular membrane permeability responses to a non-dihydropyridine (NDHP) and dihydropyridine (DHP) calcium channel antagonist (CCA) in patients with diabetic \u2026", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sYWwZaPVD1oC", "citedby": "4"}, {"bib": {"title": "Treatment of renal failure and blood pressure.", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mKu_rENv82IC", "citedby": "4"}, {"bib": {"title": "Differential effects of calcium channel blockers (CCBs) on albuminuria and glomerular permeability in NIDDM subjects with nephropathy: Pilot results of a two year randomized study.", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QAOzB4mb83kC", "citedby": "4"}, {"bib": {"title": "Renin in acute and chronic renal failure: implications for treatment", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3NQIlFlcGxIC", "citedby": "4"}, {"bib": {"title": "Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man.", "year": "1988"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QUX0mv85b1cC", "citedby": "4"}, {"bib": {"title": "Orphenadrine Citrate", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BDTQWqO089sC", "citedby": "4"}, {"bib": {"title": "Lithium prophylaxis and the kidney", "year": "1981"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MAUkC_7iAq8C", "citedby": "4"}, {"bib": {"title": "Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: a secondary analysis of the CREDENCE randomized trial", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:S_0nULq340kC", "citedby": "3"}, {"bib": {"title": "Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9KdEqzwCTsEC", "citedby": "3"}, {"bib": {"title": "FP482 EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Z8CpXElfgm4C", "citedby": "3"}, {"bib": {"title": "Big topics for diabetes care in 2018: Clinical guidelines, costs of diabetes, and information technology", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XX7pGhTe5MgC", "citedby": "3"}, {"bib": {"title": "Diabetic kidney disease: A determinant of cardiovascular risk in type 1 diabetes", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:E8M3ZPqbjf0C", "citedby": "3"}, {"bib": {"title": "Metformin exposure with gut-restricted delayed-release metformin in CKD Stage 4 does not exceed that of current metformin used on-label: results from population PK modelling", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SPgoriM2DtkC", "citedby": "3"}, {"bib": {"title": "Renal targeted therapies of antihypertensive and cardiovascular drugs for patients with stages 3 through 5d kidney disease", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RsqFu5Siv-AC", "citedby": "3"}, {"bib": {"title": "Resistant hypertension: a refractory disease or refractory patient", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Xnn2mF3JXD4C", "citedby": "3"}, {"bib": {"title": "Strategy for improved blood pressure (BP) control in resistant hypertension (RH) with diabetic kidney disease (DKD)", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HOg0WoviCygC", "citedby": "3"}, {"bib": {"title": "de FS, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER \u2026", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Sx7WuSFExYwC", "citedby": "3"}, {"bib": {"title": "New Onset Hypertension Linked to Generic Cyclosporine Substitution in Post-Renal Transplant Patient", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PFhWnMnuT1QC", "citedby": "3"}, {"bib": {"title": "Moderately increased albuminuria (microalbuminuria) and cardiovascular disease", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FkBsMxS_Bp0C", "citedby": "3"}, {"bib": {"title": "Patient adherence and the treatment of hypertension", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wUn16MOA3RoC", "citedby": "3"}, {"bib": {"title": "Abstract P602: Patiromer decreased aldosterone, urine albumin/creatinine ratio, and blood pressure in patients with chronic kidney disease and hyperkalemia on RAAS inhibitors \u2026", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UFuRdyijzaAC", "citedby": "3"}, {"bib": {"title": "Patiromer lowers serum potassium in patients with elevated potassium and diabetes and advanced CKD on RAAS inhibitors: Results from OPAL-HK and AMETHYST-DN", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LLUdpdcEW3AC", "citedby": "3"}, {"bib": {"title": "Reduction of serum K+ with patiromer for 1 year in patients with diabetic CKD who developed hyperkalemia while on maximal losartan and/or spironolactone", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AbQWx2m_oG8C", "citedby": "3"}, {"bib": {"title": "Baroreflex activation therapy improves status of resistant hypertension patients with heart failure", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3wLP7v6BnpwC", "citedby": "3"}, {"bib": {"title": "Renin inhibition in patients with chronic kidney disease: Is it conclusively non-indicated?", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Q_E8KsG3g9MC", "citedby": "3"}, {"bib": {"title": "Establishing the diagnosis of renovascular hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nIr65G9GQVgC", "citedby": "3"}, {"bib": {"title": "CaseBook challenges: Managing gout, hyperuricemia and comorbidities-dialogue with the experts", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RdUpO4xyVKMC", "citedby": "3"}, {"bib": {"title": "Chronic kidney disease: Optimal blood pressure for kidney disease\u2014lower is not better", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DwFgw5hZUzMC", "citedby": "3"}, {"bib": {"title": "Efficacy and Safety of Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) Over 52 Weeks", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jMZTt8odoasC", "citedby": "3"}, {"bib": {"title": "The Editor's Roundtable: Advances in stem cell therapy for treatment of cardiovascular disease", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wvYxNZNCP7wC", "citedby": "3"}, {"bib": {"title": "The spectrum of albuminuria as a predictor of cardiorenal outcomes", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:g8uWPOAv7ggC", "citedby": "3"}, {"bib": {"title": "FIXED-DOSE COMBINATION OF AZILSARTAN MEDOXOMIL/CLD PROVIDES SUPERIOR BP REDUCTION TO MONOTHERAPIES IN STAGE 2 HTN: PO-182", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:w2Aknop99M4C", "citedby": "3"}, {"bib": {"title": "HYPERTENSION SPECIALISTS'CURRENT AND POTENTIAL IMPACT ON RESISTANT HYPERTENSION IN THE MEDICARE POPULATION: PO-343", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TniZHWc1JwoC", "citedby": "3"}, {"bib": {"title": "The prevalence and control of hypertension", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:t-hv7AR41mYC", "citedby": "3"}, {"bib": {"title": "RESULTS OF A DOUBLE-BLIND RANDOMIZED STUDY COMPARING CHLORTHALIDONE AND HYDROCHLOROTHIAZIDE COMBINED WITH THE NEW ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL IN PRIMARY \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yCEqH1SBpFUC", "citedby": "3"}, {"bib": {"title": "ACCF", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:C-SEpTPhZ1wC", "citedby": "3"}, {"bib": {"title": "Hypertension and kidney disease: A marriage that should be prevented", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JWITY9-sCbMC", "citedby": "3"}, {"bib": {"title": "Blood Pressure Control in the Patient With Difficult\u2010to\u2010Control Hypertension: Which Agent for Which Patient?", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PyEswDtIyv0C", "citedby": "3"}, {"bib": {"title": "Does body mass index influence blood pressure reduction among subjects treated with combination of amlodipine besylate and olmesartan medoxomil versus component monotherapy?", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZOYfmFL0FrgC", "citedby": "3"}, {"bib": {"title": "Combination of amlodipine besylate and olmesartan medoxomil provides greater reduction in blood pressure compared with monotherapy in subjects with and without diabetes", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8rLWgkbgOXQC", "citedby": "3"}, {"bib": {"title": "Hypertension in kidney disease", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:F2UWTTQJPOcC", "citedby": "3"}, {"bib": {"title": "Reversal of new onset diabetes by nondiuretic based fixed dose antihypertensive drug combinations? Results of STAR 6 month extension (STAR-LET)", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Kv9jytqXTosC", "citedby": "3"}, {"bib": {"title": "Darusentan significantly reduces systolic blood pressure in patients with resistant hypertension on 4 or more antihypertensive drugs", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:za7pDTvVV8kC", "citedby": "3"}, {"bib": {"title": "Therapeutic strategies in hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1cQOl6Zi554C", "citedby": "3"}, {"bib": {"title": "Proteinuria and Blood Pressure Reduction", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-7ulzOJl1JYC", "citedby": "3"}, {"bib": {"title": "Genetics of hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BMiRioqqltAC", "citedby": "3"}, {"bib": {"title": "Combination therapy: Optimizing target-organ protection", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SGW5VrABaM0C", "citedby": "3"}, {"bib": {"title": "Blood pressure and aging", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:InLRhUNj-rwC", "citedby": "3"}, {"bib": {"title": "Peripheral Arterial Disease and Diabetes", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8p8iYwVyaVcC", "citedby": "3"}, {"bib": {"title": "P-305: Selection of explicit criteria for a JNC-7 guideline adherence tool", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vxA22ZmNLkoC", "citedby": "3"}, {"bib": {"title": "P-222: Greater efficacy of chlorthalidone over hydrochlorothiazide for achieving blood pressure goals", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PkcyUWeTMh0C", "citedby": "3"}, {"bib": {"title": "P-261: A clinical trial of an age cross-link breaker, alt-711, in systolic hypertension", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HJSXoJQnj-YC", "citedby": "3"}, {"bib": {"title": "Do findings of high mortality from pneumonia in the elderly make it the old man's friend?", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:X5YyAB84Iw4C", "citedby": "3"}, {"bib": {"title": "Pathogenisis and clinical course of essential hypertension", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mWEH9CqjF64C", "citedby": "3"}, {"bib": {"title": "P-393: Safety and efficacy of an ACE inhibitor/calcium channel blocker combination versus an ACE inhibitor alone in hypertensive patients with type 2 diabetes", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oi2SiIJ9l4AC", "citedby": "3"}, {"bib": {"title": "The place for calcium channel blockers in the treatment of hypertension in patients with diabetes mellitus", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:U_HPUtbDl20C", "citedby": "3"}, {"bib": {"title": "Salt intake and its impact on hypertension", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SAZ1SQo2q1kC", "citedby": "3"}, {"bib": {"title": "Management of hypertensive patients with diabetic nephropaty", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:x7obfLuV8acC", "citedby": "3"}, {"bib": {"title": "Differences in the antihypertensive and glomeruloprotective efficacies of calcium channel blockers in the remnant kidney model.", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JIEWM9yDoCIC", "citedby": "3"}, {"bib": {"title": "Newer approaches to antihypertensive therapy", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:io2GbE6LpKQC", "citedby": "3"}, {"bib": {"title": "Calcium channel blockers and progression of renal disease: Clinical studies put in perpecuve", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-jrNzM816MMC", "citedby": "3"}, {"bib": {"title": "Chronic pain: A pharmacologic review and behavior modification approach", "year": "1983"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:l7iSsH4_Im4C", "citedby": "3"}, {"bib": {"title": "The Seventh Report of the Joint National Committee on Prevention, Detection"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9wUeeRLfbNYC", "citedby": "3"}, {"bib": {"title": "Approach to the Patient with Hypertensive Nephrosclerosis", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Qovp55VTycgC", "citedby": "2"}, {"bib": {"title": "Kidney injury is not prevented by hydration alone", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pqufTfZDgs0C", "citedby": "2"}, {"bib": {"title": "Alterations in Kidney Function Associated with Heart Failure", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:b15ltGHXyxQC", "citedby": "2"}, {"bib": {"title": "Ambulatory blood pressure monitoring", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6syOTa9L3GQC", "citedby": "2"}, {"bib": {"title": "Comparison of effectiveness of azilsartan medoxomil and olmesartan in blacks versus whites with systemic hypertension", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:D0NosnH9lYgC", "citedby": "2"}, {"bib": {"title": "Renal denervation: one step backwards, three steps forward", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uQrt9rju91QC", "citedby": "2"}, {"bib": {"title": "Perspective on the new blood-pressure guidelines", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BeIT3YV5QzEC", "citedby": "2"}, {"bib": {"title": "Intradialytic Hypotension: Is Midodrine the Answer?", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ln2xPWQ6zl8C", "citedby": "2"}, {"bib": {"title": "Diagnosis of primary aldosteronism", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gxL4SBlKZTUC", "citedby": "2"}, {"bib": {"title": "Dual RAAS blockade with aliskiren in patients with severely impaired chronic kidney disease", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mpaOjDK6XBIC", "citedby": "2"}, {"bib": {"title": "Delayed-release metformin targeting the lower bowel elicits sustained improvements in HbA (1c) and fasting glucose with minimal systemic exposure", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZbiiB1Sm8G8C", "citedby": "2"}, {"bib": {"title": "Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for \u201cPrime Time\u201d?", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BxcezVm2apwC", "citedby": "2"}, {"bib": {"title": "Searching for the Optimal Blood Pressure Range in the Elderly: Are We There Yet?", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r5yabEp13iMC", "citedby": "2"}, {"bib": {"title": "Ambulatory blood pressure monitoring in clinical hypertension management.", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2pCWc5Tf3J4C", "citedby": "2"}, {"bib": {"title": "JS ISH-ISN-2 role of the kidney in resistant hypertension: why so resistant to BP control in CKD patients?", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OLNndOjO69MC", "citedby": "2"}, {"bib": {"title": "Hypertension: SGLT2 inhibitors: not just another glucose-lowering agent", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fHS53ZCY-AEC", "citedby": "2"}, {"bib": {"title": "Hydrochlorothiazide as the diuretic of choice for hypertension: time to kick the habit", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:96M4k3P_OWMC", "citedby": "2"}, {"bib": {"title": "Ocular effects of hypertension", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Y0-TYkg6YM4C", "citedby": "2"}, {"bib": {"title": "Vascular catheter infections: time to get technical", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gubd_9ZgCi8C", "citedby": "2"}, {"bib": {"title": "Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial (vol 314, pg 151, 2015)", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OC7j4ufeY2cC", "citedby": "2"}, {"bib": {"title": "Patiromer reduced serum K plus in hyperkalaemic patients with HF and advanced CKD on RAAS inhibitors: Results from OPAL-HK and AMETHYST-DN", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:52neCvzbxIwC", "citedby": "2"}, {"bib": {"title": "Patiromer Reduces Serum K+ in Hyperkalemic Patients with HF and CKD on RAAS Inhibitors: Results from OPAL-HK and AMETHYST-DN", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZppSRAJs3i8C", "citedby": "2"}, {"bib": {"title": "Hypertension: Impact of blood pressure lowering in type 2 diabetes", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EmjvLWWcsQIC", "citedby": "2"}, {"bib": {"title": "PATIROMER LOWERED SERUM POTASSIUM FOR UP TO 1 YEAR IN HYPERKALEMIC PATIENTS WITH DIABETES AND ADVANCED KIDNEY DISEASE ON RAAS INHIBITORS", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kFIFcbgrf0oC", "citedby": "2"}, {"bib": {"title": "PATIROMER REDUCED RECURRENT HYPERKALEMIA IN ADVANCED CKD PATIENTS ON RAASI", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hXkWDDAEazwC", "citedby": "2"}, {"bib": {"title": "Effect of finerenone in patients with diabetic Nephropathy", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hbz17DqrwuEC", "citedby": "2"}, {"bib": {"title": "Investigators OPAL\u2010HK", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZtJ3RtM1NaMC", "citedby": "2"}, {"bib": {"title": "The economics of renoprotective therapy in advanced diabetic kidney disease", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-0tLmPFCw2kC", "citedby": "2"}, {"bib": {"title": "In search for the \u2018sweet spot\u2019for blood pressure level in diabetes", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pZ2CosqRuhkC", "citedby": "2"}, {"bib": {"title": "Primary Hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DCYT7yIMjgYC", "citedby": "2"}, {"bib": {"title": "Canagliflozin demonstrates durable glycemic improvements over 104 weeks compared with glimepiride in subjects with type 2 diabetes mellitus on metformin", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LSkeIYDkhQYC", "citedby": "2"}, {"bib": {"title": "Initial single-pill combination therapy for cardiovascular risk factor management: it is not just convenience", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gnsKu8c89wgC", "citedby": "2"}, {"bib": {"title": "The OSCAR for cardiovascular disease prevention in chronic kidney disease goes to blood pressure control", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:69ZgNCALVd0C", "citedby": "2"}, {"bib": {"title": "Hypertension: Who should be treated? UpToDate", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:D_25heFg6JwC", "citedby": "2"}, {"bib": {"title": "Definition, risk factors, and evaluation of resistant hypertension", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9LpHyFPp1DQC", "citedby": "2"}, {"bib": {"title": "A reappraisal of renin\u2013angiotensin system blockade on microalbuminuria development: do they offer anything unique?", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:C33y2ycGS3YC", "citedby": "2"}, {"bib": {"title": "AZILSARTAN MEDOXOMIL/CHLORTHALIDONE FIXED-DOSE COMBINATION LOWERS BP MORE THAN OLMESARTAN/HYDROCHLOROTHIAZIDE FIXED-DOSE COMBINATION IN STAGE 2 SYSTOLIC HYPERTENSION: LB3. 4", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RVqaWcrwK10C", "citedby": "2"}, {"bib": {"title": "Pharmacodynamic (PD) assessment of blood pressure (BP) in a randomized dose-ranging trial of sorafenib (S).", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1l3MdapXzAoC", "citedby": "2"}, {"bib": {"title": "Fixed-dose combination and chronic kidney disease progression: which is the best?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EPG8bYD4jVwC", "citedby": "2"}, {"bib": {"title": "New angiotensin ii receptor blocker azilsartan medoxomil: comparison to valsartan: PP. 16.88", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Xl6nMSl579sC", "citedby": "2"}, {"bib": {"title": "Results of a novel angiotensin receptor blocker, azilsartan medoxomil, in patients with primary hypertension: 9A. 01", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rbm3iO8VlycC", "citedby": "2"}, {"bib": {"title": "EFFICACY AND SAFETY OF AZILSARTAN MEDOXOMIL, A NOVEL ANGIOTENSIN II RECEPTOR BLOCKER, IN AFRICAN-AMERICANS WITH HYPERTENSION: PO-232", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:d4Uf0zfqV5IC", "citedby": "2"}, {"bib": {"title": "ACE-inhibitoren combineren met calciumantagonisten in plaats van met thiaziden voor de behandeling van hypertensie", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_aaHSq4heJsC", "citedby": "2"}, {"bib": {"title": "Primary hypertension", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NNXJ2mIwlScC", "citedby": "2"}, {"bib": {"title": "HTA: inhibiteur calcique plut\u00f4t qu\u2019un thiazide en ajout \u00e0 un IEC?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xii_ZKWM4-0C", "citedby": "2"}, {"bib": {"title": "Inhibiting renal sodium\u2013glucose transport in diabetes: pass the salt", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ui_nyea79ooC", "citedby": "2"}, {"bib": {"title": "A 12-WEEK, DOUBLE-BLIND, RANDOMIZED, FORCED TITRATION, PARALLEL-GROUP STUDY TO ASSESS THE EFFECTS OF NAPROXCINOD AND NAPROXEN ON ARTERIAL BLOOD PRESSURE AS MEASURED BY ABPM IN \u2026", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sfsSB7lKuh0C", "citedby": "2"}, {"bib": {"title": "Hypertension: The message of World Kidney Day 2009", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-95Q15plzcUC", "citedby": "2"}, {"bib": {"title": "Electrical stimulation of the carotid baroreceptors using the Rheos System decreases renal artery stiffness", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZJ-noXUx9mkC", "citedby": "2"}, {"bib": {"title": "Microalbuminuria and chronic kidney disease as cardiovascular risk factors", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vnF2_uLGgtgC", "citedby": "2"}, {"bib": {"title": "Albuminuria reduction and nephropathy progression.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-Ex_6Thn4vsC", "citedby": "2"}, {"bib": {"title": "KEEP launches follow-up initiative aimed at predicting the future.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:L_l9e5I586QC", "citedby": "2"}, {"bib": {"title": "The Renin\u2013Angiotensin\u2013Aldosterone System and the Kidney", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NtGNdKbuCngC", "citedby": "2"}, {"bib": {"title": "The ADVANCE trial: further PROGRESS with HOPE", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rOcdG6UcVlcC", "citedby": "2"}, {"bib": {"title": "Methods and systems for measuring physician adherence to guidelines", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tHtfpZlB6tUC", "citedby": "2"}, {"bib": {"title": "Contemporary diagnosis and management of hypertension and diabetes", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:prvsfHNhuEoC", "citedby": "2"}, {"bib": {"title": "Is there an ideal strategy for achieving blood pressure goals", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ypg3kOuG8gIC", "citedby": "2"}, {"bib": {"title": "Atherosclerotic Cardiovascular Disease-Preface", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2VmNxfDIOWgC", "citedby": "2"}, {"bib": {"title": "Handbook of Diabetic Hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Fu4hY69slDoC", "citedby": "2"}, {"bib": {"title": "Albuminuria and cardiovascular risk", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zdjWy_NXXwUC", "citedby": "2"}, {"bib": {"title": "Clinical trials report. Combination drug treatment for hypertension with nondiabetic renal disease.", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Hck25ST_3aIC", "citedby": "2"}, {"bib": {"title": "The kidney and hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ziOE8S1-AIUC", "citedby": "2"}, {"bib": {"title": "P-506: Physician adherence to JNC 7 guidelines and blood pressure control", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FiDNX6EVdGUC", "citedby": "2"}, {"bib": {"title": "Preventing hypertensive kidney disease: The critical role of combination therapy", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QsaTk4IG4EwC", "citedby": "2"}, {"bib": {"title": "Carvedilol, metoprolol, and insulin resistance", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:n3vGvpFsckwC", "citedby": "2"}, {"bib": {"title": "The pathogenesis and prevention of radiocontrast medium induced renal dysfunction", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ECvNt0vk_34C", "citedby": "2"}, {"bib": {"title": "Hypertension and Peripheral Vascular Disease", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Nufq_to8ts0C", "citedby": "2"}, {"bib": {"title": "OR 55: Efficacy of angiotensin receptor blockade to improve vascular compliance in people with kidney disease: A pilot study", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:C-Rn0OCouf8C", "citedby": "2"}, {"bib": {"title": "How to adjust ACE inhibitors and ARBs in diabetes?", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sA9dB-pw3HoC", "citedby": "2"}, {"bib": {"title": "Management of hypertension in the cardiometabolic syndrome and diabetes", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mUJArPsKIAAC", "citedby": "2"}, {"bib": {"title": "Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:O0nohqN1r9EC", "citedby": "2"}, {"bib": {"title": "Hypertension and diabetes: Family physicians' pivotal role", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Wq2b2clWBLsC", "citedby": "2"}, {"bib": {"title": "Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yKzB5RS27GgC", "citedby": "2"}, {"bib": {"title": "OR-66: ACE inhibition alone or in combination with a calcium antagonist on vascular compliance in participants with hypertension and type 2 diabetes", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0aBXIfxlw9sC", "citedby": "2"}, {"bib": {"title": "Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:An6A6Jpfc1oC", "citedby": "2"}, {"bib": {"title": "A006: Resistant hypertension in a tertiary care clinic: revisited", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CYCckWUYoCcC", "citedby": "2"}, {"bib": {"title": "Renal mortality associated with non-insulin-dependent diabetes mellitus", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uVUOdF_882EC", "citedby": "2"}, {"bib": {"title": "Risk for renal injury in diabetic hypertensive patients: The physiologic basis for blood pressure control", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ow2R9nchCv8C", "citedby": "2"}, {"bib": {"title": "PRESSOR ROLE OF VASOPRESSIN IN BLACK HYPERTENSIVES", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CMPXdcK5v8EC", "citedby": "2"}, {"bib": {"title": "A ROLE FOR ADENOSINE IN POST RENAL-TRANSPLANT POLYCYTHEMIA", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lPDSu1ZU3VAC", "citedby": "2"}, {"bib": {"title": "Coarctation of the aorta.", "year": "1967"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5AT-p8ixKR4C", "citedby": "2"}, {"bib": {"title": "The comparison of 24-hour ambulatory and clinic blood pressure readings in the ACCOMPLISH trial"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5Klqo5HVOaoC", "citedby": "2"}, {"bib": {"title": "American Association for Thoracic Surgery, American College of Radiology; American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lAj_JhtUatoC", "citedby": "2"}, {"bib": {"title": "Use of sodium\u2013glucose co\u2010transporter\u20102 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J2VLEJC5QowC", "citedby": "1"}, {"bib": {"title": "Major adverse renal events (MARE): A proposal to unifying renal endpoints", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UwBXQvKX0hQC", "citedby": "1"}, {"bib": {"title": "Employment Cost Index, Historical Listing\u2013Volume V: Continuous Occupational and Industry Series: September 1975-December 2017. Table 4: employment cost index for total \u2026", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HWVPSj4JXeEC", "citedby": "1"}, {"bib": {"title": "Resistant Hypertension", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HPvNdXBGwkEC", "citedby": "1"}, {"bib": {"title": "Initial single-pill combinations for antihypertensive treatment: greater cardiovascular mortality reduction yet still not used", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Yv3O0rUKnT0C", "citedby": "1"}, {"bib": {"title": "Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r7mTg6vxT4gC", "citedby": "1"}, {"bib": {"title": "FO022 BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES-POST-HOC ANALYSES FROM BEACON", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jq7mLYt49woC", "citedby": "1"}, {"bib": {"title": "Primary hypertension", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CLPBug3NTQYC", "citedby": "1"}, {"bib": {"title": "The renin\u2013angiotensin\u2013aldosterone system and the kidney", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ui-gComCE0IC", "citedby": "1"}, {"bib": {"title": "Update on reducing the development of diabetic kidney disease and cardiovascular death in diabetes", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fveVehIkgekC", "citedby": "1"}, {"bib": {"title": "MY APPROACH to the elderly patient with resistant hypertension.", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WD7AgJrCjNIC", "citedby": "1"}, {"bib": {"title": "Olmesartan\u2010based monotherapy vs combination therapy in hypertension: A meta\u2010analysis based on age and chronic kidney disease status", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:I96H1Mlar6gC", "citedby": "1"}, {"bib": {"title": "Initial Single\u2010Pill Blood Pressure\u2013Lowering Therapy: Should It Be for Most People?", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9xhnSCvx0jcC", "citedby": "1"}, {"bib": {"title": "High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qzuIxkxWBNsC", "citedby": "1"}, {"bib": {"title": "[PP. 12.09] MASKED-UNCONTROLLED HYPERTENSION MANAGEMENT BASED ON OFFICE BP OR ON OUT-OF-OFFICE (AMBULATORY) BP MEASUREMENT (MASTER): STUDY PROTOCOL", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5Y7y0xowK3MC", "citedby": "1"}, {"bib": {"title": "Arterielle Hyper-und Hypotonie assoziiert mit Psychopharmaka: eine Risikobewertung basierend auf den Fachinformationen", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3oYmN_DgFiMC", "citedby": "1"}, {"bib": {"title": "Proteomanalyse: Neue Wege zur verbesserten Behandlung der diabetischen Nephropathie", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yKcmA0jEsUoC", "citedby": "1"}, {"bib": {"title": "Average clinician measured blood pressure predict cardiovascular outcomes in patients with type 2 diabetes following acute coronary syndromes in the examine trial", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Y20HiHuZk70C", "citedby": "1"}, {"bib": {"title": "Response by Bakris to letter regarding article,\u201cthe implications of blood pressure measurement methods on treatment targets for blood pressure\u201d", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BjLbhSWBl98C", "citedby": "1"}, {"bib": {"title": "Hypertension control and cardiovascular disease\u2013Authors' reply", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7gse_HdimRUC", "citedby": "1"}, {"bib": {"title": "Managing Diabetic Nephropathies in Clinical Practice", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QNfnWKgKwv8C", "citedby": "1"}, {"bib": {"title": "Diabetes: Blood pressure goals in T2DM\u2014time for a rethink?", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XdYaqolBBq8C", "citedby": "1"}, {"bib": {"title": "Current status of renal denervation in hypertension", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UO8fSLLLPykC", "citedby": "1"}, {"bib": {"title": "Insulin therapy for diabetes does not modify the effect of patiromer on serum potassium in hyperkalaemic patients with type 2 diabetes on RAAS inhibitors", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:renmPk63pRgC", "citedby": "1"}, {"bib": {"title": "The effects of nebivolol-valsartan single-pill combinations in reducing blood pressure in patients with stage I or II hypertension", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Dh4RK7yvr34C", "citedby": "1"}, {"bib": {"title": "Diabetes Care: \u201cLagniappe\u201d and \u201cSeeing Is Believing\u201d!", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rlwtDmSc194C", "citedby": "1"}, {"bib": {"title": "Mortality Findings from the EXAMINE Trial", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Oc-rVwKPngoC", "citedby": "1"}, {"bib": {"title": "From epidemiologic transition throughout the ages to modern cardiovascular epidemiology: focus on hypertension in the 21st century: CO-032", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:121WXH0ir18C", "citedby": "1"}, {"bib": {"title": "Patiromer treatment of hyperkalemic resistant hypertension patients with diabetic kidney disease on RAASi normalizes serum potassium and reducing discontinuations secondary to \u2026", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rCuJAniQoLoC", "citedby": "1"}, {"bib": {"title": "Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IK5eWejHrvwC", "citedby": "1"}, {"bib": {"title": "Finerenone for Albuminuria in Patients With Diabetic Nephropathy\u2014Reply", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kVKjLOQJbwAC", "citedby": "1"}, {"bib": {"title": "Treatment of hypertension in patients with heart failure", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9i1gB6tY3MIC", "citedby": "1"}, {"bib": {"title": "Cardiovascular Risk Assessment, Summary of Guidelines for the Management of Hypertension and a Critical Appraisal of the 2014 Expert Panel of the National Institutes of Health \u2026", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2C0LhDdYSbcC", "citedby": "1"}, {"bib": {"title": "Blood-Pressure Control", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5kvG9DmRKWYC", "citedby": "1"}, {"bib": {"title": "TCT-83 Long-term (24-month) blood pressure results of catheter-based renal artery denervation: SYMPLICITY HTN-3 Randomized Controlled Trial", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H0nRGT7Dr7IC", "citedby": "1"}, {"bib": {"title": "Patiromer Lowered Serum K plus in Hyperkalemic Patients with Diabetic Kidney Disease on RAAS Inhibitors", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QxlgOPrhsAcC", "citedby": "1"}, {"bib": {"title": "4A. 10: PREFERENTIAL REDUCTION IN MORNING/NOCTURNAL HYPERTENSION BY RENAL DENERVATION FOR DRUG-RESISTANT HYPERTENSION: A NEW ABPM ANALYSIS OF SYMPLICITY HTN-3 AND HTN-JAPAN.", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vbti4gW_9XwC", "citedby": "1"}, {"bib": {"title": "SuO019 PATIROMER LOWERED SERUM POTASSIUM FOR UP TO 1 YEAR IN HYPERKALEMIC PATIENTS WITH DIABETES AND ADVANCED KIDNEY DISEASE ON RAAS INHIBITORS", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:edV_OwlUe4UC", "citedby": "1"}, {"bib": {"title": "Renal Denervation Therapy and Baroreceptor Activation Therapy: Emerging Tools for Treating Resistant Hypertension", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5N-NJrZHaHcC", "citedby": "1"}, {"bib": {"title": "Differences between angiotensin-converting enzyme inhibitors and receptor blockers", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QVtou7C4vgoC", "citedby": "1"}, {"bib": {"title": "TCT-405 SYMPLICITY HTN-3: Outcomes in the African-American and non-African American Populations", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wE8AsS3ykUMC", "citedby": "1"}, {"bib": {"title": "Fixed-dose combination of nebivolol and valsartan in patients with stage 1 or 2 hypertension: ABPM substudy of a phase 3 randomized trial", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZYLUaBFA95QC", "citedby": "1"}, {"bib": {"title": "Diagnosis, prevention, and treatment of hypertensive heart disease", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5p9vMBpPSXYC", "citedby": "1"}, {"bib": {"title": "Canagliflozin is effective and generally well tolerated in subjects with type 2 diabetes mellitus and stage 3 chronic kidney disease", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qwOXE0mbtu4C", "citedby": "1"}, {"bib": {"title": "Clinical guidelines: blood pressure goals in T2DM: a Latin American perspective", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ic1VZgkJnDsC", "citedby": "1"}, {"bib": {"title": "O\u2019Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College \u2026", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:43B52WW2E64C", "citedby": "1"}, {"bib": {"title": "Gu\u00edas y recomendaciones para el diagn\u00f3stico y manejo de la diabetes mellitus Cap\u00edtulos 7 a 13", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:P--cqP0FnSgC", "citedby": "1"}, {"bib": {"title": "Clinical Laboratory Practice Guides Instructions and recommendations for the diagnosis and management of diabetes mellitus Chapters 7 to 13", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2u1QkWOsl3MC", "citedby": "1"}, {"bib": {"title": "Hypertensive goals in patients with coronary artery disease", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2ywjKiB__4kC", "citedby": "1"}, {"bib": {"title": "558 AZILSARTAN MEDOXOMIL VS OLMESARTAN AND VALSARTAN: EFFECTS ON AMBULATORY AND CLINIC BP IN HYPERTENSIVE BLACK PATIENTS", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_n8fIOMweQoC", "citedby": "1"}, {"bib": {"title": "TREATMENT-RESISTANT BLOOD PRESSURE AMONG PATIENTS WITH CORONARY ARTERY DISEASE\u2013CAUSE FOR CONCERN: NEW DATA FROM THE EXTENDED FOLLOW-UP OF THE INTERNATIONAL VERAPAMAIL SR \u2026", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ifOnle78iJkC", "citedby": "1"}, {"bib": {"title": "Combination therapy in hypertension treatment", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:u0Mu_IsstPMC", "citedby": "1"}, {"bib": {"title": "Novel Pharmacological Approaches in Hypertension Treatment", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JH5k92_tO-AC", "citedby": "1"}, {"bib": {"title": "Renal Hemodynamic Changes in Heart Failure", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yTLRzDEmwhEC", "citedby": "1"}, {"bib": {"title": "ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus \u2026", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bczYY1dZPtQC", "citedby": "1"}, {"bib": {"title": "354 Disease State Awareness, Kidney Disease, and Relationship to ESRD and Death", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:__bU50VfleQC", "citedby": "1"}, {"bib": {"title": "Blood Pressure Targets in Diabetes: Is This the Time for Change?\u2014CON (Rebuttal)", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HhcuHIWmDEUC", "citedby": "1"}, {"bib": {"title": "Individualized programming demonstrates feasibility of unilateral approach to delivery of baroreflex activation therapy", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aU4yMueWZ3QC", "citedby": "1"}, {"bib": {"title": "Hypertension and hypertensive heart disease. Foreword.", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fZtrMt_Z7PsC", "citedby": "1"}, {"bib": {"title": "Hypertension Following Kidney Injury", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Vztgr1qGG8IC", "citedby": "1"}, {"bib": {"title": "THE NEW ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL HAS SIGNIFICANTLY GREATER 24-HOUR BLOOD PRESSURE LOWERING EFFICACY TO BOTH OLMESARTAN AND VALSARTAN: 9D. 05", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2vr6o8x5NLkC", "citedby": "1"}, {"bib": {"title": "Combination therapy in hypertension: new recommendations", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6MVT8mER-OMC", "citedby": "1"}, {"bib": {"title": "Tenth anniversary of the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cG0OFEevkNgC", "citedby": "1"}, {"bib": {"title": "Pediatrics: Blood pressure target for renoprotection in children", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:z6xuaG2dYH0C", "citedby": "1"}, {"bib": {"title": "Hypertensive kidney disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xUT3DyvLuJwC", "citedby": "1"}, {"bib": {"title": "Page. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2BeMVx_SZpEC", "citedby": "1"}, {"bib": {"title": "The editor's roundtable: prehypertension", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:v6i8RKmR8ToC", "citedby": "1"}, {"bib": {"title": "Renin-angiotensin system inhibition and reduction in all-cause mortality in hospitalized elderly diastolic heart failure patients with chronic kidney disease: a propensity \u2026", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rDsFeusoTZkC", "citedby": "1"}, {"bib": {"title": "Is blockade of the renin-angiotensin system appropriate for all patients with diabetes?", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qE4H1tSSYIIC", "citedby": "1"}, {"bib": {"title": "The Effect of Renin-Angiotensin System Inhibition on All-Cause Mortality in Hospitalized Elderly Systolic Heart Failure Patients with Chronic Kidney Disease", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wLxue7F8ec0C", "citedby": "1"}, {"bib": {"title": "THE COMPARISON OF 24-HOUR AMBULATORY AND CLINIC BLOOD PRESSURE READINGS IN THE ACCOMPLISH TRIAL: LB-OR-010", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H8BRrGBkN7cC", "citedby": "1"}, {"bib": {"title": "COMPARABLE BLOOD PRESSURE CONTROL AND LV MASS REDUCTION IN PATIENTS WITH HYPERTENSION AND LVH WITH ACE INHIBITOR ALONE OR COMBINED WITH \u03b2-BLOCKADE: LB-OR-08", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6TexfgwXQfYC", "citedby": "1"}, {"bib": {"title": "ADVANCE: blood pressure lowering in diabetes", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:T_ojBgVMvoEC", "citedby": "1"}, {"bib": {"title": "Response to \u2018Telmisartan is more effective than losartan in reducing proteinuria\u2019", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KR6TXPE-FHQC", "citedby": "1"}, {"bib": {"title": "New onset diabetes: can it be delayed?", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GiYFt9mpioMC", "citedby": "1"}, {"bib": {"title": "Hypertension awareness, treatment and control in individuals with chronic kidney disease: An analysis from the NKF-KEEP database", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:h1pkognVyKwC", "citedby": "1"}, {"bib": {"title": "Combination of amlodipine plus olmesartan medoxomil (OM) is effective and safe with long term dosing while treating patients (pts) to blood pressure (BP) goal", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QtA78RmWg5MC", "citedby": "1"}, {"bib": {"title": "Level of education and type of insurance but not race predict control of hypertension in a diverse, high-risk population. Data from the University of Chicago study of \u2026", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jKT558fuBk8C", "citedby": "1"}, {"bib": {"title": "Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome (vol 29, pg 2592, 2006)", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:T-SPRlcIgBMC", "citedby": "1"}, {"bib": {"title": "An Evidence-Based Practice Protocol for the Diagnosis and Management of Microalbuminuria in the Diabetic Patient", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wE-fMHVdjMkC", "citedby": "1"}, {"bib": {"title": "Clinical Research Study", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Z7R3Ocg27JUC", "citedby": "1"}, {"bib": {"title": "Study for the evaluation of early kidney disease (SEEK): diabetic patients experience greater vitamin D deficiency during chronic kidney disease (CKD) progression", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:e3CVSTJ63dQC", "citedby": "1"}, {"bib": {"title": "Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:k_7cPK9k7w8C", "citedby": "1"}, {"bib": {"title": "Cost effectiveness of losartan in the treatment of patients with type 2 diabetes and nephropathy in Greece", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ovGv7akYl-cC", "citedby": "1"}, {"bib": {"title": "Once-daily carvedilol is effective in treating hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HKviVsUxM5wC", "citedby": "1"}, {"bib": {"title": "\u00bf Los hallazgos del estudio STAR (the Study of Trandolapril/Verapamil-SR and Insulin Resistance) cambiar\u00e1n el tratamiento de los pacientes hipertensos con el s\u00edndrome metab\u00f3lico?", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q1zXlPLtbUIC", "citedby": "1"}, {"bib": {"title": "History of hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HHUT0vUrEqMC", "citedby": "1"}, {"bib": {"title": "Management and Treatment Guidelines", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fc7zyzPI2QAC", "citedby": "1"}, {"bib": {"title": "Microalbuminuria and hyperglycemia: the changing landscape of chronic kidney disease (CKD)", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nroGzMJTTpEC", "citedby": "1"}, {"bib": {"title": "Demographic analyses of the effects of carvedilol vs. metoprolol in subjects with type 2 diabetes and hypertension in the GEMINI study", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gFrPXmx1TSsC", "citedby": "1"}, {"bib": {"title": "Rosiglitazone (RSG) Added to Metformin (MET) Reduces Urinary Albumin/Creatinine Ratio and Ambulatory Blood Pressure in Subjects with Microalbuminuria and Type 2 Diabetes (T2DM)", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yCjxvIMm6_oC", "citedby": "1"}, {"bib": {"title": "P-234: Weight changes and insulin sensitivity-not all beta-blockers are created equal", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i_7YvbSbtFEC", "citedby": "1"}, {"bib": {"title": "P-270: Predictors of goal blood pressure achievement in patients with hypertension only or kidney diesease and/or diabetes in a tertiary hypertension center", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YlPif8NxrbYC", "citedby": "1"}, {"bib": {"title": "The effects of macronutrients and dietary patterns on blood pressure", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hSRAE-fF4OAC", "citedby": "1"}, {"bib": {"title": "Pathogenesis of atherosclerotic vascular disease", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:65Yg0jNCQDAC", "citedby": "1"}, {"bib": {"title": "Risk/benefit analysis of hyperkalemia on clinical outcomes in EPHESUS", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DUFsPKDdMi0C", "citedby": "1"}, {"bib": {"title": "Increased systolic blood pressure is associated with new diabetes in hypertensive patients with coronary artery disease", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:s2G-WRnXBicC", "citedby": "1"}, {"bib": {"title": "Effects of olmesartan medoxomil (OLM) and losartan potassium (LOS) in patients with hypertension (HTN), type 2 diabetes mellitus (T2DM), and microalbuminuria", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kJDgFkosVoMC", "citedby": "1"}, {"bib": {"title": "P-351: Effects of drospirenone/estradiol on blood pressure and serum potassium in hypertensive postmenopausal women at risk for hyperkalemia", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:silx2ntsSuwC", "citedby": "1"}, {"bib": {"title": "Approaches to achieve blood pressure goals", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CCeGMaHljPEC", "citedby": "1"}, {"bib": {"title": "The Kidney and Hypertension", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ujxm2eEBZHIC", "citedby": "1"}, {"bib": {"title": "Cardiovascular outcomes in diabetic patients with hypertension and coronary artery disease: The International Verapamil/trandolapril STudy", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J4E9jCG1tHUC", "citedby": "1"}, {"bib": {"title": "Achieving Blood Pressure Goals: Is Fixed\u2010Dose Combination Therapy the Answer?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kzcSZmkxUKAC", "citedby": "1"}, {"bib": {"title": "P-614: Exaggerated blood pressure response to exercise predicts new-onset hypertension in women: women take heart study, 1992-2001", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:S0CDQJw8Yr4C", "citedby": "1"}, {"bib": {"title": "OR-75: Medication utilization to achieve goal blood pressure in a tertiary hypertension clinic", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:g5Ck-dwhA_QC", "citedby": "1"}, {"bib": {"title": "When to refer patients to a nephrologist?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BCdnXsLIVDwC", "citedby": "1"}, {"bib": {"title": "Angiotensin receptor blockers", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:V-j82LJCZ3MC", "citedby": "1"}, {"bib": {"title": "Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:x21FZCSn4ZoC", "citedby": "1"}, {"bib": {"title": "The relationship between achieved blood pressure (BP) and renal outcomes in the African American study of kidney disease (AASK).", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-38epGy1wY0C", "citedby": "1"}, {"bib": {"title": "P-228: A comparative study of celecoxib versus diclofenac on blood pressure control and renal function in hypertensive African Americans and Hispanics: A randomized crossover study", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SrKkpNFED5gC", "citedby": "1"}, {"bib": {"title": "P-171: Lack of performance-related bias in blood pressure measurements in a hypertension clinic", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ghEM2AJqZyQC", "citedby": "1"}, {"bib": {"title": "Microalbuminuria", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0lma3NU_mqEC", "citedby": "1"}, {"bib": {"title": "P-649: Prevalence and controll of cardiovascular risk factors in a tertiary hypertension clinic", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qwy9JoKyICEC", "citedby": "1"}, {"bib": {"title": "Prevention and management of renal disease in the patient with diabetes mellitus", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eGYfIraVYiQC", "citedby": "1"}, {"bib": {"title": "Editorial on Ibrahim et al's \u201cClinical Pharmacology Studies in Patients with Renal Impairment: Past Experience and Regulatory Perspectives\u201d", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rbGdIwl2e6cC", "citedby": "1"}, {"bib": {"title": "When to discontinue ACE inhibitors for nephropathy", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UmS_249rOGwC", "citedby": "1"}, {"bib": {"title": "Angiotensin II receptor blockers in hypertension and renal disease", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2v_ZtQDX9iAC", "citedby": "1"}, {"bib": {"title": "Renin-angiotensin system in diabetic nephropathy: from bench to bedside", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:isU91gLudPYC", "citedby": "1"}, {"bib": {"title": "Editorial debate", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r5Jnz2hFFzMC", "citedby": "1"}, {"bib": {"title": "Antihypertensive Therapy and Treatment of Diabetic Nephropathy: Prognostic Implications", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qe6vwMD2xtsC", "citedby": "1"}, {"bib": {"title": "HYPERTENSION AND THE KIDNEY-29TH DEIDESHEIMER-GESPRACH-APRIL 29, 1995-PANEL DISCUSSION", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YGhAHpnIhDoC", "citedby": "1"}, {"bib": {"title": "Do ACE inhibitors affect diabetic morbidity and mortality?", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j2GSQqY3pL0C", "citedby": "1"}, {"bib": {"title": "Empiric treatment of acute toxoplasma encephalitis in patients with acquired immunodeficiency syndrome", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2hlgnPHlchoC", "citedby": "1"}, {"bib": {"title": "Risk for renal injury in diabetic hypertensive patients: Pharmacologic approaches", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:27LrP4qxOz0C", "citedby": "1"}, {"bib": {"title": "Treatment of hypertension in the elderly: a review", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AYInfyleIOsC", "citedby": "1"}, {"bib": {"title": "Theophylline for Erythrocytosis after Renal Transplantation", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-A4928QJj7oC", "citedby": "1"}, {"bib": {"title": "PARATHYROID-HORMONE (PTH) SECRETION INCREASES FOLLOWING INFUSION OF DOPAMINE (D) BUT NOT FENOLDOPAM (F), A SELECTIVE DOPAMINE-1 (DA1) RECEPTOR AGONIST, IN MAN", "year": "1987"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ef2wPL15CskC", "citedby": "1"}, {"bib": {"title": "Alpha-adrenoceptor contribution to renal vascular effects of low-dose dopamine", "year": "1987"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:t9Ks5LMjN0QC", "citedby": "1"}, {"bib": {"title": "SUPPRESSION OF OXYGEN FREE-RADICALS (FR) ATTENUATES THE RADIOCONTRAST MEDIUM (RCM)-INDUCED DECLINE IN GLOMERULAR-FILTRATION RATE (GFR)", "year": "1987"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fGk8ZXjgAbkC", "citedby": "1"}, {"bib": {"title": "THE PROTECTIVE ROLE OF VERAPAMIL AGAINST RADIOCONTRAST INDUCED INTRARENAL VASOCONSTRICTION", "year": "1984"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J-ba04ztB30C", "citedby": "1"}, {"bib": {"title": "Clinical manifestations and diagnosis of fibromuscular dysplasia"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zPkyA21Y468C", "citedby": "1"}, {"bib": {"title": "NSAIDs and acetaminophen: Effects on blood pressure and hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:l_4PpDxvVJAC", "citedby": "1"}, {"bib": {"title": "Use of thiazide diuretics in patients with primary (essential) hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KD63RgGzVVoC", "citedby": "1"}, {"bib": {"title": "How to Manage Hypertension in People with Diabetes", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LdOr7sPPAccC", "citedby": "0"}, {"bib": {"title": "NEO-KIDNEY AUGMENTTM (NKA): PHASE II STUDY OF PERCUTANEOUS RENAL INJECTION OF AUTOLOGOUS HOMOLOGOUS NKA IN SUBJECTS WITH TYPE 2 DIABETES AND CKD", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_sLlIXX7spQC", "citedby": "0"}, {"bib": {"title": "OPEN-LABEL STUDY OF THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF DM199 IN SUBJECTS WITH DIABETES AND CHRONIC KIDNEY DISEASE", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yHoQYHXJRqAC", "citedby": "0"}, {"bib": {"title": "NEO-KIDNEY AUGMENTTM (NKA): PHASE II STUDY OF PERCUTANEOUS INJECTION OF AUTOLOGOUS HOMOLOGOUS NKA IN TYPE 2 DIABETES WITH PRE-STAGE 5 CHRONIC KIDNEY DISEASE", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nFloTcPoiwMC", "citedby": "0"}, {"bib": {"title": "Non\u2010steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney disease", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1In3SbHwanAC", "citedby": "0"}, {"bib": {"title": "Fear of Lowering Cardiovascular Risk by Achieving Blood Pressure Goals: The Irrationality of Combination Therapy Avoidance", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GmgqlyE4arsC", "citedby": "0"}, {"bib": {"title": "Improvement of Cardiovascular Functional Reserve After Kidney Transplant\u2014Has the CAPER Been Solved?", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7YMrAF6eRCIC", "citedby": "0"}, {"bib": {"title": "THE EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE AND CARDIOVASCULAR DEATH BY BASELINE PARTICIPANT CHARACTERISTICS: ANALYSIS OF THE CREDENCE TRIAL", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:T5V60G5X4B8C", "citedby": "0"}, {"bib": {"title": "EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES BY BASELINE LOOP DIURETIC USE: DATA FROM THE CREDENCE TRIAL", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9Df4XUWggEMC", "citedby": "0"}, {"bib": {"title": "CANAGLIFLOZIN (CANA) REDUCES CARDIOVASCULAR (CV) AND RENAL EVENTS INDEPENDENT OF BASELINE HEART FAILURE (HF): A CREDENCE SECONDARY ANALYSIS", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7jLzoj1EsW0C", "citedby": "0"}, {"bib": {"title": "Explaining the slowdown in medical spending growth among the elderly, 1999-2012.", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6KBr9xvF6m4C", "citedby": "0"}, {"bib": {"title": "SAT-156 RENAL, CARDIOVASCULAR, AND SAFETY OUTCOMES OF CANAGLIFLOZIN ACCORDING TO BASELINE ALBUMINURIA: A CREDENCE SECONDARY ANALYSIS", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:siTy-4AL0AwC", "citedby": "0"}, {"bib": {"title": "Management of Serum Potassium in Patients with Heart Failure", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MUocvVTjX6cC", "citedby": "0"}, {"bib": {"title": "Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RL3Vt95MvH0C", "citedby": "0"}, {"bib": {"title": "Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE \u2026", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KG521SxztIwC", "citedby": "0"}, {"bib": {"title": "Hypertension and Diabetes", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TLwS_1sUIYkC", "citedby": "0"}, {"bib": {"title": "Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xCS0c1RzPY8C", "citedby": "0"}, {"bib": {"title": "Bibliography Current World Literature Vol 11 No 2 March 2002", "year": "2020"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:c59VksA5Vz4C", "citedby": "0"}, {"bib": {"title": "Paradoxical Cardiorenal Responses Following Acute Vasodilator/Natriuretic Treatment in Presystolic Heart Failure: Should We Be Surprised?", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:z5I2ou_Dk_MC", "citedby": "0"}, {"bib": {"title": "Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c< 7 \u2026", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Mb21Z44dZ7IC", "citedby": "0"}, {"bib": {"title": "Improving blood pressure control among vulnerable patients: Evidence from implementing the Extension of Community Healthcare Outcomes (ECHO) model in five free clinics", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MOUuoOoUJb4C", "citedby": "0"}, {"bib": {"title": "Changes in nocturnal blood pressure post-renal denervation: comparison of treatment versus control groups in SYMPLICITY HTN-3", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CtYknXOfbFEC", "citedby": "0"}, {"bib": {"title": "1200 Changes in nocturnal blood pressure post-renal denervation: comparison of treatment versus control groups in SYMPLICITY HTN-3", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zBYNw3HCx4kC", "citedby": "0"}, {"bib": {"title": "Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SSsxPzPPytkC", "citedby": "0"}, {"bib": {"title": "Hypertensive Heart Failure: Sprinting to the Finish Line to Prevent End-Organ Damage", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:w_Qt3Pluy5YC", "citedby": "0"}, {"bib": {"title": "Hypertensive Heart Disease, An Issue of Heart Failure Clinics", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:seU1ZbiIO-YC", "citedby": "0"}, {"bib": {"title": "Assessing Wide Pulse Pressure Hypertension: Data Beyond the Guidelines", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yuCoZvLJRl8C", "citedby": "0"}, {"bib": {"title": "FP483 EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR)\u2013A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-jghkW3WqMUC", "citedby": "0"}, {"bib": {"title": "SaO010 EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES\u2013A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:54MofcL-yxcC", "citedby": "0"}, {"bib": {"title": "FP172 EFFECTS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN PROTEINURIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RRCMsQZi3KMC", "citedby": "0"}, {"bib": {"title": "1118-P: Effect of Patiromer in Patients 75 Years or Older with Diabetic Kidney Disease and Hyperkalemia Receiving a RAAS Inhibitor", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OYCXtYc4maoC", "citedby": "0"}, {"bib": {"title": "PREVALENCE AND FACTORS ASSOCIATED WITH UNDIAGNOSED CHRONIC KIDNEY DISEASE IN DIABETES MELLITUS", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4_XrlajHzhgC", "citedby": "0"}, {"bib": {"title": "Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines?\u2015An Asian Perspective\u2015", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ToZsFq5dof0C", "citedby": "0"}, {"bib": {"title": "PEER REVIEWERS LIST", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0oeUc68sgesC", "citedby": "0"}, {"bib": {"title": "Articles Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CoqsOaBEKcQC", "citedby": "0"}, {"bib": {"title": "Editor-in-Chief Joseph A. Hill", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:n5u26LFhhPsC", "citedby": "0"}, {"bib": {"title": "Management of Hypertension in Diabetes Mellitus", "year": "2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qkvbYSGtNvkC", "citedby": "0"}, {"bib": {"title": "Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZxXHo_Hcam8C", "citedby": "0"}, {"bib": {"title": "Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3utUx_xxzcoC", "citedby": "0"}, {"bib": {"title": "A4494 The effect of soursop supplement on blood pressure, serum uric acid and kidney function in prehypertensive patients for more than ten years in javanese population of \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VPl5zSG_J1oC", "citedby": "0"}, {"bib": {"title": "A6256 ASSOCIATED GENDER DIFFERENCES BETWEEN SERUM URIC ACID, MORNING HOME BLOOD PRESSURE MONITORING AND CARDIOVASCULAR RISK FACTORS PREVALENCE AFTER 10 YEARS BASED ON REGIONAL \u2026", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VU60ks20i7sC", "citedby": "0"}, {"bib": {"title": "Presence of Diabetes Does Not Mandate Lower Blood Pressure to Reduce Cardiovascular Events.", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zDMysJqCCKgC", "citedby": "0"}, {"bib": {"title": "Hyperkalaemia in diabetes: a silent risk predicting poor outcomes", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r_W8SUTUyowC", "citedby": "0"}, {"bib": {"title": "Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H7P4rdOtXtsC", "citedby": "0"}, {"bib": {"title": "SHORT-TERM BLOOD PRESSURE VARIABILITY PREDICTS CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:A_-8YG8SPFQC", "citedby": "0"}, {"bib": {"title": "FP540 SHORT-TERM BLOOD PRESSURE VARIABILITY PREDICTS CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1GSnt3Xtl_sC", "citedby": "0"}, {"bib": {"title": "CANAGLIFLOZIN AND RENAL OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M0jDNLgoRFEC", "citedby": "0"}, {"bib": {"title": "Blood pressure reduced to new guideline goals in patients with high\u2010normal glucose further reduces cardiovascular events", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xwIxJehhd2UC", "citedby": "0"}, {"bib": {"title": "SYSTEMATIC REVIEW OF PREVALENT AND INCIDENT HEART FAILURE IN CARDIOVASCULAR OUTCOME TRIALS OF PATIENTS WITH TYPE 2 DIABETES", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aXQ7jtEqGowC", "citedby": "0"}, {"bib": {"title": "Antihypertensive Drug\u2013Induced Iatrogenic Cardiovascular Syndromes", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mmBnJtEBTSAC", "citedby": "0"}, {"bib": {"title": "Iatrogenicity: Causes and consequences of iatrogenesis in cardiovascular medicine", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WzbvD7BMtBoC", "citedby": "0"}, {"bib": {"title": "The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale and design", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fBUZQ4zhMLYC", "citedby": "0"}, {"bib": {"title": "Off Topic\u2013Hypertension in 42 percent of adults (new definition: 130 mm Hg)\u2013Feb 2018", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jgpk9vOjLEcC", "citedby": "0"}, {"bib": {"title": "Diabetes Mellitus and Hypertension", "year": "2018"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Qqt8gOYqc0UC", "citedby": "0"}, {"bib": {"title": "Assessing the feasibility and effectiveness of an established telehealth model to train primary care providers on hypertension management in free and charitable clinics", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sFUlmsclzkgC", "citedby": "0"}, {"bib": {"title": "Severe menses\u2010associated hypertension successfully treated with gonadotropin\u2010releasing hormone agonist", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tai-Ft5GzhwC", "citedby": "0"}, {"bib": {"title": "SUSTAINED REDUCTION OF BLOOD PRESSURE WITH BARORECEPTOR ACTIVATION THERAPY: RESULTS OF SIX-YEAR OPEN FOLLOW-UP", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:B4wWq2ztVNgC", "citedby": "0"}, {"bib": {"title": "Visit-to-visit blood pressure variability and cardiovascular outcomes in patients with type 2 diabetes following acute coronary syndromes in the EXAMINE trial", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:X-Dm1JipzzIC", "citedby": "0"}, {"bib": {"title": "High sensitivity C-reactive protein, LDL cholesterol and cardiovascular outcomes in patients with type 2 diabetes and acute coronary syndrome from EXAMINE", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PPAp3RzCAaIC", "citedby": "0"}, {"bib": {"title": "Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The \u2026", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1TqUyixsFioC", "citedby": "0"}, {"bib": {"title": "P1652Antihypertensive treatment effect on 24h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan \u2026", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UoSa6IK8DwsC", "citedby": "0"}, {"bib": {"title": "Delayed-Release Metformin Targeting the Lower Bowel Elicits Sustained Improvements in A1c and Fasting Glucose with Minimal Systemic Exposure", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sCWLdL-sCz8C", "citedby": "0"}, {"bib": {"title": "Special Considerations for Primary and Secondary Stroke Prevention in Women", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_8F20clBW_QC", "citedby": "0"}, {"bib": {"title": "Effect of staffing on improving newborn health", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zuN7wi50mysC", "citedby": "0"}, {"bib": {"title": "Use of Combination Therapies", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pXiCqeVOhFwC", "citedby": "0"}, {"bib": {"title": "Putting All Guidelines Into Perspective", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TpYZtc-0n-8C", "citedby": "0"}, {"bib": {"title": "Hypertension and Chronic Kidney", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:A5aiAONn640C", "citedby": "0"}, {"bib": {"title": "The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:h6vPvb0CPpsC", "citedby": "0"}, {"bib": {"title": "Initial Single-Pill Blood Pressure\u2013Lowering Therapy: Should It Be for Most People?", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4PzMk9GH2tkC", "citedby": "0"}, {"bib": {"title": "Managing Diabetic Nephropathies in Clinical Practice: Emerging and Future Therapies", "year": "2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5s9rAH04UEoC", "citedby": "0"}, {"bib": {"title": "Renal Biomarkers Predict Long-Term Adverse Events in Patients With Type 2 Diabetes Mellitus and Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AUmYgNQ2pq4C", "citedby": "0"}, {"bib": {"title": "Current Issue Highlights", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0sTkTiv_uMkC", "citedby": "0"}, {"bib": {"title": "MPS 03-08 ON-TREATMENT BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN OLDER ADULTS WITH ISOLATED SYSTOLIC HYPERTENSION: VALSARTAN IN ELDERLY ISOLATED SYSTOLIC HYPERTENSION \u2026", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-152x6qmK5kC", "citedby": "0"}, {"bib": {"title": "OS 19-03 TREATMENT WITH PATIROMER RESULTED IN DECREASES IN ALDOSTERONE IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERKALEMIA ON RAAS INHIBITORS: RESULTS FROM OPAL-HK.", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Zp9IZb6oESQC", "citedby": "0"}, {"bib": {"title": "DB 03-2 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (CON).", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PbrqR9PZhrEC", "citedby": "0"}, {"bib": {"title": "OS 07-02 DIFFERENCES IN CIRCADIAN BLOOD PRESSURE VARIABILITY PATTERNS BETWEEN JAPANESE AND AMERICAN TREATMENT-RESISTANT HYPERTENSIVE POPULATIONS.", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Xc8JtHQmRf8C", "citedby": "0"}, {"bib": {"title": "[OP. 7D. 01] SAFETY AND BLOOD PRESSURE EFFECTS OF SECOND-VERSUS FIRST-GENERATION SYSTEM FOR ADMINISTERING BAROREFLEX ACTIVATION THERAPY", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:N2osnxbUuuUC", "citedby": "0"}, {"bib": {"title": "Mortality risk following a non-fatal CV event in patients with type 2 diabetes: findings from the EXAMINE trial", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DxlTmyU89zoC", "citedby": "0"}, {"bib": {"title": "SYMPLICITY HTN-3 screen failure patient cohort", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:njp6nI0QjqAC", "citedby": "0"}, {"bib": {"title": "Efecto de la finerenona sobre la albuminuria en pacientes con nefropat\u00eda diab\u00e9tica.\u00bf Grandes esperanzas en tiempos dif\u00edciles?", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:u76CbRzuV8AC", "citedby": "0"}, {"bib": {"title": "Renal Outcomes Associated with Alogliptin vs. Placebo in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndrome: Results from the EXAMINE Trial", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:45AZ0Vt6gvEC", "citedby": "0"}, {"bib": {"title": "PATIROMER PROTECTED AGAINST RECURRENT HYPERKALEMIA FOR UP TO 52 WEEKS IN PATIENTS WITH DIABETIC KIDNEY DISEASE (DKD) RECEIVING COMBINED RAAS INHIBITOR THERAPY", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KxdiYzj_eL0C", "citedby": "0"}, {"bib": {"title": "Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalemia: CO-001", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oQQVFBP0nzwC", "citedby": "0"}, {"bib": {"title": "Thank you to our reviewers 2015", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-3_NAp5WSNkC", "citedby": "0"}, {"bib": {"title": "Sodium\u2010glucose cotransporter 2 inhibitors for macroalbuminuria: A new indication", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IEHkmGLyHGEC", "citedby": "0"}, {"bib": {"title": "Reviewers for the Journal, July\u2013December 2015", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GGgVawPscysC", "citedby": "0"}, {"bib": {"title": "Building Momentum: Taking on the Real \u201cIssues\u201d of Diabetes Care!", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7bRg-L-9LFcC", "citedby": "0"}, {"bib": {"title": "Front & Back Matter", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IT5EXw6i2GUC", "citedby": "0"}, {"bib": {"title": "Front & Back Matter", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M3zsPnPgUlUC", "citedby": "0"}, {"bib": {"title": "Cardiovascular Outcomes in the EXAMINE Trial", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vM5yiaU9oLoC", "citedby": "0"}, {"bib": {"title": "Reviewers for the Journal, January\u2013June 2016", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nOKOSwxqtg8C", "citedby": "0"}, {"bib": {"title": "Treatment of fibromuscular dysplasia of the renal arteries", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dY-VugTTHzcC", "citedby": "0"}, {"bib": {"title": "Carotid Baroreceptor Stimulation", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EfTNjLFZ3b0C", "citedby": "0"}, {"bib": {"title": "Front & Back Matter", "year": "2016"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jPVjDSAV6m0C", "citedby": "0"}, {"bib": {"title": "TREATMENT OPTION 1 Maintain the Current Antihypertensive Regimen", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cAUKuAERoUMC", "citedby": "0"}, {"bib": {"title": "Patiromer induced a rapid onset of action and sustained potassium (K+) lowering throughout the dosing period in CKD patients with hyperkalemia", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HkunuPqSaCsC", "citedby": "0"}, {"bib": {"title": "Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1DAnfT_YoJgC", "citedby": "0"}, {"bib": {"title": "20. Major Cardiovascular Outcomes in the EXAMINE Trial According to ACE Inhibitor Use (12-OR)", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:e0CZ6poB34oC", "citedby": "0"}, {"bib": {"title": "Patiromer effective for drug-associated hyperkalaemia", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xMZGxf1v-3YC", "citedby": "0"}, {"bib": {"title": "Potential reduction in office and nocturnal blood pressure after renal denervation in patients with obstructive sleep apnea: a subgroup analysis of SYMPLICITY HTN-3", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rQKKVauEoioC", "citedby": "0"}, {"bib": {"title": "PP. 21.16: META-ANALYSIS OF OLMESARTAN-BASED SINGLE PILL COMBINATION VERSUS MONOTHERAPY FOR REDUCING BLOOD PRESSURE", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1Lk_dUza_R0C", "citedby": "0"}, {"bib": {"title": "PP. 21.34: EXTENSIVE DEVELOPMENT OF A NEW ANTIHYPERTENSIVE STRATEGY: A SINGLE-PILL COMBINATION INDICATED AS FIRST LINE THERAPY", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0uG9q0SNyf4C", "citedby": "0"}, {"bib": {"title": "Effect of cardiovascular comorbidities on the mortality risk associated with serum potassium: P458", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Qs68GpkTGbMC", "citedby": "0"}, {"bib": {"title": "Arterial hypertension in diabetes: etiology and treatment", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Agc8PWtS8JkC", "citedby": "0"}, {"bib": {"title": "Systolic blood pressure reductions with sotagliflozin (LX4211), a dual SGLT1 and SGLT2 inhibitor, are associated with reductions in urinary sodium excretion", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pfJNqKtVkuoC", "citedby": "0"}, {"bib": {"title": "Relationship between abdominal obesity, hypertension, and aldosterone production in post-menopausal females", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Vxkav03X4woC", "citedby": "0"}, {"bib": {"title": "Patiromer increased time to RAAS inhibitor discontinuation compared with placebo in advanced CKD patients with hyperkalemia", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eG7oJ4UONFcC", "citedby": "0"}, {"bib": {"title": "AN ASSESSMENT OF THE PERFORMANCE OF PRE-PARTICIPATION GUIDELINES APPLIED TO NOVICE OLDER ENDURANCE ATHLETES", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:W2VW_RKN1OwC", "citedby": "0"}, {"bib": {"title": "VASCULAR RESPONSE TO LIPID-LOWERING THERAPY IN DIABETES VERSUS NON-DIABETES PATIENTS: SERIAL OPTICAL COHERENCE TOMOGRAPHY AND INTRAVASCULAR ULTRASOUND STUDY", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:P76ttB97BVgC", "citedby": "0"}, {"bib": {"title": "ACE INHIBITOR USE AND MAJOR CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES TREATED WITH THE DPP-4 INHIBITOR ALOGLIPTIN", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EcS_2O1c4Q0C", "citedby": "0"}, {"bib": {"title": "Implementing Guideline-Recommended Therapy for Patients With CKD: Is Hope on the Horizon?", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YEBtnu9hOHUC", "citedby": "0"}, {"bib": {"title": "Special Issue on Algorithms for Data and Text Mining in Bioinformatics", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bKwnt0rjkrwC", "citedby": "0"}, {"bib": {"title": "\u0412\u043b\u0438\u044f\u043d\u0438\u0435 \u043d\u0435\u0431\u0438\u0432\u043e\u043b\u043e\u043b\u0430 \u043d\u0430 \u043f\u043e\u0434\u0430\u0442\u043b\u0438\u0432\u043e\u0441\u0442\u044c \u0430\u043e\u0440\u0442\u044b \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0441\u0430\u0445\u0430\u0440\u043d\u044b\u043c \u0434\u0438\u0430\u0431\u0435\u0442\u043e\u043c \u0438 \u043c\u0430\u043a\u0441\u0438\u043c\u0430\u043b\u044c\u043d\u043e\u0439 \u0431\u043b\u043e\u043a\u0430\u0434\u043e\u0439 \u0440\u0435\u043d\u0438\u043d-\u0430\u043d\u0433\u0438\u043e\u0442\u0435\u043d\u0437\u0438\u043d\u043e\u0432\u043e\u0439 \u0441\u0438\u0441\u0442\u0435\u043c\u044b: \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 EFFORT", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ktX0m338QuYC", "citedby": "0"}, {"bib": {"title": "William T. Cefalu, MD", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:84Dmd_oSKgsC", "citedby": "0"}, {"bib": {"title": "\u0412\u043f\u043b\u0438\u0432 \u043d\u0435\u0431\u0456\u0432\u043e\u043b\u043e\u043b\u0443 \u043d\u0430 \u043f\u043e\u0434\u0430\u0442\u043b\u0438\u0432\u0456\u0441\u0442\u044c \u0430\u043e\u0440\u0442\u0438 \u0432 \u043f\u0430\u0446\u0456\u0454\u043d\u0442\u0456\u0432 \u0456\u0437 \u0446\u0443\u043a\u0440\u043e\u0432\u0438\u043c \u0434\u0456\u0430\u0431\u0435\u0442\u043e\u043c \u0442\u0430 \u043c\u0430\u043a\u0441\u0438\u043c\u0430\u043b\u044c\u043d\u043e\u044e \u0431\u043b\u043e\u043a\u0430\u0434\u043e\u044e \u0440\u0435\u043d\u0456\u043d-\u0430\u043d\u0433\u0456\u043e\u0442\u0435\u043d\u0437\u0438\u043d\u043e\u0432\u043e\u0457 \u0441\u0438\u0441\u0442\u0435\u043c\u0438: \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u043d\u044f EFFORT", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ns2bVKt8YxIC", "citedby": "0"}, {"bib": {"title": "PATIROMER REDUCED RECURRENT HYPERKALEMIA IN", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fhZv66dCuXAC", "citedby": "0"}, {"bib": {"title": "American Society of Hypertension Self-Assessment Guide", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H8haQKU-3ZsC", "citedby": "0"}, {"bib": {"title": "Hypertension: Handling the Pressure in CKD", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uQyLbZAWguAC", "citedby": "0"}, {"bib": {"title": "Changes in Guideline Trends and Applications in Practice: JNC 2013 and the Future", "year": "2015"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PPrs6GlykQcC", "citedby": "0"}, {"bib": {"title": "N-Terminal-pro-Brain Natriuretic Peptide Decreases Following Treatment with Alogliptin in Patients with Type 2 Diabetes and Recent Acute Coronary Syndromes: Results from EXAMINE", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gxb_f1p9zx4C", "citedby": "0"}, {"bib": {"title": "Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ve7iT2ZEuL4C", "citedby": "0"}, {"bib": {"title": "ATS Core Curriculum 2014: Part II. Adult Critical Care Medicine", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LTdYzzxxQecC", "citedby": "0"}, {"bib": {"title": "Ambulatory blood pressure results of symplicity HTN-3 trial", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Gs1AF5H0x94C", "citedby": "0"}, {"bib": {"title": "Introduction to Hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tBp-nognM3UC", "citedby": "0"}, {"bib": {"title": "5-YEARS CLINICAL OUTCOMES OF KNOWN DIABETES MELLITUS AND NEWLY DIAGNOSED DIABETES AND PREDIABETES AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY \u2026", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:I8ubwoE7ciMC", "citedby": "0"}, {"bib": {"title": "Prior antihypertensive regimen usage and the cardiovascular risk reduction derived from combination therapy with angiotensin converting enzyme inhibition-calcium channel \u2026", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CmbFvBriOyMC", "citedby": "0"}, {"bib": {"title": "Plasma renin activity and aldosterone levels in patients with hypertension receiving fixed-dose combination of nebivolol and valsartan: substudy of a phase 3 randomized trial", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DTjSuSUbmXsC", "citedby": "0"}, {"bib": {"title": "Efficacy and safety of perindopril arginine+ amlodipine in hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aVq8r21TQD4C", "citedby": "0"}, {"bib": {"title": "Treatment of baroreceptor dysfunction: a focus away from alpha agonist and steroid therapies", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rUnQDpM0TEQC", "citedby": "0"}, {"bib": {"title": "P302 Pratique des changements de cath\u00e9ters des patients diab\u00e9tiques type 1 dans la vie quotidienne et \u00e9volution des param\u00e8tres glyc\u00e9miques", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nvAonm6-wpUC", "citedby": "0"}, {"bib": {"title": "P304 Efficacit\u00e9 et tol\u00e9rance de la canagliflozine sur une p\u00e9riode de 52 semaines chez des patients diab\u00e9tiques de type 2 pr\u00e9sentant une insuffisance r\u00e9nale chronique", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_V0JUKP8578C", "citedby": "0"}, {"bib": {"title": "The following reviewers assisted in the evaluation of the manuscripts for the year 2014. Their valuable help is gratefully acknowledged.", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aar0OkpPRdAC", "citedby": "0"}, {"bib": {"title": "Clinical Practice Guidelines for theManagement of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XOE35tnTnDYC", "citedby": "0"}, {"bib": {"title": "Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_8B_re9sV0EC", "citedby": "0"}, {"bib": {"title": "Contents Vol. 39, 2014", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ziW8EwMpto0C", "citedby": "0"}, {"bib": {"title": "Contents Vol. 40, 2014", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Uo5fLKClJkAC", "citedby": "0"}, {"bib": {"title": "Position Statement from ADA/AACE/EASD/TES in Response to a Recently Published Letter to the Editor in The Lancet and an Editorial Addressing the Israeli-Palestinian Fighting in \u2026", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HevVnK7dagcC", "citedby": "0"}, {"bib": {"title": "The Role of Aldosterone in the Spectrum of Cardiovascular and Kidney Disease Risk: Introduction", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WTSGYGHz1bkC", "citedby": "0"}, {"bib": {"title": "Contents Vol. 3-4, 2014", "year": "2014"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AFmTUeZ1pmEC", "citedby": "0"}, {"bib": {"title": "Meerderheid van pati\u00ebnten behoeft meerdere antihypertensiva om streefbloeddruk te behalen", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RXC-vbXDMdwC", "citedby": "0"}, {"bib": {"title": "Majority of patients require multiple antihypertensive drugs to achieve target BP", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uqZYSrDi9MMC", "citedby": "0"}, {"bib": {"title": "Most hypertensive patients need combination therapy to achieve target blood pressure", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gI9wzKcniAoC", "citedby": "0"}, {"bib": {"title": "Efficacy and safety of canagliflozin in subjects with type 2 diabetes mellitus and chronic kidney disease over 52 weeks", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pwA0zy_liR0C", "citedby": "0"}, {"bib": {"title": "4th World Congress on", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZJWHNt7Cjk4C", "citedby": "0"}, {"bib": {"title": "Treatment of Primary Hypertension", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j6V8Syvup0UC", "citedby": "0"}, {"bib": {"title": "Cardiovascular Effects Based on Magnitude of Weight Loss (WL) in Obese/Overweight Subjects with Hypertension Receiving Phentermine and Topiramate Extended-Release (PHEN/TPM ER \u2026", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:puFLaqDw8dcC", "citedby": "0"}, {"bib": {"title": "Obesity, blood pressure, and cardiovascular outcomes\u2013Authors' reply", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wlzmIqt2EaEC", "citedby": "0"}, {"bib": {"title": "Diabetes and hypertension: Evaluation and management", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VBDT71xRUdcC", "citedby": "0"}, {"bib": {"title": "Azilsartan gives better and persistent reduction in blood pressure than ramipril", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ojlX30-wUrgC", "citedby": "0"}, {"bib": {"title": "RELATIONSHIPS BETWEEN SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HIGH RISK HYPERTENSION: AN ANALYSIS OF THE ACCOMPLISH TRIAL", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5LPo_wSKItgC", "citedby": "0"}, {"bib": {"title": "BMI affects CV outcomes in hypertensive patients", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:m_tu6TPmoiMC", "citedby": "0"}, {"bib": {"title": "BMI be\u00efnvloedt frequentie CV aandoeningen bij hypertensie", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FIkAGs9z2eEC", "citedby": "0"}, {"bib": {"title": "CV outcomes in hypertensive patients are affected by BMI", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GtqhT-R7ZnwC", "citedby": "0"}, {"bib": {"title": "HIGH BLOOD PRESSURE DEFINITION", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:P6jpBLdrFncC", "citedby": "0"}, {"bib": {"title": "Thiazide diuretics, potassium and the development of diabetes: A quantitative review.", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5Hlrm_bZEgcC", "citedby": "0"}, {"bib": {"title": "Kidney Disease in Hypertension", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bO_hriczGZwC", "citedby": "0"}, {"bib": {"title": "Front & Back Matter", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:C4Vd9JCM9EcC", "citedby": "0"}, {"bib": {"title": "Nghi\u00ean c\u1ee9u \u0111\u1ec1 xu\u1ea5t c\u00e1c gi\u1ea3i ph\u00e1p \u0111\u1ec3 th\u00fac \u0111\u1ea9y chuy\u1ec3n d\u1ecbch c\u01a1 c\u1ea5u kinh t\u1ebf, chuy\u1ec3n \u0111\u1ed5i m\u00f4 h\u00ecnh t\u0103ng tr\u01b0\u1edfng kinh t\u1ebf t\u1ec9nh H\u1eadu Giang theo h\u01b0\u1edbng c\u1ea1nh tranh giai \u0111o\u1ea1n t\u1eeb n\u0103m 2011-2020 \u2026", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kGbpvR7Ecy8C", "citedby": "0"}, {"bib": {"title": "Contents Vol. 36, 2013", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vNwWLMROEM0C", "citedby": "0"}, {"bib": {"title": "Chung, N, 198 Cicero, AFG, 32 Cohen, R, 336 Cummings, DM, 363", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:s_OEDnM-dbEC", "citedby": "0"}, {"bib": {"title": "From the Editor 101", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ohFW0PAxsewC", "citedby": "0"}, {"bib": {"title": "Contents Vol. 38, 2013", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:h9G0ZmjYpDoC", "citedby": "0"}, {"bib": {"title": "Lowering blood pressure limits in patients with type 2 diabetes: Is it still warranted?", "year": "2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1xBWf43XMUgC", "citedby": "0"}, {"bib": {"title": "24 Analogy Between Endothelial/Mesangial Cell", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:y7JhAc_VBLgC", "citedby": "0"}, {"bib": {"title": "Prostate Cancer News", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kcGNQN_anIUC", "citedby": "0"}, {"bib": {"title": "The Kidney in Heart Failure", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ufKn5pxu7C0C", "citedby": "0"}, {"bib": {"title": "Inadequate sleep equates to inadequate BP control REPLY", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:c3iu29LiD84C", "citedby": "0"}, {"bib": {"title": "EFFECT OF BODY MASS ON CARDIOVASCULAR OUTCOMES DURING HYPERTENSION TREATMENT: AN ACCOMPLISH ANALYSIS: LB-OR-03", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:in81wS_EFI4C", "citedby": "0"}, {"bib": {"title": "Author's reply: Inadequate sleep equates to inadequate BP control", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DIubQTN3OvUC", "citedby": "0"}, {"bib": {"title": "Azilsartan medoxomil/chloortalidon voor bloeddrukverlaging", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9u2w3wkYHSMC", "citedby": "0"}, {"bib": {"title": "Azilsartan medoxomil/chlorthalidone for blood pressure reduction", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Cvh0bltMcLgC", "citedby": "0"}, {"bib": {"title": "INCREASES IN NITRIC OXIDE BIOAVAILABILITY FAIL TO IMPROVE VASCULAR COMPLIANCE IN ELDERLY PATIENTS WITH TYPE 2 DIABETES", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:feST4K8J0scC", "citedby": "0"}, {"bib": {"title": "BAROREFLEX ACTIVATION THERAPY PROVIDES DURABLE BENEFIT IN PATIENTS WITH RESISTANT HYPERTENSION: LONG-TERM FOLLOW-UP RESULTS FROM THE RHEOS PIVOTAL TRIAL", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3_LpOwP6eMYC", "citedby": "0"}, {"bib": {"title": "Can ambulatory blood pressure serve as a biomarker for presence of chronic kidney disease?", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YTuZlYwrTOUC", "citedby": "0"}, {"bib": {"title": "Baroreflex Activation Therapy and Resistant Hypertension Randomization Is Not Enough, You Should Measure Blood Pressure Appropriately Reply", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:L8oS6_awjPoC", "citedby": "0"}, {"bib": {"title": "From the Editor 241", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:R6aXIXmdpM0C", "citedby": "0"}, {"bib": {"title": "Angiotensin type-1 receptor blockade with losartan increases insulin sensitivity and improves glucose homeostasis in subjects with type 2 diabetes and nephropathy.", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jevOW3VBe2YC", "citedby": "0"}, {"bib": {"title": "Clinical Trial: African American Study of Kidney Disease", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BQCiT8P4igIC", "citedby": "0"}, {"bib": {"title": "Oxford American Cardiology Library: Hypertension", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hKmHnHMtuq0C", "citedby": "0"}, {"bib": {"title": "From the Editor 83", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Q17yWvk9gpwC", "citedby": "0"}, {"bib": {"title": "Changes in Kidney Function Following Heart Failure Treatment: Focus on Renin\u2013Angiotensin System Blockade", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hefNtdE4IMkC", "citedby": "0"}, {"bib": {"title": "Antihypertensive Therapy and New-Onset Diabetes", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:w2UhwfzvF0QC", "citedby": "0"}, {"bib": {"title": "Primary hypertension", "year": "2012"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pYKElYtJMmwC", "citedby": "0"}, {"bib": {"title": "Translation: Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BmWJbWwHJAwC", "citedby": "0"}, {"bib": {"title": "FIXED-DOSE COMBINATION OF AZILSARTAN MEDOXOMIL PLUS CHLORTHALIDONE RESULTS IN SUBSTANTIAL BP REDUCTION IN HYPERTENSIVE BLACKS", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oFn-K-OQSCAC", "citedby": "0"}, {"bib": {"title": "Confirmation of sustainability of hemodynamic response to baroreflex activation therapy in patients with resistant hypertension", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Oo_WeVVXg5wC", "citedby": "0"}, {"bib": {"title": "Assessment and management of vascular disease risk in patients with chronic kidney disease", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H_jBuBxbQIAC", "citedby": "0"}, {"bib": {"title": "FIXED-DOSE COMBINATION OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE PROVIDES SUPERIOR BP REDUCTION TO MONOTHERAPIES IN STAGE 2 HYPERTENSION: PP. 14.382", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dMpQl7XwOw4C", "citedby": "0"}, {"bib": {"title": "EFFICACY AND SAFETY OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE WITH OLMESARTAN/HYDROCHLOROTHIAZIDE COMBINATIONS IN STAGE 2 SYSTOLIC HYPERTENSION: 4A. 09", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:q0uBw5dMOAkC", "citedby": "0"}, {"bib": {"title": "PROJECT ECHO: AN INNOVATIVE CAMPUS-COMMUNITY PARTNERSHIP FOR MANAGING RESISTANT HYPERTENSION", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:djft3U1LymYC", "citedby": "0"}, {"bib": {"title": "The role of nitric oxide in improving endothelial function andcardiovascular health: focus on nebivolol", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1_W9tMSvGuwC", "citedby": "0"}, {"bib": {"title": "EFFECTS OF SIMVASTATIN AND ROSIGLITAZONE COMBINATION IN PATIENTS WITH THE METABOLIC SYNDROME (THE SIROCO STUDY): PO-95", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Es-9c2L5hKwC", "citedby": "0"}, {"bib": {"title": "38 Race Does Not Influence ESRD and Mortality in Obese Patients with CKD Stages 3-4: Results From The Kidney Early Evaluation Program (KEEP)", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Og1tA8FjbJAC", "citedby": "0"}, {"bib": {"title": "Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Kaaf24wrr50C", "citedby": "0"}, {"bib": {"title": "\uc2e4\ud589 \uc694\uc57d: \ub2f9\ub1e8\ubcd1\uc758 \uc9c4\ub2e8\uacfc \uad00\ub9ac\uc5d0\uc11c \uac80\uc0ac\uc2e4\uc801 \ubd84\uc11d\uc5d0 \ub300\ud55c \uc9c0\uce68\uacfc \uad8c\uace0\uc548", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:k4O5U3vRA4YC", "citedby": "0"}, {"bib": {"title": "\u0420\u043e\u043b\u044c \u043e\u043a\u0441\u0438\u0434\u0430 \u0430\u0437\u043e\u0442\u0430 \u0432 \u0443\u043b\u0443\u0447\u0448\u0435\u043d\u0438\u0438 \u0444\u0443\u043d\u043a\u0446\u0438\u0438 \u044d\u043d\u0434\u043e\u0442\u0435\u043b\u0438\u044f \u0438 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u043e\u0433\u043e \u0437\u0434\u043e\u0440\u043e\u0432\u044c\u044f: \u0444\u043e\u043a\u0443\u0441 \u043d\u0430 \u043d\u0435\u0431\u0438\u0432\u043e\u043b\u043e\u043b", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CcPklOTAPUcC", "citedby": "0"}, {"bib": {"title": "Evaluation of laxative activity of Alstonia scholaris.", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vct99db0rDQC", "citedby": "0"}, {"bib": {"title": "Implications of EMPHASIS-HF for Clinical Practice.", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FepLwMwnKBMC", "citedby": "0"}, {"bib": {"title": "Clinical Trial", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RgMnzfD6kpIC", "citedby": "0"}, {"bib": {"title": "NATIONAL KIDNEY FOUNDATION\u2019S KIDNEY EARLY EVALUATION PROGRAM (KEEP) ANNUAL DATA REPORT 2010", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8JTMrWI6FdcC", "citedby": "0"}, {"bib": {"title": "The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9tXw7Op4-u0C", "citedby": "0"}, {"bib": {"title": "Cardiovascular Risk Assessment and Summary of Guidelines for the Management of Hypertension", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yZoBfgUKqwcC", "citedby": "0"}, {"bib": {"title": "\u5fc3\u8840\u7ba1\u75be\u60a3, \u814e\u81d3\u75c5\u304a\u3088\u3073\u7cd6\u5c3f\u75c5\u306e\u30ea\u30b9\u30af\u306b\u95a2\u3059\u308b\u7c73\u56fd\u814e\u81d3\u8ca1\u56e3\u30b3\u30f3\u30bb\u30f3\u30b5\u30b9\u4f1a\u8b70--\u30a4\u30d9\u30f3\u30c8\u4f4e\u6e1b\u306e\u305f\u3081\u306e\u7d71\u5408\u7684\u6cbb\u7642\u30a2\u30d7\u30ed\u30fc\u30c1", "year": "2011"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:I858iXPj1OkC", "citedby": "0"}, {"bib": {"title": "Effect of Combination Therapy with Benazepril/Amlodipine Compared with Benazepril/Hydrochlorothiazide in Patients with High-Risk, Stage 2 Hypertension with or Without Known \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:x2hKVfJWtf0C", "citedby": "0"}, {"bib": {"title": "The Incidence and Risk of Hypokalemia in Patients With High Risk Hypertension: The ACCOMPLISH Study", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ul_CLA4dPeMC", "citedby": "0"}, {"bib": {"title": "Corrigendum to \u201cA propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure\u201d[Int. J. Cardiol. 137 (2009) 1\u20138]", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sEK1m4D7fbcC", "citedby": "0"}, {"bib": {"title": "Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YB4bud6kWLwC", "citedby": "0"}, {"bib": {"title": "Intensive lowering of systolic blood pressure to a target of less than 120 mm Hg has no effect on the rate of fatal and non-fatal major cardiovascular events in high-risk \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9DLIHnF0jcYC", "citedby": "0"}, {"bib": {"title": "Gestational diabetes alone, in the absence of subsequent diabetes, is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP)", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2POsdo3tyOAC", "citedby": "0"}, {"bib": {"title": "Diabetes, the kidney, and cardiovascular risk. Preface.", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:clk6yq2jaZ8C", "citedby": "0"}, {"bib": {"title": "Leadership Message", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4aZ_i-5WJEQC", "citedby": "0"}, {"bib": {"title": "More complete renin\u2013angiotensin system blockade: better outcomes or smoke and mirrors", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WMtz-WDmgKQC", "citedby": "0"}, {"bib": {"title": "\u00bf Es \u00fatil el tratamiento con antagonistas selectivos de los receptores de la endotelina en la hipertensi\u00f3n arterial resistente?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QsKbpXNoaWkC", "citedby": "0"}, {"bib": {"title": "255: The Association of Serum Phosphorus and Pulse Pressure in Men and Women With Chronic Kidney Disease: Data From the Kidney Early Evaluation Program", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bXQfdp6S9ecC", "citedby": "0"}, {"bib": {"title": "58: Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP)", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AZju0d2GQJ0C", "citedby": "0"}, {"bib": {"title": "Breast Medicine", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XtJa11BXPS4C", "citedby": "0"}, {"bib": {"title": "Overview of the KEEP international articles", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BJrgspguQaEC", "citedby": "0"}, {"bib": {"title": "National Kidney Foundation\u00ae: KEEPTM-Kidney Early Evaluation Program: ANNUAL DATA REPORT 2009", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0xcHesCNKywC", "citedby": "0"}, {"bib": {"title": "Renin-Angiotensin System Blockade Versus Endothelin Antagonism for Halting Progression of Chronic Kidney Disease", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GL0K47J-u9kC", "citedby": "0"}, {"bib": {"title": "The Kidney Early Evaluation Program: An International Comparative Perspective", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hImZayhCRfQC", "citedby": "0"}, {"bib": {"title": "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:d9ydBXnamCkC", "citedby": "0"}, {"bib": {"title": "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jM2XaDTMsSgC", "citedby": "0"}, {"bib": {"title": "ISHIB Consensus Statement", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:84dCbUURXyIC", "citedby": "0"}, {"bib": {"title": "The Pathogenesis and Prevention of Radiocontrast Medium-Induced Renal Dysfunction\u2606", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PRLG7g5oK-wC", "citedby": "0"}, {"bib": {"title": "ACEI Plus Second Agent for Hypertension--Amlodipine or Hydrochlorothiazide?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wdLM4YbmhYkC", "citedby": "0"}, {"bib": {"title": "Acknowledgment to reviewers", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0BSZZHtHo6cC", "citedby": "0"}, {"bib": {"title": "\u041e\u0433\u0440\u0430\u043d\u0438\u0447\u0435\u043d\u0438\u044f \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043d\u0438\u044f \u043c\u0435\u0442\u0444\u043e\u0440\u043c\u0438\u043d\u0430 \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u044c\u044e \u043f\u043e\u0447\u0435\u043a: \u043f\u0440\u0430\u0432\u043e\u043c\u043e\u0447\u043d\u044b \u043b\u0438 \u043e\u043d\u0438?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RZBefGmQYygC", "citedby": "0"}, {"bib": {"title": "Prehypertension--\u814e\u81d3\u75c5\u5c02\u9580\u533b\u306b\u3068\u3063\u3066\u91cd\u8981\u304b", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:htyGaKyDgHMC", "citedby": "0"}, {"bib": {"title": "KEEP 2009: Tenth anniversary of the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qPeb-qHga9sC", "citedby": "0"}, {"bib": {"title": "Microalbuminuria and Kidney Disease: An Evidence-based Perspective", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:17ZO-CJnx_8C", "citedby": "0"}, {"bib": {"title": "Sverre E. Kjeidsen, MD,|| Richard B. Devereux, MD, f Eric J. Velazquez, MD,# Bj\u00f6rn Dahl\u00f6f, MD,** Roxzana Y. Kelly, MS, ft Tsushung A. Hua, PblD. tt Allen Hester, Pl~ lD, tf \u2026", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:l6Q3WhenKVUC", "citedby": "0"}, {"bib": {"title": "Forging Ahead with Lessons from the Past", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:iyewoVqAXLQC", "citedby": "0"}, {"bib": {"title": "Protein\u00fcrideki Azalma B\u00f6brek Hastal\u0131\u011f\u0131 Bulunan Olgularda \u0130la\u00e7 Se\u00e7imi \u0130\u00e7in Bir K\u0131stas Olmal\u0131 m\u0131?", "year": "2010"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:G1UMdFYMoxkC", "citedby": "0"}, {"bib": {"title": "614 Br\u00e8ves", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DPO9WFcz7UcC", "citedby": "0"}, {"bib": {"title": "Une nouvelle classe d\u2019antihypertenseur", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-fu4zM_6qcIC", "citedby": "0"}, {"bib": {"title": "Retraction Statement", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:R-LXmdHK_14C", "citedby": "0"}, {"bib": {"title": "Renal Dysfunction, Fitness and the Risk of Death in Women", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WM2K3OHRCGMC", "citedby": "0"}, {"bib": {"title": "Lessons an Renoprotection in CKD patients from the New Big Combination Studies", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NnTm98qLMbgC", "citedby": "0"}, {"bib": {"title": "Inhibiting the renin\u2011angiotensin system in patients with type 1 diabetes: is it worth it?", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:L24QuVWYgZ0C", "citedby": "0"}, {"bib": {"title": "Risk of Hyperkalemia in Nondiabetics with Chronic Kidney Disease on Antihypertensive Therapy", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3x-KLxxGyuUC", "citedby": "0"}, {"bib": {"title": "ANGIOTENSIN RECEPTOR BLOCKER VERSUS ANGIOTENSIN-CONVERTING ENZYME INHIBITOR USE AND ALL-CAUSE MORTALITY IN HOSPITALIZED EELDERLY HEART FAILURE PATIENTS WITH CHRONIC KIDNEY DISEASE", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rzmi0EmCOGEC", "citedby": "0"}, {"bib": {"title": "Home blood pressure monitoring to manage hypertension in patients with nephropathy: The time has arrived", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lbI08cpqPnQC", "citedby": "0"}, {"bib": {"title": "Hypertension guidelines and chronic kidney disease: Physicians, please follow directions", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EaFouW7jFu4C", "citedby": "0"}, {"bib": {"title": "The future of blood pressure control in a population with a growing girth", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tBlTYpvFGQIC", "citedby": "0"}, {"bib": {"title": "Mensagem para o Dia Mundial do Rim 2009: Hipertens\u00e3o e Doen\u00e7a Renal: um casamento que deve ser prevenido", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:m1cs02wJCiwC", "citedby": "0"}, {"bib": {"title": "FIXED DOSES OF DARUSENTAN AS COMPARED TO PLACEBO IN TREATMENT-RESISTANT HYPERTENSION: LB-OR-06", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZgPQhQxLujAC", "citedby": "0"}, {"bib": {"title": "RENAL DYSFUNCTION, CARDIORESPIRATORY FITNESS AND THE RISK OF DEATH IN WOMEN: LB-OR-05", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7XCffrwrS2sC", "citedby": "0"}, {"bib": {"title": "ACE-Hemmer-Fixkombinationen. Kalziumantagonist ist Diuretikum \u00fcberlegen", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FsLZdJ3BAzkC", "citedby": "0"}, {"bib": {"title": "TREATMENT OF BENAZEPRIL PLUS AMLODIPINE OR BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE HAVE DIVERSE EFFECTS IN HYPERTENSIVE PATIENTS WITH GFR BELOW AND ABOVE 60 ML/MIN/1.73 M2; AN \u2026", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5VjbC5aozO0C", "citedby": "0"}, {"bib": {"title": "RENAL OUTCOMES OF COMBINED THERAPY WITH BENAZEPRIL PLUS AMLODIPINE COMPARED WITH BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTS AT HIGH RISK: THE ACCOMPLISH TRIAL", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vjZqxyZ7hS4C", "citedby": "0"}, {"bib": {"title": "Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?(vol 121, pg 77, 2009)", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:g30IDTdgJMgC", "citedby": "0"}, {"bib": {"title": "DIABETES MELLITUS AND CKD AWARENESS: THE KIDNEY EARLY EVALUATION PROGRAM AND NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SPgmg5JLkoEC", "citedby": "0"}, {"bib": {"title": "HYPERTENSION IN EARLY-STAGE KIDNEY DISEASE: AN UPDATE FROM THE KIDNEY EARLY EVALUATION PROGRAM", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:U3qCfcK-7lkC", "citedby": "0"}, {"bib": {"title": "THE KIDNEY EARLY EVALUATION PROGRAM (KEEP): A COMMUNITY BASED SCREENING APPROACH TO ADDRESS DISPARITIES IN CKD.", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cww_0JKUTDwC", "citedby": "0"}, {"bib": {"title": "PREDICTORS OF SELF REFERRED REPEAT CKD SCREENING IN THE KIDNEY EARLY EVALUATION PROGRAM (KEEP)", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KqnX2w3egDsC", "citedby": "0"}, {"bib": {"title": "Blood Pressure Reduction With Potassium Supplementation Reply", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:iUf_yyxph5wC", "citedby": "0"}, {"bib": {"title": "Cardiovascular Risk Modi. cation in Chronic Kidney Disease Patients with Coronary Disease: Results From the Kidney Early Evaluation Program (KEEP)", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qCaWouos7ogC", "citedby": "0"}, {"bib": {"title": "World Kidney Day 2009: Chronic Kidney Disease and Hypertension: Two Sides of the Same Coin", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wuD5JclIwkYC", "citedby": "0"}, {"bib": {"title": "ADVANCE: Blood Pressure Lowering in Diabetes", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KxNY-X0OflYC", "citedby": "0"}, {"bib": {"title": "The Message for World Kidney Day 2009: Hypertension and Kidney Disease: a marriage that should be prevented (Reprinted)", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5bfplxN71z4C", "citedby": "0"}, {"bib": {"title": "Hypertension and kidney disease: a combination that should be prevented.", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wSy_KLzO7YEC", "citedby": "0"}, {"bib": {"title": "Annual Data Report 2008. National Kidney Foundation Kidney Early Evaluation Program", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NAGhd4NKCV8C", "citedby": "0"}, {"bib": {"title": "Plasmid metagenome reveals high levels of antibiotic resistance genes and mobile genetic elements in activated sludge.", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i_ypWuZoRC8C", "citedby": "0"}, {"bib": {"title": "Mitochondrial reactive oxygen species-mediated signaling in endothelial cells.", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zVd9Rc0DoukC", "citedby": "0"}, {"bib": {"title": "La asociaci\u00f3n de un IECA y un calcio-antagonista es m\u00e1s eficaz para reducir las complicaciones cardiovasculares en pacientes hipertensos", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nyUGVxR7BcAC", "citedby": "0"}, {"bib": {"title": "Consultants for the American Journal of Nephrology 2009", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:f4T9rk490XkC", "citedby": "0"}, {"bib": {"title": "Author Index Vol. 30, 2009", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SrsqWtBqNIQC", "citedby": "0"}, {"bib": {"title": "Financial Disclosure", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:twffdjNOitAC", "citedby": "0"}, {"bib": {"title": "Contents Vol. 30, 2009", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FnaCo-ypupUC", "citedby": "0"}, {"bib": {"title": "Subject Index Vol. 30, 2009", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:x9HjRiAMpasC", "citedby": "0"}, {"bib": {"title": "The role of calcium antagonists in chronic kidney disease", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BzPC9jo9PWgC", "citedby": "0"}, {"bib": {"title": "Doyle, A. c7 \u00d0ukanovi\u0107, L. c127 El Nahas, M. c68, c154, c203, c211 Er, L. c39 Feng, Q. c87", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MDQ-9Oe3GGUC", "citedby": "0"}, {"bib": {"title": "Low potassium diet", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:F9HO9s0W2bwC", "citedby": "0"}, {"bib": {"title": "Epidemiology and CKD-1", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PuOEWVtPfzwC", "citedby": "0"}, {"bib": {"title": "Darusentan treatment significantly decreases blood pressure and results in better systolic blood pressure control when added to multi-drug therapy in patients with resistant \u2026", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kUhpeDhEZMUC", "citedby": "0"}, {"bib": {"title": "Darusentan lowers blood pressure significant on top of multi-drug treatment in patients with resistant hypertension", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ymY9cBF3mdcC", "citedby": "0"}, {"bib": {"title": "Hypertension-1", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:m4fbC6XIj1kC", "citedby": "0"}, {"bib": {"title": "\u0418\u043d\u0433\u0438\u0431\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0435 \u0440\u0435\u043d\u0438\u043d-\u0430\u043d\u0433\u0438\u043e\u0442\u0435\u043d\u0437\u0438\u043d\u043e\u0432\u043e\u0439 \u0441\u0438\u0441\u0442\u0435\u043c\u044b \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0441\u0430\u0445\u0430\u0440\u043d\u044b\u043c \u0434\u0438\u0430\u0431\u0435\u0442\u043e\u043c 1-\u0433\u043e \u0442\u0438\u043f\u0430", "year": "2009"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:c_xDhezhKKUC", "citedby": "0"}, {"bib": {"title": "Response to \u2018Diuretics should be used as the second-line agent in combination with RAS inhibitors in proteinuric patients with CKD\u20191", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WIXB4To3Tx4C", "citedby": "0"}, {"bib": {"title": "ASH: renaissance of a society--a movement of vigorous renewal.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bCDyRX4i8-MC", "citedby": "0"}, {"bib": {"title": "Should a lower blood pressure goal and albuminuria reduction be mandated to slow hypertensive nephropathy?", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1tZ8xJnm2c8C", "citedby": "0"}, {"bib": {"title": "Efficacy of the combination of amlodipine besylate plus olmesartan medoxomil compared to monotherapy in controlling blood pressure in patients with mild-to-severe hypertension", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jRIwE-1ttnoC", "citedby": "0"}, {"bib": {"title": "The long-term effect of amlodipine besylate plus olmesartan medoxomil combination therapy on achieving blood pressure goals in patients with diabetes", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hEXC_dOfxuUC", "citedby": "0"}, {"bib": {"title": "Executive summary: Kidney Early Evaluation Program (KEEP) 2007 Annual Data Report (vol 51, pg S1, 2008)", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:I-2NeQpV75MC", "citedby": "0"}, {"bib": {"title": "219: Hypertension and Chronic Kidney Disease: KEEP and NHANES", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ShjGdcaqzI0C", "citedby": "0"}, {"bib": {"title": "163: Racial and Gender Differences in Prevalence and Predictors of Anemia of Chronic Kidney Disease: KEEP and NHANES 1999-2004", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Zh0EY9V9P6UC", "citedby": "0"}, {"bib": {"title": "207: Prevalent Components of Cardiometabolic Syndrome and Cardiovascular Disease from the Kidney Early Evaluation Program (KEEP)", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZqE1mSdD_DYC", "citedby": "0"}, {"bib": {"title": "Challenges to the Diagnosis, Evaluation, Treatment, and Management of Clustered Cardiometabolic Risk Factors", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yJjnfzR0HrkC", "citedby": "0"}, {"bib": {"title": "Habitual physical activity and cardiometabolic risk factors in adults with cerebral palsy.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kAoMiUvgv_QC", "citedby": "0"}, {"bib": {"title": "Influence of thyroid hormone autoantibodies on thyroid hormone assays.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6lhY8CtEloYC", "citedby": "0"}, {"bib": {"title": "Target organ protection from a novel angiotensin II receptor (AT1) vaccine ATR 12181 in spontaneously hypertensive rats.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8RJSsxxtMAkC", "citedby": "0"}, {"bib": {"title": "Make Every Mother and Child Count.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sk-5v2XeZBgC", "citedby": "0"}, {"bib": {"title": "System\u2013Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans Lawrence J. Appel, MD, MPH", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZpgFv6i7Z4gC", "citedby": "0"}, {"bib": {"title": "Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. Commentary", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NtCmTCuxid4C", "citedby": "0"}, {"bib": {"title": "T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Commentary", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ej9njvOgR2oC", "citedby": "0"}, {"bib": {"title": "Managing Chronic Kidney Disease: Key Therapeutic Issues", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:xGWFX6Gbr9MC", "citedby": "0"}, {"bib": {"title": "Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension.", "year": "2008"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YPNY0knpFBYC", "citedby": "0"}, {"bib": {"title": "Chronic Kidney Disease and Risk for Premature Cardiovascular Disease", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DGzKIA18-3YC", "citedby": "0"}, {"bib": {"title": "Lifestyle changes and unanswered questions about hypertension and cardiovascular risk", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:h168fVGZblEC", "citedby": "0"}, {"bib": {"title": "Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eI34FqJmdUoC", "citedby": "0"}, {"bib": {"title": "Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular \u2026", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:FQ36aI_S1AEC", "citedby": "0"}, {"bib": {"title": "Influence of Glycaemic Control on Proteinuria in Patients with Type 2 Diabetes and Overt Nephropathy and Hypertension: Results of the AMADEO Trial.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RJujIP1NYNUC", "citedby": "0"}, {"bib": {"title": "Evaluation of Hemocue Albumin 201 System in Comparison to Existing Semiquantitative Dipstick Testing for Urine Albumin Excretion.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:o9ULDYDKYbIC", "citedby": "0"}, {"bib": {"title": "The Changing Landscape of Hypertension and the Evolving Role of Vasodilatory Beta-Blockers", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ipSP0SfFaZ8C", "citedby": "0"}, {"bib": {"title": "Glucose control in hypertensive patients treated with the vasodilating, selective (beta-blocker, nebivolol", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XeErXHja3Z8C", "citedby": "0"}, {"bib": {"title": "Can antihypertensive therapy contribute to impaired glucose tolerance in metabolic syndrome patients? The study of trandolapril/verapamil SR and insulin resistance (STAR)", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Ei5r6KrKXVQC", "citedby": "0"}, {"bib": {"title": "Erratum: Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome (Diabetes Care (2006) 29 (2592-2597))", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j7XjBeKFbTsC", "citedby": "0"}, {"bib": {"title": "53: Correlates of Chronic Kidney Disease (CKD) Among Hispanic Subgroups: Results from the Kidney Early Evaluation Program (KEEP)", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:adHtZc2wMuEC", "citedby": "0"}, {"bib": {"title": "127: Association of Chronic Kidney Disease with Birth Weight and Gender in the Kidney Early Evaluation Program Participants", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KS-xo-ZNxMsC", "citedby": "0"}, {"bib": {"title": "Verapamil/trandolapril beneficial in metabolic syndrome", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:a2necdfpwlEC", "citedby": "0"}, {"bib": {"title": "Recommended amount of physical activity.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lg5bARUibhcC", "citedby": "0"}, {"bib": {"title": "Public Health, Food and Industrial Microbiology.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3ERjdSgnfPsC", "citedby": "0"}, {"bib": {"title": "Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats.", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8PKVFmgK5mUC", "citedby": "0"}, {"bib": {"title": "CME: The questions from NephSAP\u00ae: Answer with commentary", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fh7vmlWxvT0C", "citedby": "0"}, {"bib": {"title": "CME-The questions from NephSAP\u00ae", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9N3KX2BFTccC", "citedby": "0"}, {"bib": {"title": "Kidney Disease in Hypertension", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jkTRWqoJ8oAC", "citedby": "0"}, {"bib": {"title": "Control of Blood Glucose and Insulin Resistance", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0q7iQwrhYWUC", "citedby": "0"}, {"bib": {"title": "Treatment of Hypertension in Patients with Renal Disease", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KQ7zX_ltr48C", "citedby": "0"}, {"bib": {"title": "for Multiple Behavior Change David J. Hyman, MD, MPH; Valory N. Pavlik, PhD; Wendell C. Taylor, PhD, MPH; G. Kenneth Goodrick, PhD", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tL5YfqkXb3gC", "citedby": "0"}, {"bib": {"title": "Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. Commentary", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:urP0JZOBBUsC", "citedby": "0"}, {"bib": {"title": "Czy u wszystkich chorych na cukrzyc\u0119 typu 2 nale\u017cy od pocz\u0105tku stosowa\u0107 skojarzone leczenie hipotensyjne?", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oynPyU19kbsC", "citedby": "0"}, {"bib": {"title": "Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study. Commentary", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mVC4hKzE2FoC", "citedby": "0"}, {"bib": {"title": "PREVENZIONE PRIMARIA DELLE MALATTIE CARDIOVASCOLARI IN PERSONE AFFETTE DA DIABETE MELLITO: LINEE GUIDE REDATTE DA PARTE DI AMERICAN HEART ASSOCIATION E AMERICAN DIABETES \u2026", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oYLFIHfuHKwC", "citedby": "0"}, {"bib": {"title": "Wirkung von Ruboxistaurin auf Albuminurie und GFR bei Patienten mit Typ-2-Diabetes und diabetischer Nephropathie", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cSdaV2aYdYsC", "citedby": "0"}, {"bib": {"title": "Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: good news to be taken with caution. Commentary: a pilot study", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:V_vSwabWVtYC", "citedby": "0"}, {"bib": {"title": "Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: Results of the IMPROVE trial. Commentary", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KTwcwpFFj4wC", "citedby": "0"}, {"bib": {"title": "Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. Commentary", "year": "2007"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jmjb1lOE9QIC", "citedby": "0"}, {"bib": {"title": "The Journal is dependent not only on its Editorial Board members but also on external consultants who generously provide their time to review submitted manuscripts. We express \u2026", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:T_0gP6tLVL0C", "citedby": "0"}, {"bib": {"title": "Early prediction of renal protection with antihypertensive therapy", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DquSII9TDu4C", "citedby": "0"}, {"bib": {"title": "Role of beta blockers for treatment of hypertension in people with type 2 diabetes: Focus on the gemini trial", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aEW5N-EHWIMC", "citedby": "0"}, {"bib": {"title": "Editorial Advisory Board (EAB)", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JqN3CTdJtl0C", "citedby": "0"}, {"bib": {"title": "Rosiglitazone tops glibenclamide for microalbuminuria, BP reduction", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BOlwja0KXvYC", "citedby": "0"}, {"bib": {"title": "The continuum of blood pressure risk: When is the best time to intervene?", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hQUaER0FWQ4C", "citedby": "0"}, {"bib": {"title": "Evaluation of the validity of quantitative insulin sensitivity check index as a measure of insulin sensitivity in hypertensive patients", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Oj-SLI0tZTcC", "citedby": "0"}, {"bib": {"title": "Darusentan treatment significantly improves systolic blood pressure control in patients with resistant hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:s1ouQE5r0WUC", "citedby": "0"}, {"bib": {"title": "Losartan reduces the burden and cost of diabetic end-stage renal disease in Greece", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bCjgOgSFrM0C", "citedby": "0"}, {"bib": {"title": "Association of urine albumin to creatinine ratio and C-reactive protein in hypertensive patients with type 2 diabetes", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uoRD4RTSUPoC", "citedby": "0"}, {"bib": {"title": "Racial and gender differences in hypertension control in chronic kidney disease: Results from the Kidney Early Evaluation Program (KEEP)", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KqW5X_olkfQC", "citedby": "0"}, {"bib": {"title": "Secondary hyperparathyroidism (SHP) in stages 3 and 4 chronic kidney disease (CKD) despite K/DOQI target phosphorus: NKF's kidney early evaluation program (KEEP) results.", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PZE8UkGerEcC", "citedby": "0"}, {"bib": {"title": "Approaches to cardiovascular risk reduction in patients with cardio\u2013metabolic\u2013renal risk", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qaiyjGHpP8sC", "citedby": "0"}, {"bib": {"title": "Diagnostic and therapeutic strategies in renal artery stenosis", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RiW20FJDrgsC", "citedby": "0"}, {"bib": {"title": "The presence of proteinuria and antihypertensive therapy selection", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:He_SdS2HmmMC", "citedby": "0"}, {"bib": {"title": "CCaaarrrdddiiiooolllooogggiiiaa HHuuunnngggaaarrriiicccaa", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aKo_o5XvxeMC", "citedby": "0"}, {"bib": {"title": "Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells.", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GsgvGxwuA5UC", "citedby": "0"}, {"bib": {"title": "Randomised controlled feasibility trial of an evidence-informed behavioural intervention for obese adults with additional risk factors.", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qVBRRHSSJ04C", "citedby": "0"}, {"bib": {"title": "Model list of essential medicines 16th list.", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gqMmJtG4vxUC", "citedby": "0"}, {"bib": {"title": "Dear Readers, As the year draws to an end, we would like to thank you for your continued interest in the American Journal of Cardiovascular Drugs. We hope that you have found \u2026", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ae0xyBWlIcIC", "citedby": "0"}, {"bib": {"title": "Darusentan for resistant hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:I9gX6wnfuA8C", "citedby": "0"}, {"bib": {"title": "Hypertensive Cardiovascular Disorders-Irbesartan/HCTZ Fixed Combinations in Patients of Different Racial/Ethnic Groups with Uncontrolled Systolic Blood Pressure on Monotherapy", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M0j1y4EgrScC", "citedby": "0"}, {"bib": {"title": "Consultants for the American Journal of Nephrology 2006", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BJtnxTr0fRcC", "citedby": "0"}, {"bib": {"title": "Potassium and Cardiovascular Disease", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WzTVkKNmPSkC", "citedby": "0"}, {"bib": {"title": "HYPERTENSION: DIAGNOSIS, EVALUATION, AND MANAGEMENT", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TGkaJS32XoUC", "citedby": "0"}, {"bib": {"title": "Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Commentary", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:I8rxH6phXEkC", "citedby": "0"}, {"bib": {"title": "Will the findings of the STAR (Study of Trandolapril/Verapamil-SR and Insulin Resistance) study change the treatment of hypertensive patients with metabolic syndrome?", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9NZAP19TdFAC", "citedby": "0"}, {"bib": {"title": "Syllabus-Hypertension", "year": "2006"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sfnaS5RM6jYC", "citedby": "0"}, {"bib": {"title": "Association of NEDD4L with Essential Hypertension in African Americans and Exclusion in Autosomal Dominant Orthostatic Hypotension Disorder: P43", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hB2aVRuWZNwC", "citedby": "0"}, {"bib": {"title": "Effects of rosiglitazone in combination with metformin on cardiovascular biomarkers in type 2 diabetes subjects with microalbuminuria", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TeJ9juy8vcMC", "citedby": "0"}, {"bib": {"title": "Inhibition of platelet aggregation to high dose clopidogrel quantified using a novel platelet aggregation assay, is unaffected by diabetic status and glycemic control", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:37Fl7vPTsUIC", "citedby": "0"}, {"bib": {"title": "The Effects of Macronutrients and Dietary Patterns on Blood Pressure", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5XSfyxoPzb8C", "citedby": "0"}, {"bib": {"title": "Pregnancy and Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CqsiOOvXZmUC", "citedby": "0"}, {"bib": {"title": "Antihypertensive Treatment Trials: Quality of Life", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LimhlhUO2s4C", "citedby": "0"}, {"bib": {"title": "Impact of Treating Blood Pressure", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yxAilOxaV9sC", "citedby": "0"}, {"bib": {"title": "Blood Pressure and Aging", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qdelZCX8GBYC", "citedby": "0"}, {"bib": {"title": "Regulation of Fluid and Electrolyte Balance in Hypertension: Role of Hormones and Peptides", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qKtbcrzMvwAC", "citedby": "0"}, {"bib": {"title": "Genetics of Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oEW5MyxtvQ4C", "citedby": "0"}, {"bib": {"title": "History of Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QaBZMoE9kVYC", "citedby": "0"}, {"bib": {"title": "Epidemiology of Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:P1qO8dLd1z8C", "citedby": "0"}, {"bib": {"title": "Vascular Remodeling in Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WY6AygvC5sMC", "citedby": "0"}, {"bib": {"title": "b-Adrenergic Receptor Blockers in Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tvutLEwYQz8C", "citedby": "0"}, {"bib": {"title": "a 1-Receptor Inhibitory Drugs in the Treatment of Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:npT69zEmqdIC", "citedby": "0"}, {"bib": {"title": "Major clinical trials of hypertension-What should be done next?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6G1OFF11MdUC", "citedby": "0"}, {"bib": {"title": "Hypertension and Kidney", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i9zlNfTiRXIC", "citedby": "0"}, {"bib": {"title": "Differential Effect of [beta]-Blocker Therapy on Insulin Resistance as a Function of Insulin Sensitizer Use", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BFa5h04uPMwC", "citedby": "0"}, {"bib": {"title": "Efficacy and Safety of Fixed Combinations of Irbesartan/HCTZ in Patients with Type 2 Diabetes with Uncontrolled SBP on Mono-therapy in the INCLUSIVE Trial", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uEM9VtRl8xsC", "citedby": "0"}, {"bib": {"title": "Quality of Life Scores Show Improvement in Diabetes Symptoms on Carvedilol vs Metoprolol in GEMINI", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Q3-QASNKTMEC", "citedby": "0"}, {"bib": {"title": "P-255: Ambulatory blood pressure monitoring in the primary care setting: Assessment of therapy on circadian variation of blood pressure from the MICCAT-2 trial", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:as11RrW_MxEC", "citedby": "0"}, {"bib": {"title": "P-269: Correlation between ascending aortic pressures and outcomes in patients with coronary artery disease", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZqLB7dQ1iF4C", "citedby": "0"}, {"bib": {"title": "Is ethnicity a factor in choice of antihypertensive drug?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eAUscmXIlQ8C", "citedby": "0"}, {"bib": {"title": "P-222: Differential effects of [beta]-blockers in combination with renin angiotensin system blockers on microalbuminuria in patients with type 2 diabetes and hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:XDrR66g3YHsC", "citedby": "0"}, {"bib": {"title": "P-256: \u03b2-Blockers in combination with renin antiotensin system blockade facilitate attaining blood pressure goals with differences in metabolic consequences", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KWzIFqRkAKkC", "citedby": "0"}, {"bib": {"title": "Lack of insurance is associated with a higher prevalence of chronic kidney disease: Results from the kidney early evaluation program", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-vzq6BoH5oUC", "citedby": "0"}, {"bib": {"title": "Metabolic effects of carvedilol versus metoprolol in patients with type 2 diabetes and hypertension: Results of the GEMINI trial", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TiIbgCYny7sC", "citedby": "0"}, {"bib": {"title": "T04-P-037 Effects of novel aldosterone antagonist hormone therapy drospirenone/E2 on blood pressure and potassium in high risk hypertensive postmenopausal women", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:natZJ_-F0IUC", "citedby": "0"}, {"bib": {"title": "George Bakris, MD: researching ways to combat hypertension. Interview by Mike Mitka.", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:In6cVmBjs0IC", "citedby": "0"}, {"bib": {"title": "Carvedilol, Metoprolol, and Insulin Resistance\u2014Reply", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Yo42cslQ7-cC", "citedby": "0"}, {"bib": {"title": "80 ANTIPLATELET ACTIVITY TO HIGH LOADING DOSE OF CLOPIDOGREL IS SIMILAR IN DIABETIC VERSUS NON-DIABETIC PATIENTS QUANTIFIED USING A NOVEL POINT-OF-CARE PLATELET AGGREGATION", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oldoQiaHq2UC", "citedby": "0"}, {"bib": {"title": "GEMINI (metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes Mellitus and hypertension)", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:onKP9CxGSkIC", "citedby": "0"}, {"bib": {"title": "Differential effects of beta-blockers in addition to blockers of the renin angiotensin system on the cardiovascular risk marker, microalbuminuria, in patients with type 2 \u2026", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:koF6b02d8EEC", "citedby": "0"}, {"bib": {"title": "Age over 30 becomes a cardiovascular risk factor in patients screened for chronic kidney disease: Results from the Kidney Early Evaluation Program (KEEP)", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4E1Y8I9HL1wC", "citedby": "0"}, {"bib": {"title": "Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CYCz2uKfkRAC", "citedby": "0"}, {"bib": {"title": "A note of thanks to referees", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hzvVvKpMvx4C", "citedby": "0"}, {"bib": {"title": "The renin-angiotensin-aldosterone-system", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:B71Od6CY_ssC", "citedby": "0"}, {"bib": {"title": "Effect of ruboxistaurin on albuminuria and estimated glomerular filtration rate (GFR) in persons with type 2 diabetes and nephropathy", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mJbmKSuM8toC", "citedby": "0"}, {"bib": {"title": "Chronic kidney disease is a major public health problem in the United States and is the most common identifiable cause of hypertension, present in 2%-5% of hypertensive \u2026", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:j8pvxH-kN2QC", "citedby": "0"}, {"bib": {"title": "Differential effects of \u03b2-blockers on albuminuria in patients with type 2 diabetes. Commentary", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:idthP5jqfYAC", "citedby": "0"}, {"bib": {"title": "Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Commentary", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:E7VqQtBCVmcC", "citedby": "0"}, {"bib": {"title": "ACE inhibitor for a diabetic patient with normal blood pressure?", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dAp6zn-oMfAC", "citedby": "0"}, {"bib": {"title": "Issues Scheduled for 2005 and 2006-Hypertension-March 2005", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jtI9f0ekYq0C", "citedby": "0"}, {"bib": {"title": "Management of hypertension in patients with the metabolic syndrome", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LGlY6t8CeOMC", "citedby": "0"}, {"bib": {"title": "Consultants for the American Journal of Nephrology 2005", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NMlhSUseqAsC", "citedby": "0"}, {"bib": {"title": "Diabetes and Hypertension", "year": "2005"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:UuEBAcK4md4C", "citedby": "0"}, {"bib": {"title": "Effets metaboliques du carvedilol vs metoprolol chez des patients presentant un diabete de type 2 et une hypertension: Essai randomise et comparatif", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NU-BerS4NX4C", "citedby": "0"}, {"bib": {"title": "Albuminuria: Risk marker and target for treatment-Introduction", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EupYgYwc-6gC", "citedby": "0"}, {"bib": {"title": "Abbott, KC, 116 Ahya, SN, 398 Al Aly, Z., 310 Anderson, GD, 357", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J6OZcwVsj5AC", "citedby": "0"}, {"bib": {"title": "Article reviewers for 2004", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DwWRdx-KAo4C", "citedby": "0"}, {"bib": {"title": "Hypertension and the kidney", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:W1ZWpF0a3GIC", "citedby": "0"}, {"bib": {"title": "458 Aldosterone antagonism reduces circulating interleukin\u20106 and soluble intercellular adhesion molecule\u20101 in patients with advanced chronic heart failure", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wUCFpcnEedwC", "citedby": "0"}, {"bib": {"title": "P-260: Impact of abnormal nocturnal blood pressure fall on aortic root performance in diabetic hypertensives", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dyiPZ63SVtYC", "citedby": "0"}, {"bib": {"title": "P-76: A large-scale ambulatory blood pressure monitoring (ABPM) trial in the practice setting: efficacy of the angiotensin receptor blocker, telmisartan", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VnuxuLaQPLMC", "citedby": "0"}, {"bib": {"title": "P-187: Combination therapy with an ace-inhibitor (ACEI)/calcium channel blocker (CCB) for hypertensive patients non-responsive to ace-inhibitor monotherapy: An efficacy and \u2026", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wGzT3bKASkAC", "citedby": "0"}, {"bib": {"title": "P-440: Achievement of blood pressure goals for diabetic subpopulation in a hypertension clinic", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gV6rEsy15s0C", "citedby": "0"}, {"bib": {"title": "P-200: Treatment of hypertension in patients with diabetes mellitus: initial losartan/hydrochlorothiazide combination versus ramipril monotherapy", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yIeBiWEAh44C", "citedby": "0"}, {"bib": {"title": "Optimizing target-organ protection in patients with renal impairment", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DXE8ND7PrJAC", "citedby": "0"}, {"bib": {"title": "Wednesday, May 19, 10:00 AM \u2013 12:00 PM: Optimizing Blood Pressure Control in Clinical Practice: Optimizing target-organ protection in patients with renal \u2026", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:s85pQhAUCrAC", "citedby": "0"}, {"bib": {"title": "Guest editorial: hypertension and kidney disease", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_tF6a-HnqWAC", "citedby": "0"}, {"bib": {"title": "Curriculum in Cardiology", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6IBXqrN-DEwC", "citedby": "0"}, {"bib": {"title": "Achieved vs Initial Blood Pressure in Predicting Renal Outcomes\u2014Reply", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Azgs6IHzeyYC", "citedby": "0"}, {"bib": {"title": "Mechanism of action of diuretics.", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JQG40wivBEIC", "citedby": "0"}, {"bib": {"title": "\u00bf Qu\u00e9 se ha aprendido de los estudios cl\u00ednicos actuales?", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9QTmwX2E1jEC", "citedby": "0"}, {"bib": {"title": "Author Index Vol. 22, No. 1, 2004", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r4zddjZt6C4C", "citedby": "0"}, {"bib": {"title": "Subject Index Vol. 22, No. 1, 2004", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jW3pDOCzWhQC", "citedby": "0"}, {"bib": {"title": "DALE E. HAMMERSCHMIDT", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uQVPmWFBlwUC", "citedby": "0"}, {"bib": {"title": "Hypertension in chapter", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Gb6Hms-Uo9kC", "citedby": "0"}, {"bib": {"title": "Albuminuria: Risk Marker and Target for Treatment", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BW2nPTmhBn4C", "citedby": "0"}, {"bib": {"title": "Section 3-Renin Angiotensin System (RAS) Inhibition in Chronic Renal Disease: Risk/Benefit Profile-Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in \u2026", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Nw_I7GeUguwC", "citedby": "0"}, {"bib": {"title": "Author Index Vol. 24, 2004", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oqD4_j7ulsYC", "citedby": "0"}, {"bib": {"title": "Strategies de traitement de l'hypertension arterielle avec ou sans inhibiteur calcique chez des patients coronariens.: INVEST (International Verapamil-Trandolapril Study \u2026", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:60iIaj97TE0C", "citedby": "0"}, {"bib": {"title": "Strategies de traitement de l'hypertension arterielle avec ou sans inhibiteur calcique chez des patients coronariens", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Y9VhQm-5nPIC", "citedby": "0"}, {"bib": {"title": "Jak potencovat \u00fa\u010dinek inhibitoru ACE u pacient\u016f s diabetem 2. typu a mikroalbuminuri\u00ed blok\u00e1tory kalciov\u00fdch kan\u00e1l\u016f nebo diuretiky?", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:37UQlXuwjP4C", "citedby": "0"}, {"bib": {"title": "Editorial Commentaries-New Onset Diabetes and Cardiovascular Risk", "year": "2004"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:c1e4I3QdEKYC", "citedby": "0"}, {"bib": {"title": "Treatment of hypertension in African Americans", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LwieBGrN4GEC", "citedby": "0"}, {"bib": {"title": "Approaches to maximize cardiovascular risk reduction in kidney disease", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BFeJNCPbDVwC", "citedby": "0"}, {"bib": {"title": "Diabetes with and without proteinuria", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8xglSJ46CyEC", "citedby": "0"}, {"bib": {"title": "The kidney and hypertension in South and East Asians", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OKy9v0bssVUC", "citedby": "0"}, {"bib": {"title": "Microalbuminuria/proteinuria: What does it mean? How do you measure it?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pQTOvowfQioC", "citedby": "0"}, {"bib": {"title": "ACCOMPLISH (Avoiding cardiovascular events through combination therapy in patients living with systolic hypertension) trial: Design and rationale.", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ynsZFq2pu0MC", "citedby": "0"}, {"bib": {"title": "Fixed-dose combination therapy with amlodipine besylate/benazepril HCl is superior to enalapril monotherapy in African Americans with hypertension and type 2 diabetes.", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cOfwuRB03ygC", "citedby": "0"}, {"bib": {"title": "Best diagnostic approach to hyperkalemia?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cF7EPgIk0B4C", "citedby": "0"}, {"bib": {"title": "ACE inhibitor use and elevated creatinine levels-Reply", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QeguYG95ZbAC", "citedby": "0"}, {"bib": {"title": "Recent BP trials and JNC 7: what they mean in practice", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Kqc1aDSOPooC", "citedby": "0"}, {"bib": {"title": "Arterial Hypertension in Diabetes: Etiology and Treatment", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uUvzmPk0f8oC", "citedby": "0"}, {"bib": {"title": "SHORT TERM EFFECTS OF RENAL ARTERY STENTING ON BLOOD PRESSURE AND RENAL FUNCTION IN RENAL TRANSPLANT RECEPIENTS", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lo0OIn9KAZgC", "citedby": "0"}, {"bib": {"title": "ARE THE COX-2 INHIBITORS AS GOOD AS THEY WERE INITIALLY THOUGHT TO BE??", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HNqp4bORoCIC", "citedby": "0"}, {"bib": {"title": "341. ACE inhibitors slow GFR decline better than \u03b2-blockers or dihydropyridines.", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eJD0kABLposC", "citedby": "0"}, {"bib": {"title": "P-588: The short term effect of renal artery stenting on hypertension and renal function", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GJVTs2krol4C", "citedby": "0"}, {"bib": {"title": "Septieme rapport du Joint National Committe on Prevention, Detection, Evaluation and treatment of High Blood Pressure: Rapport du JNC 7", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i91s68tWr-MC", "citedby": "0"}, {"bib": {"title": "Thursday, May 15, 6: 30 AM-8: 00 AM-From Hypertension to Heart Failure: Breaking the Chain of Cardiovascular Disease*: Management of diabetic renal disease: do [beta] blockers \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cB__R-XWw9UC", "citedby": "0"}, {"bib": {"title": "P-430: COX-2 inhibitors: are they good, bad or ugly?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oursBaop5wYC", "citedby": "0"}, {"bib": {"title": "P-428: 24 hour ambulatory blood pressure monitoring in diabetic hypertensive patients with varying degrees of albuminuria", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cNe27ouKFcQC", "citedby": "0"}, {"bib": {"title": "P-151: Modeling the clinical outcomes of Tarka in diabetic nephropathy", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:txeM2kYbVNMC", "citedby": "0"}, {"bib": {"title": "Wednesday, May 14, 10: 00 AM-12: 00 PM-Achieving Blood Pressure Goals: Is Fixed-Dose Combination Therapy the Answer?: Who should be considered for initial therapy with \u2026", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J3LtWjKFLicC", "citedby": "0"}, {"bib": {"title": "P-572: Mild renal insufficiency-a cardiovascular risk in hypertensive patients", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TesyEGJKHF4C", "citedby": "0"}, {"bib": {"title": "Current Problems in", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:PklR0melJeUC", "citedby": "0"}, {"bib": {"title": "The management of hypertension and diabetes: guidelines and blood pressure targets", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:naSTrk-c4S8C", "citedby": "0"}, {"bib": {"title": "Hypoglycemic and antihyperglycemic activity of Syzygium alternifolium (Wt.) Walp. seed extracts in normal and diabetic rats.", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Lmuc1furtc4C", "citedby": "0"}, {"bib": {"title": "Il Settimo Rapporto del Joint National Committee sulla Prevenzione, Diagnosi, Valutazione e Trattamento dell'Ipertensione Arteriosa The JNC 7 Report", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6Dd5luMImnEC", "citedby": "0"}, {"bib": {"title": "American journal of nephrology", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fXbrI0tPCuEC", "citedby": "0"}, {"bib": {"title": "The Editorial Office thanks the following colleagues for reviewing papers for the period of 1 November 2001 to 31 October 2002", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6e4D8M0GhXMC", "citedby": "0"}, {"bib": {"title": "CARDIOLOGY PATIENT PAGE CARDIOLOGY PATIENT PAGE", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4pF9x-cDGsoC", "citedby": "0"}, {"bib": {"title": "Cholesterol as the Risk Factor for Coronary Artery Disease and Stroke in Old Age Annelies WE Weverling-Rijnsburger, MD; Iris JAM Jonkers, MD; Eric van Exel, MD", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:d6JCS5z0ckYC", "citedby": "0"}, {"bib": {"title": "Efecto preventivo de la disminuci\u00f3n de las cifras de presi\u00f3n arterial y los antihipertensivos en la nefropat\u00eda hipertensiva", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qbqt7gslDFUC", "citedby": "0"}, {"bib": {"title": "Hipertensi\u00f3n arterial. El s\u00e9ptimo informe del Joint National Committee", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Mx5hWS9ctUkC", "citedby": "0"}, {"bib": {"title": "Management of diabetic renal disease: do \u03b2 blockers have a role?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8VtEwCQfWZkC", "citedby": "0"}, {"bib": {"title": "Vliv v\u00fd\u0161e krevn\u00edho tlaku na ren\u00e1ln\u00ed progn\u00f3zu a kardiovaskul\u00e1rn\u00ed progn\u00f3za u pacient\u016f s diabetickou nefropati\u00ed na podklad\u011b diabetu 2. typu", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oTdOBqtIf_kC", "citedby": "0"}, {"bib": {"title": "Who should be considered for initial therapy with combination antihypertensive agents?", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jlhcAiayVhoC", "citedby": "0"}, {"bib": {"title": "Efectos del tratamiento antihipertensivo sobre la progresi\u00f3n de la nefroangioesclerosis hipertensiva: resultados del estudio AASK", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AzKEL7Gb_04C", "citedby": "0"}, {"bib": {"title": "Contents Vol. 23, 2003", "year": "2003"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-yGd096yOn8C", "citedby": "0"}, {"bib": {"title": "Hypertension and diabetes: family physicians' pivotal role-Editorials", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:v7LLNfYe7h0C", "citedby": "0"}, {"bib": {"title": "Association of baseline proteinuria and GFR with progression of kidney disease in the African American study of kidney disease (AASK).", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IExZWSxeYXUC", "citedby": "0"}, {"bib": {"title": "Differential actions of COX-2 inhibitor-Celebrex and NSAID-Diclofenac sodium on renal function and blood pressure.", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KsTgnNRry18C", "citedby": "0"}, {"bib": {"title": "Heart failure as an etiology for hospitalization in chronic dialysis patients.", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oH8HCDhqVGsC", "citedby": "0"}, {"bib": {"title": "Measures of kidney dysfunction (KD) in individuals participating in the National Kidney Foundation Kidney Early Evaluation Program (KEEP)(R).", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1paMEeroeoQC", "citedby": "0"}, {"bib": {"title": "The effect of different blood pressure goals and antihypertensive drug regimes on change in proteinuria: Results from the African-American study of kidney disease.", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:L7vk9XBBNxgC", "citedby": "0"}, {"bib": {"title": "Contrasting effects of combining an angiotensin receptor blocker with an ACE inhibitor or a calcium channel blocker (CCB) on glomerulosclerosis (GS) in the remnant kidney (RK \u2026", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5rMqqAh47xYC", "citedby": "0"}, {"bib": {"title": "Articles appearing on AJKD ELECTRONIC PAGES are referred to by journal number, a colon, the letter E and a number. Page references to Supplement 1 (February 2002) and \u2026", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bXvxhPDrUX0C", "citedby": "0"}, {"bib": {"title": "Benefits of BP Control Using ACE/CCB Therapy in Type 2 Diabetes", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lRPiJ3GhvscC", "citedby": "0"}, {"bib": {"title": "Roundtable Discussion: Problems in the Management of Hypertension", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nqdriD65xNoC", "citedby": "0"}, {"bib": {"title": "Benefits of BP control using ACE/CCB in type 2 diabetics", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9VeumLvkZSQC", "citedby": "0"}, {"bib": {"title": "P-453: Weight loss with orlistat reduces cardiovascular risk in obese individuals with treated but insufficiently controlled hypertension", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hHIA4WEVY-EC", "citedby": "0"}, {"bib": {"title": "Treatment Strategy and Goals for Lowering Blood Pressure In Patients with Diabetes and/or Renal Impairment", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nU66GSXDKhoC", "citedby": "0"}, {"bib": {"title": "Treatment of diabetic hypertension: goals and choices", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AdUz3-SiDfgC", "citedby": "0"}, {"bib": {"title": "A note of thanks to referees", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Nb0HLiwjfsIC", "citedby": "0"}, {"bib": {"title": "SYMPOSIUM ON HYPERTENSION IN AFRICAN AMERICANS-BARRIERS TO BLOOD PRESSURE CONTROL IN AFRICAN AMERICANS-Overcoming obstacles is challenging, but target goals can be attained \u2026", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:54SpJiyHbzwC", "citedby": "0"}, {"bib": {"title": "The Editorial Office thanks the following colleagues for reviewing papers for the period of 1 November 2000 to 31 October 2001", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gNZucvRojEcC", "citedby": "0"}, {"bib": {"title": "Calcium Antagonists: Are They All Created Equal in Regard to Slowing Progression", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZyBjE3zI-i8C", "citedby": "0"}, {"bib": {"title": "Acknowledgment of Manuscript Consultants JASN Volume 13", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fMcxjvj1mj8C", "citedby": "0"}, {"bib": {"title": "The Journal of Human Hypertension gratefully acknowledges the assistance given to the Editorial offices by the following referees during the year 2002", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:CKf5m1HYVjMC", "citedby": "0"}, {"bib": {"title": "Cumulative contents", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bbjcffOLshcC", "citedby": "0"}, {"bib": {"title": "Primer, Philadelphia: Lippincott Williams & Wilkins, 2003: 175-177. Frohlich ED. Systolic blood pressure, hypertensive complications, and changes in therapeutic intensity. In \u2026", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Nnq8S6OXqDYC", "citedby": "0"}, {"bib": {"title": "SYMPOSIUM ON HYPERTENSION IN AFRICAN AMERICANS-HYPERTENSION-RELATED DISEASE IN AFRICAN AMERICANS-Factors underlying disparities in illness and its outcome-The proposed reasons \u2026", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3MwzVuqRcA0C", "citedby": "0"}, {"bib": {"title": "SYMPOSIUM ON HYPERTENSION IN AFRICAN AMERICANS-OPTIMAL TREATMENT OF HYPERTENSION IN AFRICAN AMERICANS-Reaching and maintaining target blood pressure goals-Focus on prevention \u2026", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:hfzGNhXhx5MC", "citedby": "0"}, {"bib": {"title": "Consultant List", "year": "2002"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TaaCk18tZOkC", "citedby": "0"}, {"bib": {"title": "Effect of orlistat in overweight or obese patients with treated but inadequately controlled diastolic hypertension", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:N6_Y7JlWxwsC", "citedby": "0"}, {"bib": {"title": "P-196: Effects of an ACE inhibitor (ACEI) with and without addition of a calcium antagonist (CA) on lipid subfractions and microalbuminuria (MA) in people with type 2 diabetes \u2026", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eFf2swCANGcC", "citedby": "0"}, {"bib": {"title": "Epidemiology of obstructive sleep apnea: A population health perspective.", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Q4B7mEBXgMkC", "citedby": "0"}, {"bib": {"title": "Chicago, Ill", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KKhxhHPhcTsC", "citedby": "0"}, {"bib": {"title": "The Editorial Office thanks the following colleagues for reviewing papers for the period of 1 November 1999 to 31 October 2000", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6sy8ByAbWgIC", "citedby": "0"}, {"bib": {"title": "Effects on Renal Disease Progression", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AeM5kdmBKVwC", "citedby": "0"}, {"bib": {"title": "Not to Treat: A Clinical Dilemma", "year": "2001"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1YatL4jblGcC", "citedby": "0"}, {"bib": {"title": "Treatment guidelines for patients with hypertension and diabetes", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ndLnGcHYRF0C", "citedby": "0"}, {"bib": {"title": "Renoprotection and blood pressure-Reply", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2Iopv88g0QUC", "citedby": "0"}, {"bib": {"title": "Disease in the Patient with Diabetes Mellitus'", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:s9ia6_kGH2AC", "citedby": "0"}, {"bib": {"title": "Managing hypertension in patients at increased risk for cardiovascular events", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aDl3D7KC1E4C", "citedby": "0"}, {"bib": {"title": "Oral antidiabetic agents safe with renal disease?", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RMgMIBzvq-4C", "citedby": "0"}, {"bib": {"title": "stabilise within 2\u20134 weeks\u2019. They add that patients who experience increases in creatinine level of> 30% may require dose reduction, or discontinuation, of ACE inhibitor therapy.", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4oJvMfeQlr8C", "citedby": "0"}, {"bib": {"title": "Friday, may 19, broadway ballroom north, 5: 00 pm to 6: 30 pm. Theme II: Choice of drugs in hypertensive patients with comorbid conditions: Should ACE inhibitors or AT1 \u2026", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wBLCggQE-ToC", "citedby": "0"}, {"bib": {"title": "Diabetic Kidney Disease", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cUMtEw7vMgQC", "citedby": "0"}, {"bib": {"title": "Joseph S. Alpert, MD", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eEnCcB-k6EAC", "citedby": "0"}, {"bib": {"title": "Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the \u2026", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WxjA8IQWSGYC", "citedby": "0"}, {"bib": {"title": "Raised serum sialic acid concentration precedes onset of microalbuminuria in iddm.", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2Zz6vCQtBj4C", "citedby": "0"}, {"bib": {"title": "Screening for type2 diabetes: Literature review and economic modeling.", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:U6twwk6Vgq8C", "citedby": "0"}, {"bib": {"title": "Prevalence of conventional risk factors in patients with coronary heart disease.", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nZgPvcLaoyMC", "citedby": "0"}, {"bib": {"title": "Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women.", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:vCSeWdjOjw8C", "citedby": "0"}, {"bib": {"title": "Childhood obesity, obesity-related diabetes tied to cardiovascular risk", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8VbLR7ExW8oC", "citedby": "0"}, {"bib": {"title": "Byberg L 175 Caesar M 473 (L) Caiazza A 573 Calls J 17 Calm\u00f3n G S6 (Suppl 1)", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BZGggv0hN9sC", "citedby": "0"}, {"bib": {"title": "Consultants for the American Journal of Nephrology 2000", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kFM4V80Y5EsC", "citedby": "0"}, {"bib": {"title": "Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors-Kidney Int 56: 206-210, 1999", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MGPUR4WVBMEC", "citedby": "0"}, {"bib": {"title": "Combination therapy for hypertension and renal disease in diabetes", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bVQMTfhMCi4C", "citedby": "0"}, {"bib": {"title": "Should ACE inhibitors or AT1 receptor blockers be used as initial therapy in people with renal disease or diabetes?", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:W2uZP3ddy8sC", "citedby": "0"}, {"bib": {"title": "FOREFRONTS IN NEPHROLOGY: NEWS IN ALDOSTERONE ACTION-Chateau de Montvillargenne, Paris-Chantilly, France-August 15-18, 1999-VASCULAR BIOLOGY-HEMODYNAMICS-HYPERTENSION-Lack of \u2026", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nPTYJWkExTIC", "citedby": "0"}, {"bib": {"title": "DESIGNING THE IDEAL AII RECEPTOR ANTAGONIST", "year": "2000"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oPLKW5k6eA4C", "citedby": "0"}, {"bib": {"title": "Importance of blood pressure for cardio-renal event reduction: Is the level or the agent used more important?", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8gBurD7jEYQC", "citedby": "0"}, {"bib": {"title": "Wednesday, May 19, Broadway Ballroom South, 10: 00 AM to 12: 30 PM: Intensive BP control: Treatment goals, strategies, and outcomes: Importance of blood pressure for cardio \u2026", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ukw-9cB-YDkC", "citedby": "0"}, {"bib": {"title": "VASCULAR BIOLOGY-HEMODYNAMICS-HYPERTENSION-Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IyMil-iDmu0C", "citedby": "0"}, {"bib": {"title": "Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors.", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_3zdsQPSqRAC", "citedby": "0"}, {"bib": {"title": "The Journal of Human Hypertension gratefully acknowledges the assistance given to the Editorial offices by the following referees during the year 1999", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qNJvDq80yDAC", "citedby": "0"}, {"bib": {"title": "Consultants for the American Journal of Nephrology 1999", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M3hCyctIOBoC", "citedby": "0"}, {"bib": {"title": "Manuscript Consultants", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:r5WMYYrv30cC", "citedby": "0"}, {"bib": {"title": "Heartstyles TM profiles: implications of health lifestyle analysis for improving hypertension control.", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kQqwFFzsCTwC", "citedby": "0"}, {"bib": {"title": "Abe, Keishi, Sendai, Japan Adam, Albert, Montreal, Canada Agabiti-Rosei, Enrico, Brescia, Italy Alderman, Michael H., Bronx, NY", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:v6PuF9mNY3oC", "citedby": "0"}, {"bib": {"title": "Tailoring antihypertensive treatment for special populations-Hypertension and diabetes", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QaSi33NTfwYC", "citedby": "0"}, {"bib": {"title": "Intensive BP control: treatment goals, strategies, and outcomes-Importance of blood pressure for cardio-renal event reduction: Is the level or the agent used more important?", "year": "1999"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ji7lAbPyDbYC", "citedby": "0"}, {"bib": {"title": "Assessing kidneys that may be fragile", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SpPTWFSNUtQC", "citedby": "0"}, {"bib": {"title": "Risks for renal involvement in diabetes", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1EqfMoDn7-AC", "citedby": "0"}, {"bib": {"title": "Anglotensin II receptor blockers in hypertension and renal disease (vol 33, pg 19, 1998)", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5F1dSjz1ScoC", "citedby": "0"}, {"bib": {"title": "Wednesday, May 13, Astor Ballroom 10: 30 AM: New Directions in the Management on Hypertension (JNC VI) Value of combination therapy for patients with renal disease", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NxmKEeNBbOMC", "citedby": "0"}, {"bib": {"title": "CLINICAL NEPHROLOGY-EPIDEMIOLOGY-CLINICAL TRIALS-Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RPps9qLA3-kC", "citedby": "0"}, {"bib": {"title": "Design and Analysis of Single-Factor Experiment: Completely Randomized Design Statistical Principles in Experimental Design.", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:10ZmGoIvuzkC", "citedby": "0"}, {"bib": {"title": "Davison, J., Newcastle-upon-Tyne, England De Freitas, DEM, Chicago, IL De Gaudemaris, R., Grenoble, France De Quateli Doi, S., Bethesda, MD", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:KaRcLhEUy5UC", "citedby": "0"}, {"bib": {"title": "Renin-Angiotensin System in Diabetic Nephropathy: from Bench to Bedside: 12 Tables", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6jAoOr-ogVAC", "citedby": "0"}, {"bib": {"title": "Manuscript Consultants", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_IwLajd9sWMC", "citedby": "0"}, {"bib": {"title": "Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:o0eFlWRwRSUC", "citedby": "0"}, {"bib": {"title": "Effects of Diabetes and Hypertension on the Aging Kidney", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mo9XK3BEATIC", "citedby": "0"}, {"bib": {"title": "The role of combination antihypertensive therapy and the progression of renal disease hypertension-a randomized multicentered study (abst)", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Sf6vrWCRp3YC", "citedby": "0"}, {"bib": {"title": "Combination Therapy for Hypertension and Renal Disease in Diabetes", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i8eIfGGcn98C", "citedby": "0"}, {"bib": {"title": "SUPPLEMENT: HYPERTENSION: LOOKING TOWARD THE NEXT MILLENNIUM? The Role of Combination Antihypertensive Therapy and the Progression of Renal Disease Hypertension: Looking Toward \u2026", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZysSsiWj_g4C", "citedby": "0"}, {"bib": {"title": "ION CHANNELS-MEMBRANE TRANSPORT-INTEGRATIVE PHYSIOLOGY-Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_mQi-xiA4oYC", "citedby": "0"}, {"bib": {"title": "Preservation of renal function: the spectrum of effects by calcium channel blockers: Reply", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H7nrzBkawXsC", "citedby": "0"}, {"bib": {"title": "Consultants for the American Journal aof Nephrology 1998", "year": "1998"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RuPIJ_LgqDgC", "citedby": "0"}, {"bib": {"title": "The Lanai Symposium Hypertensive patient profiles: approaches to management and disease prevention", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:e84hm74t-eoC", "citedby": "0"}, {"bib": {"title": "Relative antihypertensive and glomeruloprotective efficacies of angiotensin converting enzyme inhibition (ACEI) and receptor (AT (1)) blockade in the remnant kidney model.", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VjBpw8Hezy4C", "citedby": "0"}, {"bib": {"title": "Modifiable risk factors predicted the development of diabetic nephropathy", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:YDt8mvgFZ2cC", "citedby": "0"}, {"bib": {"title": "The influence of dietary salt on the antiproteinuric effect of calcium channel blockers-Reply", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:co-xmOEWlm8C", "citedby": "0"}, {"bib": {"title": "More on calcium channel blockers in nephrology-In reply", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M8Ejg5y-C14C", "citedby": "0"}, {"bib": {"title": "The kidney a cardiovascular risk marker and a new target for therapy.", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AOgtTcItT4oC", "citedby": "0"}, {"bib": {"title": "More on calcium channel blockers in nephrology.", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Tfl4UtY-dJUC", "citedby": "0"}, {"bib": {"title": "BLOOD PRESSURE CONTROL AND PROGRESSION OF DIABETIC NEPHROPATHY: DO EITHERTHE LEVEL OF REDUCTION OR AGENTS USED TO ACHIEVE IT MATTER?", "year": "1997"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:DQNrXyjhriIC", "citedby": "0"}, {"bib": {"title": "1995 update of the working group reports on chronic renal failure and renovascular hypertension-National High Blood Pressure Education Program Working Group", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:h4edN3iSU_gC", "citedby": "0"}, {"bib": {"title": "Calcium antagonists prevent reductions in arterial pressure mediated by vasopressin receptor antagonism", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GUYAmugLYisC", "citedby": "0"}, {"bib": {"title": "24 Analogy Between", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IF0FbId8XVwC", "citedby": "0"}, {"bib": {"title": "Cardiac risk factors, medication and recurrent clinical events after acute coronary disease: A prospective cohort study.", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QAsQKsfVUN4C", "citedby": "0"}, {"bib": {"title": "Hypertension in dialysis patients", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bzhzIcV5SW4C", "citedby": "0"}, {"bib": {"title": "The kidney in cardiovascular disease: victim or culprit?", "year": "1996"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zzCxg_vo7cAC", "citedby": "0"}, {"bib": {"title": "ACUTE RENAL HEMODYNAMIC-CHANGES ASSOCIATED WITH CALCIUM-ANTAGONISTS (CA) PERSIST FOR YEARS", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:I2jIoRS3jIgC", "citedby": "0"}, {"bib": {"title": "SODIUM-INTAKE DETERMINES THE DEGREE OF ALBUMINURIA REDUCTION WITH CERTAIN CALCIUM-ANTAGONISTS", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:E8ajGqO0XoUC", "citedby": "0"}, {"bib": {"title": "Hypertension and chest pain: expect the expected", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:b8wqy9DyMDUC", "citedby": "0"}, {"bib": {"title": "Acker, BAC van 2274,(Abst) 574, 576 Ackermann, A. 1546 Ackermann, D. 1614", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7f0ks1Axv_QC", "citedby": "0"}, {"bib": {"title": "Comparison of two different dihydropyridine calcium antagonists on albuminuria in hypertensive diabetic subjects: a randomized prospective cross-over study.", "year": "1995"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6ZzL7HXColQC", "citedby": "0"}, {"bib": {"title": "Captopril reduced progression of microalbuminuria in normotensive type 1 diabetes", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:HygtOXotxAUC", "citedby": "0"}, {"bib": {"title": "Microalbuminuria in Non\\p= m-\\Insulin-Dependent", "year": "1994"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:OWf_fnsf0g4C", "citedby": "0"}, {"bib": {"title": "Severe Hypertension in a Young Patient: Case Commentary", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:kOdZbmsmKqcC", "citedby": "0"}, {"bib": {"title": "Severe hypertension in a young patient.", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8RAEygVn5_EC", "citedby": "0"}, {"bib": {"title": "ALPHA-BLOCKERS IN DIABETIC NEPHROPATHY-RESPONSE", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RgznTc0nqo4C", "citedby": "0"}, {"bib": {"title": "ENDOCRINOLOGY: ACE INHIBITOR AND CALCIUM ANTAGONIST SLOW PROGRESSION OF DIABETIC RENAL DISEASE", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:jgTXuCzW-kcC", "citedby": "0"}, {"bib": {"title": "The Medical Bookshelf.", "year": "1993"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BHd7YmozNHgC", "citedby": "0"}, {"bib": {"title": "The Antiproteinuric Effect of Antihypertensive Agents in Diabetic Nephropathy-Reply", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:wyM6WWKXmoIC", "citedby": "0"}, {"bib": {"title": "Comparing angiotensin-converting enzyme inhibitors and calcium blockers in protein uric diabetic patients", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nPT8s1NX_-sC", "citedby": "0"}, {"bib": {"title": "DILTIAZEM AND MORTALITY IN MYOCARDIAL-INFARCTION-REPLY", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sAujV351FBYC", "citedby": "0"}, {"bib": {"title": "Cardioprotective effects carvedilol on acute autoimmune myocarditis: Anti-inflammatory effects associated with antioxidant property.", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gmhHX4scLhsC", "citedby": "0"}, {"bib": {"title": "GENITOURINARY DISEASE: Slowing the Course of Renal Failure in Patients with Diabetes", "year": "1992"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8dzOF9BpDQoC", "citedby": "0"}, {"bib": {"title": "THE MECHANISM OF GLOMERULAR HYPERFILTRATION IN DIABETIC DOGS", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ehoypfNsBj8C", "citedby": "0"}, {"bib": {"title": "CALCIUM-CHANNEL ANTAGONISTS REDUCE RENAL PROTEIN EXCRETION-REPLY", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pxXbYLTb8EgC", "citedby": "0"}, {"bib": {"title": "Alderman, Michael, Bronx, NY Anderson, Sharon, Portland, OR Atlas, Steve, New York, NY August, Phyllis, New York, NY Aviv, Abraham, Newark, NJ", "year": "1991"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Z98IfIjqAwMC", "citedby": "0"}, {"bib": {"title": "THEOPHYLLINE FOR ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION-REPLY", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8igAKu_hPxwC", "citedby": "0"}, {"bib": {"title": "F120 Radiocontrast medium-induced declines in renal function", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NN0YOz9s3UgC", "citedby": "0"}, {"bib": {"title": "Calcium antagonists: new indications", "year": "1990"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:sbeIDTyQOFgC", "citedby": "0"}, {"bib": {"title": "INSULIN DECREASES ENDOTHELIN PRODUCED BY HUMAN MESANGIAL CELLS IN CULTURE", "year": "1989"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IvSMUa3B7yYC", "citedby": "0"}, {"bib": {"title": "THEOPHYLLINE DECREASES ERYTHROPOIETIN IN POST-RENAL TRANSPLANT POLYCYTHEMIA", "year": "1989"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dFKc6_kCK1wC", "citedby": "0"}, {"bib": {"title": "SUPEROXIDE-DISMUTASE ATTENUATES RADIOCONTRAST MEDIUM-INDUCED INCREASES IN URINARY TAMM-HORSFALL PROTEIN EXCRETION", "year": "1989"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:eIKNFFVQvJAC", "citedby": "0"}, {"bib": {"title": "Urinary Tamm-Horsfall protein as a marker of tubular injury following contrast medium administration", "year": "1989"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qOpkhvVCMvUC", "citedby": "0"}, {"bib": {"title": "INHIBITION OF OXYGEN FREE-RADICAL (OFR) FORMATION FOLLOWING RADIOCONTRAST MEDIUM (RCM) ADMINISTRATION PROTECTS AGAINST DECLINES IN GLOMERULAR-FILTRATION RATE (GFR)", "year": "1988"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:TNEldfgDb5MC", "citedby": "0"}, {"bib": {"title": "\u00df-blocker) with regard to antihyper\u00ac", "year": "1987"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tDdgxD0hSQMC", "citedby": "0"}, {"bib": {"title": "A ROLE FOR CALCIUM IN RADIOCONTRAST-MEDIATED INTRARENAL VASOCONSTRICTION", "year": "1984"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:_TjUWtciUekC", "citedby": "0"}, {"bib": {"title": "THE RENAL RESPONSE TO ORTHOSTASIS IN THE PRESENCE AND ABSENCE OF VENTRICULAR MECHANORECEPTOR DESENSITIZATION", "year": "1984"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:RmcNAhKkducC", "citedby": "0"}, {"bib": {"title": "RENAL INTERSTITIAL PRESSURE DYNAMICS (PI) DURING ACUTE LOW OUTPUT FAILURE", "year": "1984"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:w5CyTnyFq80C", "citedby": "0"}, {"bib": {"title": "Editor's Mail", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0Tn0GYh_KFEC", "citedby": "0"}, {"bib": {"title": "Clonidine for opiate withdrawal in the chronic pain patient.", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BKYZGPsuSFYC", "citedby": "0"}, {"bib": {"title": "An effective alternative for muscle contraction headaches. Orphenadrine citrate.", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EO1llL0aI9sC", "citedby": "0"}, {"bib": {"title": "ORPHENADRINE CITRATE-AN EFFECTIVE ALTERNATIVE FOR MUSCLE-CONTRACTION HEADACHES", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:NRnkAyzcrGMC", "citedby": "0"}, {"bib": {"title": "HOW CLONIDINE WORKS IN EASING OPIATE WITHDRAWAL-REPLY", "year": "1982"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4WewbtJKmRkC", "citedby": "0"}, {"bib": {"title": "Synthesis and evaluation of antiplatelet activity of trihydroxychalcone Derivatives.", "year": "1980"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Fla6ZGMkO9sC", "citedby": "0"}, {"bib": {"title": "Sinus arrhythmia in acute myocardial infarction.", "year": "1978"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H8Dy_DhitWcC", "citedby": "0"}, {"bib": {"title": "Kudzu root: Traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases.", "year": "1969"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lvi_KyGYEDoC", "citedby": "0"}, {"bib": {"title": "Search worldwide, life-sciences literature"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rywEMSoAiS0C", "citedby": "0"}, {"bib": {"title": "Hoger CV event risico bij slechtere nierfunctie in TECOS, niet be\u00efnvloed door DPP4 remmer"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:H1aCVKaixnMC", "citedby": "0"}, {"bib": {"title": "GRAPHICS View All"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oHSet2Z0r48C", "citedby": "0"}, {"bib": {"title": "Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function: data from the CANVAS Program"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zMY8q35v6VMC", "citedby": "0"}, {"bib": {"title": "AJKD EDITORIAL BOARD AmericanJournalof"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4x91efyQ1HQC", "citedby": "0"}, {"bib": {"title": "Device Therapy in Heart Failure Patients With Chronic Kidney Disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:6w2ZCmoKEM0C", "citedby": "0"}, {"bib": {"title": "GRAPHICS View All"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GdooyxxgJVwC", "citedby": "0"}, {"bib": {"title": "Renal Denervation"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LGA7_l5-FVwC", "citedby": "0"}, {"bib": {"title": "Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from t he Kidney Early Evaluation Program (KEEP)."}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9kZNi-u_WhAC", "citedby": "0"}, {"bib": {"title": "From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i_acAUMCj1cC", "citedby": "0"}, {"bib": {"title": "Renin-angiotensin blockade and kidney disease Full source Lancet 2008; 372: 511-512 Text"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JmU_-KX0ghQC", "citedby": "0"}, {"bib": {"title": "You've saved your first item"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MOFHY6MwG3AC", "citedby": "0"}, {"bib": {"title": "Posts Tagged \u2018Genome Research\u2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Pptk7XUfJl0C", "citedby": "0"}, {"bib": {"title": "Almatsier S. 2009. Prinsip Dasar Ilmu Gizi. Jakarta: Gramedia Pustaka Utama. p 61. Anderson JW. 2004. Whole Grains and Coronary Heart Disease: The Whole Kernel of Truth. Am J \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JE23Nz_pzJ0C", "citedby": "0"}, {"bib": {"title": "Aanhoudende bloeddrukdaling op lange termijn met baroreflexactivatietherapie"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:i_QFVEgXGzMC", "citedby": "0"}, {"bib": {"title": "Geen extra risico bij combinatie ACE-remmer en DPP-4 remmer in hoogrisico diabetische pati\u00ebnten"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3A6oGT7R4jcC", "citedby": "0"}, {"bib": {"title": "Changes in Guideline Trends and Applications in Practice: JNC 2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-1RNHcZo4Y8C", "citedby": "0"}, {"bib": {"title": "Thanks to reviewers-2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:D2lc7i8A8ooC", "citedby": "0"}, {"bib": {"title": "Treatment of diabetic kidney disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:srBcWmd28BQC", "citedby": "0"}, {"bib": {"title": "KH\u00b6 OST N\u00e5NG \u00a7 \u00e9 VITAMIN D3 (25-OH) HUY\u00d5T THANH"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3z7foVzkq2cC", "citedby": "0"}, {"bib": {"title": "Archive for the \u2018Cell Biology, Signaling & Cell Circuits\u2019 Category"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:yptliwwhi3IC", "citedby": "0"}, {"bib": {"title": "Tijdschrift voor Evidence-Based Medicine"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Rh7tE70epTYC", "citedby": "0"}, {"bib": {"title": "Monitoring and Managing Urinary Albumin Excretion"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pa8xeX_DvI4C", "citedby": "0"}, {"bib": {"title": "0091-7435/$-see front matter D 2004 Elsevier Inc. All rights reserved."}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dJuzUO4sCEAC", "citedby": "0"}, {"bib": {"title": "on behalf of the American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension, Council on Cardiovascular and Stroke \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:2PzkjEKH0twC", "citedby": "0"}, {"bib": {"title": "Hypertension after kidney transplantation"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:gToihe7qpOEC", "citedby": "0"}, {"bib": {"title": "Renal Related Endpoints: Are Surrogates Inevitable"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IbYibzvn7iEC", "citedby": "0"}, {"bib": {"title": "Renal Endpoints in CV Prevention Trials"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8-xnCJp56iQC", "citedby": "0"}, {"bib": {"title": "Adverse effects of angiotensin converting enzyme inhibitors and receptor blockers in pregnancy"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7ioeYXKzaWoC", "citedby": "0"}, {"bib": {"title": "Hypertension following erythropoiesis-stimulating agents (ESAs) in chronic kidney disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ujJXPdh5xs4C", "citedby": "0"}, {"bib": {"title": "Mechanisms of glomerular hyperfiltration in diabetes mellitus"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QppYajJO_VYC", "citedby": "0"}, {"bib": {"title": "Antihypertensive therapy and progression of chronic kidney disease: Experimental studies"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:x-Ysmmx-H-kC", "citedby": "0"}, {"bib": {"title": "Patient education: Diabetic kidney disease (Beyond the Basics)"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AU0JsVlt-AkC", "citedby": "0"}, {"bib": {"title": "Secondary factors and progression of chronic kidney disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GpOSJs1ZbLkC", "citedby": "0"}, {"bib": {"title": "AJKD"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:8LfMcXwVQboC", "citedby": "0"}, {"bib": {"title": "The Renal Endothelin System in Health and Disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:LAaCg2gyLagC", "citedby": "0"}, {"bib": {"title": "Resistant Hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:-mAZECE-jN4C", "citedby": "0"}, {"bib": {"title": "Canagliflozina es Eficaz y por lo general Bien Tolerada en Sujetos con Diabetes Mellitus Tipo 2 y Enfermedad Renal Cr\u00f3nica Etapa 3"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:bQkGhl1z2hUC", "citedby": "0"}, {"bib": {"title": "African Lineage, Hypertension Linked"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QbuKDewGlxwC", "citedby": "0"}, {"bib": {"title": "Treatment of Hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:22I2CSi1iVUC", "citedby": "0"}, {"bib": {"title": "Aging and the Kidney"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:aXI_bbQgCfgC", "citedby": "0"}, {"bib": {"title": "Supplemental Figure and Tables Complete Renin-Angiotensin-Aldosterone System (RAAS) Blockade in High Risk Patients: Recent Insights from Renin Blockade Studies"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:mq6pegT_rlEC", "citedby": "0"}, {"bib": {"title": "Anonymous, 1997. Effect of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high normal blood pressure: the \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:x7X4uJ7IbpoC", "citedby": "0"}, {"bib": {"title": "High Sensitivity C-Reactive Protein, Low-Density Cholesterol, and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Acute Coronary Syndrome From the EXAMINE Trial"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZuSUVyMx-TgC", "citedby": "0"}, {"bib": {"title": "Editorial review: Fixed-dose combination and chronic kidney disease progression: which is the best?"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Y6EZgx1ah38C", "citedby": "0"}, {"bib": {"title": "Chronic kidney disease as independent risk factor for cardiovascular disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:04dtUmz_MT0C", "citedby": "0"}, {"bib": {"title": "The Editors are grateful to the following Reviewers, who reviewed manuscripts for Kidney International from July 1, 1994 to February 28, 1995, during the production of volume \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rQcm2j6_ZE8C", "citedby": "0"}, {"bib": {"title": "C ORIGINAL CONTRIBUTIONS"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3K1WWmVGZRgC", "citedby": "0"}, {"bib": {"title": "How to Treat Hypertension in Diabetes in 2017"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Y4-Jr3-UGfkC", "citedby": "0"}, {"bib": {"title": "A., et al.(2010). Paliperidone extended-release in schizoaffective disorder: A randomized, controlled study comparing a flexible dose with placebo in patients treated with and \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:7N_8t4gx0K8C", "citedby": "0"}, {"bib": {"title": "Presenter Disclosure Information"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:JG67p0iyyesC", "citedby": "0"}, {"bib": {"title": "A question of balance: Risks vs. benefits of intensive hemodialysis"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ewB7xoWXMOgC", "citedby": "0"}, {"bib": {"title": "Higher CV event risk with worse kidney function in TECOS, event rate unaffected by DPP4 inhibitor"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:GjXqcohcbckC", "citedby": "0"}, {"bib": {"title": "No increased risk with combination ACE inhibitor and DPP-4 inhibitor in high risk diabetic patients"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:69viAa4lnfgC", "citedby": "0"}, {"bib": {"title": "Effect of antihypertensive treatment on renal function in primary (essential) hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:zJAXUfKFhq0C", "citedby": "0"}, {"bib": {"title": "Hypertensive complications in black patients"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:MRFs4rWx_PcC", "citedby": "0"}, {"bib": {"title": "Renal effects of ACE inhibitors in hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:WmQWPPBrFVcC", "citedby": "0"}, {"bib": {"title": "Our thanks to all those who have helped with this issue of Therapy. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:J3KpcKIlIpsC", "citedby": "0"}, {"bib": {"title": "Archive for 2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:QSG1pgF8pGAC", "citedby": "0"}, {"bib": {"title": "Archive for December, 2013"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:f5lEeLvKxmwC", "citedby": "0"}, {"bib": {"title": "QUIZ PAGE"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lDOOmgye57wC", "citedby": "0"}, {"bib": {"title": "The Editors are grateful to the following Reviewers who reviewed manuscripts for Kidney International from Februaiy 1, 1996 through August 31, 1996, during the production of \u2026"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:5McdzzY_mmwC", "citedby": "0"}, {"bib": {"title": "Aldosterone in Hypertension and Cardiorenal Disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0dtNEdnCFDAC", "citedby": "0"}, {"bib": {"title": "Diabetes & Obesity"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AdGrMoNItN4C", "citedby": "0"}, {"bib": {"title": "2012 ACOG Presidential Initiative"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ZbXHRDTBJTgC", "citedby": "0"}, {"bib": {"title": "Posts Tagged \u2018New England Journal of Medicine\u2019"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SoGhKUJvMTQC", "citedby": "0"}, {"bib": {"title": "Leaders in Pharmaceutical Business Intelligence (LPBI) Group"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oYVvnHz_XzQC", "citedby": "0"}, {"bib": {"title": "ASH Scientific Statement"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Vch7EZszQGgC", "citedby": "0"}, {"bib": {"title": "CLONIDINE APPEARS USEFUL IN TREATING DRUG DEPENDENCE"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Cy13deThEpcC", "citedby": "0"}, {"bib": {"title": "Foreword xv"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:ExNiBuTMO9IC", "citedby": "0"}, {"bib": {"title": "High blood pressure treatment in adults"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M7C5BM2v8n8C", "citedby": "0"}, {"bib": {"title": "ASH Position Article"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pe4chHNxNLUC", "citedby": "0"}, {"bib": {"title": "Rethinking Lower Blood Pressure Goals for Diabetic Patients with Coronary Artery Disease\u2013Findings from the INternational VErapamil SR\u2013Trandolapril STudy (INVEST)"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:dJ_BR67V0s4C", "citedby": "0"}, {"bib": {"title": "Li\u0161\u00ed se r\u016fzn\u00e9 typy antagonist\u016f kalcia sv\u00fdm vlivem na progresi chronick\u00fdch nefropati\u00ed?"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:0urtJCGzaFQC", "citedby": "0"}, {"bib": {"title": "AJKD EDITORIAL BOARD AmericanJournalof"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cx97FdCJQX8C", "citedby": "0"}, {"bib": {"title": "Hypertension and the Kidney: New Avenues for an Improved Management of Hypertension in Renal Diseases"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:9CGX2owmTHMC", "citedby": "0"}, {"bib": {"title": "ANNUAL DATA REPORT NATIONAL KIDNEY FOUNDATION KIDNEY EARLY EVALUATION PROGRAM"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:oYwriLWYh5YC", "citedby": "0"}, {"bib": {"title": "AND ITS"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:uWy0R8PweswC", "citedby": "0"}, {"bib": {"title": "ardiology"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EsrhoZGmrkoC", "citedby": "0"}, {"bib": {"title": "Expert Consensus Document"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:fF_gHTpLxhAC", "citedby": "0"}, {"bib": {"title": "Health Disparities in Kidney Disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1Aeql8wG3wEC", "citedby": "0"}, {"bib": {"title": "Diabetes and Chronic Kidney Disease Work Group Membership"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Lo8V22OuN40C", "citedby": "0"}, {"bib": {"title": "Optimal Care for the Patient with Diabetes Across the Cardiovascular Disease Spectrum"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:tFzHCjejgA0C", "citedby": "0"}, {"bib": {"title": "Faculty Disclosures"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:Yw6v6SrDvuUC", "citedby": "0"}, {"bib": {"title": "Complicati"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:k8to_Y4Q4_EC", "citedby": "0"}, {"bib": {"title": "Pathogenesis and Treatment of Kidney Disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:e0LTWoPxLYMC", "citedby": "0"}, {"bib": {"title": "ardiology"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:SgM-ki2adj0C", "citedby": "0"}, {"bib": {"title": "T~ URNALOF"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4tNoA7Af41QC", "citedby": "0"}, {"bib": {"title": "Patient information: High blood pressure treatment"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:nOiSByfp82kC", "citedby": "0"}, {"bib": {"title": "Comorbid Clustering in Hypertensive African Americans"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cdwqcPQS8ssC", "citedby": "0"}, {"bib": {"title": "When Should I Suspect Resistant Hypertension in My Patients? What Testing Should I Do and What Are the Best Therapies Available for Treatment?"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:IT1MJ6E3JesC", "citedby": "0"}, {"bib": {"title": "Low-renin essential (primary) hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:pRWBApOjXDcC", "citedby": "0"}, {"bib": {"title": "Clinical features, diagnosis, and treatment of hypertensive nephrosclerosis"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:AFXcoJnoRH0C", "citedby": "0"}, {"bib": {"title": "Essential hypertension in women"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:K4-iKlO5MD4C", "citedby": "0"}, {"bib": {"title": "\u041a\u043e\u0440\u0440\u0438\u0433\u0438\u0440\u0443\u0435\u043c\u044b\u0435 \u0444\u0430\u043a\u0442\u043e\u0440\u044b \u0440\u0438\u0441\u043a\u0430 \u0434\u0438\u0430\u0431\u0435\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043d\u0435\u0444\u0440\u043e\u043f\u0430\u0442\u0438\u0438"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:cRMvf6lLvU8C", "citedby": "0"}, {"bib": {"title": "Microalbuminuria and cardiovascular disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:c1AJUTjuCtUC", "citedby": "0"}, {"bib": {"title": "Thiazides versus loop diuretics in treatment of hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:EBV337fEn3EC", "citedby": "0"}, {"bib": {"title": "Albuminuria: risk marker and target for treatment(New York NY, 16-18 May 2004)"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qsWQJNntlusC", "citedby": "0"}, {"bib": {"title": "RISK FACTOR REDUCTION: PHARMACOLOGIC AND NONPHARMACOLOGIC STRATEGIES"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:as0KMg8qHbkC", "citedby": "0"}, {"bib": {"title": "NephSAP"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:BAanoTsO0WEC", "citedby": "0"}, {"bib": {"title": "Who should be screened for renovascular or other causes of secondary hypertension?"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:3A3nxV7CjKIC", "citedby": "0"}, {"bib": {"title": "Blood pressure management in patients with atherosclerotic cardiovascular disease"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:VRfTbSk87rEC", "citedby": "0"}, {"bib": {"title": "N. Kaperonis"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:rLGzs9wiiwIC", "citedby": "0"}, {"bib": {"title": "Comparative Effectiveness in Hypertension: What Can We ACCOMPLISH?"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:M0leSnx2MbUC", "citedby": "0"}, {"bib": {"title": "NSAIDs and acetaminophen: Effects on blood pressure and hypertension"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:1r-w4gtu6w8C", "citedby": "0"}, {"bib": {"title": "George L. Bakris, MD Mark Richardson, PhD"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:qmtmRrLr0tkC", "citedby": "0"}, {"bib": {"title": "Clinical Physiology and Pharmacology of Blood PressureControl"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:4e5Qn2KL_jwC", "citedby": "0"}, {"bib": {"title": "_ Choice of _"}, "source": "citations", "id_citations": "mX8RcWMAAAAJ:lYAcb2jw7qUC", "citedby": "0"}]}